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ABSTRACT 
Pyrroloisoquinoline (n = I) and the pyridoisoquinoline (n = 2) ring systems (2) are 
fOWld to be the major structural motif of the ely lhrina and the protoberberine group of 
alkaloids, respecti vely. We have recognised that suitable bicylic lactams (I) could act as 
precursors, in an intramolecular N-acyliminium ion mediated cycJisation, resulting in a 
stereoselective approach to the core of the erylhrina and protoberberine ring systems. 
,~ no, 
b~ "('OMe 
n = I, 2 OMe 
(I) 
TiCl, 
• 
~-OH 
./ 
MeO (2) OMe 
Access to the tetracycJ ic core of the erylhrinQ alkaloids (3) through the appl ication of N-
acy liminium ion chemistry is well establi shed within our group. I This has been 
demonstrated in a formal asymmetric synthesis of both enantiomers of the ery lhrina 
alkaloid, 3-demethoxyerythratidinone (4),2 and described in this thesis. 
B-\, j p-j 
MeO (3) OMe MeO (4) OMe 
Our investigations have also involved the manipulation of this methodology toward the 
synthesis of the erylhrinQ alkaloid, (-)-erysotrine (5)3 and the protoberberine alkaloid, 
(-)-xylopinine (6).4 
MeO 
MeO 
MeO 
MeO 
MeO\'\" ~ 
(5) 
N 
(6) OMe OMe 
(I) Allin, S. M.; James, S. L. ; Elsegood, M. R. J.; Manin, W. P. J. Org. Chem. 2002, 67, 9464-9467. 
(2) Allin, S. M.; Streetley, G. S .; Slaler, M.; James, S. L.; Manin, W. P. Tetrahedron Lell. 2004, 45, 
5493-5496. 
(3) Tsuda, V.; Hosoi, S.; Kalagir i, N.; Kaneko, C.; Sa no, T. Heterocycles 1992, 33, 497-502. 
(4) Davis, F. A.; Mohanty, P. K. J. Org. Chem. 2002, 67, 1290- 1296. 
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Chapter 1 Introduction 
1.1 Erythrina Alkaloids 
The erylhrina famil y of alkalo ids are a well known class of structurall y interesting and 
biologically acti ve natural products. I The genus erylhrina comprises over I 10 species of 
orange and red-nowered trees, shrubs and herbaceous plants, and the majority are found 
throughout the tropical and subtropical regions o f the world . 1-3 In the flowers, seeds and 
bark of the genus erylhrina, there have been found erythrinan alkaloids, some of which 
possess curare-like and hypnoti c activity. These di scoveries have resulted in their 
alkaloidal ex tracts being used in indigenous fo lk medicines. 1,4-10 
In recent years the study of alkaloids containing the IH-indolo[7a, I-a] isoquinoline ring 
systems (I) have been of considerable interest due to their strong curare-like muscle 
relaxant acti vity which was observed after oral administration. I I 
\ j 
(1) 
This curare-like activity is due to nicotinic cholinergic receptor-blocking properties of 
thi s family of alkaloids.12 The erythrinan skeleton is associated with a number of 
pharmacological effects including sedative, hypotensive, neuromuscular blocking and 
eNS depressant properti es.s-IO Ery lhrina alkaloids possess a unique spirocyclic amine 
stTucture and it is this chemical constituent which is responsible fo r these 
pharmacological acti vities. These pharmacological applications are restricted due to the 
poor selecti vity between the di ffe rent cholinergic sites. However thi s induces a large 
array of physiological responses,12 including paralysis of smooth muscle. 13 Although 
the pharmacologica l applications are of interest, the polycondensed carbon framework 
of erylhrina alka loids means that they are an ideal testing ground for new ring-forming 
methodoJogies,I2,I4 
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1.1.1 Structure of Erythrillu Alkaloids 
Most naturally occurnng erylhrinu alkaloids possess the tetracyclic framework and 
substitution pattern shown in structure (2). 
x 
MeD 
z 
(2) X or Z = 0 ; R = Mc 
This structure possesses a tetrahydroisoquinolinc system (C and D rings), which is fused 
to a perhydroindole subunit (A and B rings). These two subun its share a common 
. d ' b 12- 14 nitrogen atom an a splro car on centre. 
The tetracyclic structure of the ery lhrina alkaloids can be classified into two different 
groups depending on the structure o f the D-ring. Those with an aromatic D-ring, e.g. 3-
demethoxyerythratidinone (3) and those whose D-ring possess an unsaturated lactone, 
e.g. cocculolidine '5 (4) and ~-erythroidine ' 6 (5). 
MeO O~ 15"" N "" o I MeO MeO 
(3) 0 (4) (5) 
Cocculolidine (5) was isolated by Wada and co-workers' ) in 1966 from Cocculus 
Irilobus DC as an insecticide. The first total synthesis of (±)-cocculolidine (5), a non-
aromatic eryli1rina alkaloid, was reported much later by Kitahara and co-workers. 15 
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Alkaloids possessing an aromatic D-ring, can be further classified into two different 
sub-groups based on the structure of AlB-rings: the di enoid type and alkenoid type.18,19 
The alkenoids, e.g. erythratidine (6), contains one double bond in the A-ring whereas 
the dienoids, e.g. erysotrine (7), contain two double bonds in the A-ring and for the B-
o 14 19 
ring. ' 
MeO 
""'" 
MeO 
MeO .# MeO 
MeD""'" 
(6) OH (7) 
1.1.2 Biosynthesis of Erylllrilla Alkaloids 
Many investi gations into the biosynthesis of erylhrina alkaloids have been reported and 
many different sequences been hypothes ised.2o•22 The first proposed biosynthetic 
pathway for the biosynthesis o f thi s unusual class of alka loids was reported by Barton 
and Cohen in 1957 2 1 The general belief, at that time, for the biosynthes is of erylhrina 
alkaloids was based upon the tyros ine-deri ved bisphenethylamine precursor o f type (i). 
HO~ 
~ HN RO 
RO 
Type (i) OH 
There are two possible variations on this approach depending on the order of the two 
coupling processes necessary to fo rm the erythrinan ring system. The first possibility is 
that the tetraphenol (8), where R=H, could be oxidised to an a -quinone (9) . The 
subsequent cycli sation o f the secondary amine would then generate the indole porti on o f 
the skeleton (10). Further ox idati ve coupling of (10) would then form the erylhrinG 
skeleton (11), where R=H (Scheme I). 
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H0X):) HO~ 
1 #' HN 1 HN 
RO RO #' . . 
• 
( 
"'" )' 
RO #' G 
(8) OH (9) 1 0 
HO 
"'" 
HO "'" 
#' 1 N RO 
I"'" 
RO HO #' 
0 OH 
(11 ) Scheme I (10) 
The second possibili ty proceeds via an initial C-C coupling o f the phenyl radicals 
derived from the suitably blocked phenol (12), where R=Me, to give the biphenyl 
deri vative (13). 
H0X):) OX):) H 
"'" 1 #' HN 1 #' HN 
RO MeO MeO 
"'" 
• ~ • 
RO #' MeO 
""" OH 
OH O. (13) 
(12) j 
HO 0 
RO • HO 
""" 
RO MeO 
0 0 
(14) 
Scheme 2 
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The ox idation of the intermediate (13) would generate the diphenoquinone (14) and the 
subsequent cyclisation of the secondary amine would give the required ery lhrina system 
(Scheme 2)23 
Subsequently, Barton and co-workers23 made an important experimental observation 
and di scovered erylhrina alkaloids to be formed by skeletal rearrangement from 
benzy li soquinoline alkaloids. By feeding potential precursors to young E. crisla-galli 
plants they identified (S)-norprotosinomenine (15) as a potential precursor for the 
synthesis of the spirocyclic erylhrina alkaloids23 This intermediate IS a natural 
compound that has since been isolated from the Erylhrina variegala L. (formerly 
Erylhrina lilhosperma BLUM E) fruits by Ghosal and co-workers.24 
Barton and co-workers23 had proposed that a phenolic oxidation of (S)-
norprotosinomenine (15) would yield the tetracyclic dienone (16) . 
HO 
""" 
# NH Me MeO 
• 
""" 
Me # # MeO 
OH OH 
(15) 
j 
HO 
,:? HO ,:? 
MeO ~ reduction MeO ~ 
• 
MeO MeO 
OH OH 
(16) Scheme 3 
Subsequent ring opening and the reduction of the corresponding imine would generate 
the biphenyl intermediate (16) (Scheme 3). This intermediate could then be converted to 
the erythrinan skeleton as shown previously in Scheme 2.25 
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Franck and Teetz26 have, however, since reported that (S)-norreti culine (17), where R = 
Me, and not (S)-norprotosinomenine (IS), as a more reasonable precursor to the 
biosynthesis of ery li1r ina alkaloids. They demonstrated that (S)-norreti culine (17), a 
pos itional isomer of (S)-norprotosinomenine (IS), would on biomimetic grounds be a 
more likely precursor in ery li1rina a lkaloids biosynthesis. 
HO ~ RO ~ 
# # NH MeO H'\"'" HO H'\"'" 
HO ~ R' ~ 
MeO # RO # 
(IS) (17) R= Me, RI = OH 
(18) R=H, RI = H 
Thi s observation was supported Maier and Zen~7 who fed (S)-no rprotosinomenine (IS) 
to Cocculus laurifolius plants and di scovered that there was no incorporation o f (S)-
norprotosinomenine (IS) into any of the Cocculus a lkalo ids thus confirming that (IS) is 
not a precursor to ely li1rina alkaloids. 
Norcoclaurine (18) eR = H) is the precursor to (S)-norreticuline (17) eR = Me) and is 
believed to be derived from tyrosine. Tyros ine supplies both halves o f the ery li1rina 
alka loids, with dopamine (19) being incorporated into the isoquino line unit of (18) onl y. 
H0X)! 
I # NH2 
HO 
(19) 
(Y"CHO 
HO~ 
(20) 
The benzyl part of these precursors are deri ved from 4-hydroxyphenylacetaldehyde (20) 
which in turn is also derived from tyrosine via p-hydroxyphenylpyruvate and 
subsequent decarboxylati on to yield the aldehyde27 
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1.2 Protoberberine Alkaloids 
The protoberberine alkaloids display a broad diversity of physiological and biological 
acti vities and feature predominantly as active components in many traditional medicines 
especial ly in China and other As ian countries28 
The biological acti vi ty associated with these molecules vari es widely but does include: 
anti-inflammatory, antimicrobial, and antil eukemic, as well as antitumor properties2 8.31 
There are also examples of natural berbine alkaloids which have shown hypotensive 
acti vity32 and recently the protoberberine alkalo id (±)-tetrahydropahnatine33 has been 
used as an antipsychoti c drug which has subsequently increased the interest in thi s class 
of compound32 
The protoberberines also play key roles as precursors in the biosynthes is of many 
isoquinoline alkaloids such as rhoeadine, secoberberine and benzo(c] phenanthridine.34 
1.2.1 Structure of J>rotobcrbcrinc Alkaloids 
Protoberberine a lkaloids are a large class of natural products typicall y characteri sed by a 
tetracyclic ring skeleton with an isoquinoline core.30.35 There are approx imately 70 
known species and their structures are based on two forms: the quaternary 
protoberberine salts (21) and the tetrahydroprotoberberines (22) . 
(21) ~ (22) ~ 
Most naturall y occurring protoberberine alkaloids possess the tetracyclic framework 
shown in structure (23) 
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4 5 
3 ~ 6 
I A B N 7 2 #' 8 
14 C 
13 
,p- g 
D I 
12 """ 10 
11 
(23) 
The tetracyclic structure of these alkaloids; contain two aromatic rings (the A- and D-
ring) and the stereochemistry is in the (S) configuration. These molecules display a wide 
range of substitution panerns surrounding the ring skeleton especially around the A- and 
D-rings. Protoberberines commonly bear substituents on the A- and D-rings, at position 
C(2), C(3), and at C(9), and C( l 0) (e.g. (S)-Sinactine (24) and (S)-Corypalmine (25» or 
at C( IO) and C( ll ) (e.g. (S)-Xylopinine (26». The substituents present are usually a 
combination of various alkoxy groups, (e.g. methoxy, methylene-dioxy) (24), or 
hydroxy groups (25) . 
MeO ~ 
#' N MeO H'\'\'" 
(S)-Sinactine (24) 
MeO ~ 
#' N MeO H \\"'" 
,p-
""" 
OMe 
(S)-Xylop inine (26) 
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HO 
MeO 
,p-
""" (S)-Corypalmine (25) 
(S)-Ophiocarpine (27) 
OMe 
OMe 
OMe 
OMe 
In addition to this there is also a stereogenic carbon atom present at C( 14) and 
sometimes there are also alkyl or hydroxyl groups at C(13) (e.g. (S)-Ophiocarpine) 
(27)30.)6 
1.2.2 Biosynthesis of Protobcrbcrinc Alka loids 
The biosynthesis of protoberberine alkaloids has been studied extensively and as a 
result protoberberine biosynthesis is now fully understood37 Although the initial 
precursors to the biosynthesis of pro to berberine alkaloids are very similar to those of the 
eryli1rina alkaloids, subtle changes have led to a significant difference in their 
biosynthetic pathways and these differences will be discussed below. 
It is generally known that the key precursor to the biosynthesis of protoberberine 
alkaloids is (S)-reticuline (2S) (R = Me). 
RO ~ 
#' NR HO H""·'· 
HO ~ 
RO #' (R = Me(2S), H (29» 
Initial investigations into the biosynthesis of protoberberine alkaloids by Battersby and 
co-workers assumed that norlaudanosoline (29) (R = H) was the universal precursor to 
(S)-reticuline (2S)38 This compound was proposed purely on chemical reasoning, 
though subsequent work has now established (S)-norcoclaurine (1S) as the true 
intermediate to (S)-reticuline (2S)39 The biosyntheti c pathway from tyrosine to (S)-
reticuline (2S) has been reported and wi ll be discussed below. The synthesis of (S)-
norcocIaurine (1S) proceeds via an enzyme catalysed condensation of dopamine (19) 
and 4-hydroxyphenylacetaldehyde (20). The preparation of (19) and (20) has been 
discussed previously in Chapter 1.2.2 for the biosynthesis of eryli1rina alkaloids, and 
will not be discussed further. O-Methylation at C6 gave the key intermediate (S)-
coclaurine (30), a known biosynthetic precursor of (S)-reticuline (2S). N-Methylation of 
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(S)-coclaurine (30) followed by hydroxylation at C3' generates intermediate (31). 
Finally, O-methylation at C4' produces the desired precursor, (S)-reticuline (2S), to the 
protoberberine alkaloids (32) . 
It is generall y believed that the biosynthesis of protoberberine alkaloids proceeds as 
illustrated in Scheme 4: 
H0X)! HO ~ MeO 6 ~ 
I #' NH2 #' NH #' NH 
HO (19) HO H"'···· HO H""'" 
• + • 
~ 3' ~ 
lfCHO #' I #' HO HO 4' HO #' (IS) j (30) (20) 
MeO ~ MeO MeO 
#' NMe HO H\\"'" HO H""'" HO H""'" 
.. HO ~ HO ~ ~ 
MeO #' HO #' HO #' 
(2S) (31) 
~ 
MeO ~ 
#' N HO H"" '" 
,:?' OH 
(32) ~ OMe 
Scheme 4 
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1.3_ N-Acyliminium ions 
1.3_1 History of N-Acyliminium Ions 
In the last few decades there have been many advances in classical and modern 
reagents in terms of their chemo-, regio- and stereoselectivity4o Iminium ions are an 
important reacti ve species in organic synthesis for the construction of carbon-carbon 
and carbon-heteroatom bonds41 The well-known Mannich42-45 and Pictet-Spengler46,47 
reactions have been used in organic chemistry for nearly 100 years as they make 
effective use o f the iminium ion. The iminium ion (Mannich reagent) (33) and more 
recently the amidoalkylation reagent (N-acyliminium ion) (34) are well known, though 
the latter reagent was initially developed to al low Mannich type condensations with 
primary amines40 
(33) (34) 
The N-acyliminium ion is a sub-class of iminium ions where the nitrogen atom has been 
acy lated. The electron-attracting properties of the carbonyl group on the nitrogen cause 
the iminium carbon to be more electron-defici ent, thus making the N-acyliminium ion a 
more reactive electrophile than simple N-alkyliminium ions. This has led to a new area 
of versatile electrophilic chemistry known as a -amidoalky lation reactions, which are 
generall y expressed as shown in Scheme 54 1 
\ /R 
C= N (i) R' 11( 
o 
+ H-Nu 
I / R 
------t.~ Nu- C- N R' 
11( 
o 
+ HX 
Nu = nucleophile 
Scheme 5 
Due to thi s new intermediate being more reacti ve it is therefore no surpri se that there 
have been a number of advances in the use of the N-acyliminium ion. The main reason 
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for the continued interest in thi s area is that previously unreacti ve nuc leophiles, e.g. 
unacti vated benzenoids, now react effectively under N-acyliminium ion conditions. The 
N-acy liminium ion is a versatile intermediate though the majori ty of its synthetic 
applications are o f the intermolecular type, however a new dimension in the reactivi ty 
and selecti vity of thi s species has now been developed ror its intramolecul ar reactions, 
especiall y in the synthes is of alka lo id natural products4 0,48-5o 
The first reported use of N-acylimini um ion cyc lisati ons occllITed in the 1950's where it 
was mainly used in the synthesis of isoquino line and indole alkaloids 5 1-56 An earl y 
pioneer in the use of thi s cycli sation methodo logy was Belleau 's erythrinan synthes is 
which affo rded the spi rocyclic lactam (36) via the N-acy liminium ion (35) (Scheme 
6).54 
Ph~O (X1-0 . I #~ & • 
(35) (36) 
Schemc 6 
1.3_2 Mechanistic aspccts 
N-Acyliminium ions can be generated as d iscrete salts, paired with non-nucleophilic 
anions,4o although thi s is rare and restricted to physicochemical studies4o,57-60 In 
syntheti c appl ications, the N-acyliminium ions are almost exclusive ly produced in situ, 
due to their limited stabili ty and high reacti vity. An N-acyliminiurn ion is most likely 
not generated stoichiometri cally in the course 
equilibrium with a covalent adduct (Scheme 7)41 
Scheme 7 
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of the reaction, as it can ex ist in 
The proportion of the ionic form and the covalent form may vary significantly 
depending on the nature of the anion and on experimental conditions 41 The mechanism 
fo r the format ion of the N-acyliminium ion and its subsequent reaction wi th a 
nucleophi le is shown in Scheme 8. 
o OR 
11 1/ 
/ C' N/ C,---
I 
(37) 
Acidic catalyst Nu 
(39) 
Scheme 8 
The N-acyliminium ion species (38) is generated by acid activation of the precursor (37) 
with an acid ic catalyst. The subsequent irreversible reaction with the nucleophile yields 
the product (39). Mechanistically thi s process closely resembles a SN I-type reaction40 
Zaugg and Martin have highlighted two extreme kinetic situations. The rate limiting 
step can be either: 
(i) the formation of the N-acyliminium ion, or 
(ii) the reaction of the N-acyliminium ion with the nucleophile. 
The former case suggests that the more stable N-acyliminium ion leads to a faste r 
reaction whereas in the latter case the opposite is true. In the latter case the reaction of 
an a-hydroxymethyl amide with relati vely unreacti ve aromatic nucleoprules requi res a 
strongly acidic media whereas more reactive aromatic nucleoprules only require mi ld ly 
acidic conditions. In summary, the rate-limiting step is the formation of the N-
acy liminium ion, rather than the electrophili c substitution.4o 
1.3.3 N-Acyliminium v's Iminium ions 
N-acyliminium ions are a significant class of electrophile, which are used in 
carbon-carbon bond forming reactions. Reactions between N-acyliminium ions and 
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nucleophiles (amidoalkylation or Mannich type condensations) are frequentl y used to 
introduce substituents at the a -carbon of an amine6 1 
However, ill the last two decades it has been established that substitution w ith e1 ectron-
attracting groups at the nitrogen makes the Mannich intermediate (40) more reacti ve, as 
it enhances its cationic character. Some examples of these modifi ed cations are the N-
acyl derivative (41) and the carbamate (42) w hich have been widely ex plo ited, although 
other electronegati ve substituents such as the amide (43) and N-tosyl (44) cations have 
also been investi gated. Various cyclic and linear compounds have been distingui shed 
and new variations, e.g. the hydrazonium (45) cations have also been deve loped, 
however thi s depends on the type o f RI , R2 and R3 groups ' present.6 1 
(40) R = H, alky l 
(41) R = acyl 
(42) R = CO,R 
(43) R = CONR2 
(44) R = Tos 
(45) R = NR2 
Due to tbe presence of an electron withdrawing carbonyl group you would expect the N-
acyliminiun ion (41) to be more electron-poor than the Mannich reagent (40), therefo re 
one would expect N-acylimilliun ion to be more reactive than the Mannich reagent. 
Visua l comparison of tbe 13 C NMR spectra of a number of iminium salts (Scheme 9), 
has higbJighted a shift in the imine carbon resonance. For example, substitution of the 
N-methyl (46) with an N-acety l (47) group resulted in a 5 ppm down-fi eld shi ft in the 
imine carbon absorption. The carbamate (48) deri ved N-acyliminium ion exhibits an 
imine carbon absorption at around 190 ppm, thus we can conclude that N-acyliminium 
ions are more electrophilic, i .e. more reacti ve than iminium ions4o,59 
184.6 
Ph ) 0/Me ~N p/ - H 
SbCI~ 
(46) 
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189.7 (0 
Ph ) 0 )ll 
r N, Me 
Ph H 
SbCI~ 
(47) 
Scheme 9 
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152.0 
p~O) 0~ 
r N, OEt 
Ph Et 
SbCI~ 
(48) 
To support this further, it is known that, in intermolecular arylations, Mannich reagents 
onl y react with strongly activated aromatics (e.g. phenyls),43 whereas the equivalent N-
acy liminiun ions can react quite easily even with extTemely poor nucleophjles (e.g . 
nitTobenzene)49.62 The difference in reactivity with respect to intramolecular reactions 
can be illustrated clearly with the olefin cycli sations, used in the synthesis of ery rhrina 
alkaloids. For example, the N-acyliminiun ions (50a, SOb) generated from the keto 
amide (49) gave the cyclised product as expected, however the attempted cyclisation 
with the equivalent iminium ion (51) resulted in an unidentifiable product.63 
(49) (50a) RI = 0, R2= H2 
(SOb) RI = H2' R2 = 0 
Scheme JO 
(51) 
Other groups have investigated other iminium ion systems, such as (52)64 and (53)65 
below and have found that these also fail to undergo cyclisation. 
(53) 
The actual difference in reactivity between the N-acyliminiun ion and the iminium ion is 
not a lways that obvious since one also has to consider that the olefin cyclisation 
reaction is a reversible reaction (Grob fragmentation)66 The products of the N-
acy liminjun-{) Iefin cycli sation are generally stable to the conditions of their formation. 
This is due to the fact that the product is an amide and therefore less susceptible to 
fragmentation in comparison with the product of the iminium-olefin cycli sation, which 
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is an amine. There fore, the usefulness of the N-acyliminiun ion cyclisations in organic 
synthesis may be attributed to their irreversibility40 
1.3.4 The Structure of N-acyliminium Ions 
As previously stated, in Chapter 1.3.2, in synthetic applications, the N-acylimillium ions 
are almost exclusively produced in situ, due to their limited stability and high reacti vity . 
However, there are a few examples where the transient N-acylimillium intermediate 
have been observed in dynamic NMR spectroscopy. 
The structure of an N-acyliminium ion intermediate was first reported by Yamamoto 
and co-workers60 who observed it ' s formation during their work with the 
alkoxycarbamate (54). They reported that when the alkoxycarbamate (54), was cooled 
to -55°C, in the presence of BF3.OMe2, they were able to obtai n a clean I3C NMR 
spectra of the corresponding N-acyliminium ion intermediate (55) (Scheme 11 ). 
(54) 
BF3·0Mez 
CDCI3 
-55°C 
Scheme 11 (55) 
Heaney and Taha67 reported a second example where the bis(homoalkyl) hydroxylactam 
(56) was treated with BF3.OErz, at 25°C, producing the 13C NMR spectra of its 
corresponding N-acy lirninium ion (57). They reported that the N-acylimillium ion (57) 
had reasonable stabili ty for ca. I h before it cyclised slowly producing the fluoro 
compound (58). The reason for the unexpected stability is unclear but the NMR data 
shows a greater electron withdrawing ability of the amide carbonyl in compari son to the 
carbamate (Scheme 12). 
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Phi Phi 
H 
0 N OH o ~ 
BF3·Et20 
• • 
~ 
""" """ 
H 
~ ~ ~ ~ ~ 
(56) (57) (58) 
Scheme 12 
1.3.5 The Stereochemical Outcome of N-acyliminium Ion Cyclisations 
The stereochemical outcome of the N-acyliminium ion cyclisations has received a great 
deal of attention over the years in various synthetic applications and many types of 
reaction have affo rded excellent stereoselecti vity . Lndeed stereochemical control has 
become a feature of N-acyliminium ion cyclisations and can be applied to the 
preparation of a range of enantiomeri call y enriched compounds containing aromatic, 
heterocyclic, alkene, alkyne and keto/enol nucleophiles.4o,6 l ,68 
However, on most occasIOns the favoured stereochemistry has an sen from 
straightforward stereoelectronic reasons, which are similar to the related cationic 1{-
cyclisations.69•71 The most significant control factors are (i) steric approach contro l of 
the nucleophile to the iminium species, (ii) steric interactions involving substituents, 
and, if relevant, (iii) steric interactions in the addition of nuc!eophiles to the new cycli c 
carbocation41 Garcia and co-workers72 have expanded this observation and have 
reported that the stereoselecti vi ty is due to the steri c control caused by substituents 
already present in the ring (Scheme 13), 16,73.75 or along the chain connecting the 1{-
nucleophile, and the ni trogen atom (Scheme 14)76.78 
(i) NaBH4 
• 
o 
(ii) TFA 
Scheme 13 
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Me >--0 
(\ ~NrtMe )Lr 0 Me 
Me 
(i) DIBAL-H 
Scheme 14 
• 
Me 
Me 
H 
Me 
o ) =0 
Me 
The synthesis of ery thrina alkaloids has developed into an important area for 
stereochemical observations. The "Bell eau-type" N-acy liminium ion cyclisation shown 
in Scheme 6 occurs with so le formation of the eis-fused perhydro indole system.56 The 
stereochemical outcome observed during thi s reaction can be explained by steric effects. 
These steric effects ari se due to the orthogonal approach of the 7[-orbital of the arene 
nucleophile to the plane of the iminium ions6 
The alternative "Mondon" cycli sation also proceeds stereoselectively to the eis- fused 
isomer, as illustrated by product (59) (Scheme 15) s 2.79,80 This observation has been 
found to be general for a number of different substrates 9 , 11 ,81-87 
MeO 
MeO 0 
• MeO 
Scheme 15 (59) 
Padwa and co-workers84 have illustrated thi s fact in a more complex system where the 
N-acyliminium ion precursor is converted exclusively to the tetracyclic lactam (60) . In 
thi s case, the Lewis acid assisted ring opening of the isomilnchnone cycloadducts, 
undergo rapid proton loss to produce the product (60) (Scheme \6). 
Meo~ 
~~N 0 
MeO (IS( 
o C0
2
Et 
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MeO 
• MeO 
H 
(60) 
The stereocontrol occurs from the preferenti al addition of the arene nucleophile to the 
stericall y less hindered face of the N-acyliminium ion. 
1.3.6 Synthesis of N-acyliminium ions and their precursors 
The generation of N-acyliminium ions and the synthesis of their precursors were first 
reported by Zaugg and Martin49 in 1965. In subsequent years these methods have been 
refined and new methods have been added, resulting in five principle methods for the 
formation of N-acyliminjum ions, as illustrated in Scheme 17. 
d) Oxidation 
Scheme 17 
Route A: N-Acylation of [mines (Schiff Bases) 
The synthesis o f imines is easily achieved, in high yields, by the condensation of 
aldehydes or ketones with primary amines.88 The acy lation of imines, wi th reactive 
carboxy lic acid deri vatives like acid chlorides or anhydrides, was fLrs t reported by 
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James and Judd89 when they reacted benzalaniline (61) with benzoyl chloride (Scheme 
18). 
~ ...-Ph 
Ph N 
SbCls 
(61) 
H 0 
I 
Ph)lH ..... Ny Ph 4 Ph + 
0 
Scheme 18 
Perhaps the most direct route to N-acyliminium ion species is though acy lation of N-
alkyl or N-ary l irnines. Venkov reported the synthesis of the isoquinoline derivative (65) 
utilising thi s methodology. N-acylation of the imine (62) with benzyl chloride afforded 
the intermediate (63). Lewis acid activation of (63) generated the N-acylirninium 
species (64) which underwent an intramolecular cyclisation producing the isoquinoline 
derivative (65) (Scheme \9). 
~ ...-Ph Ar N 
• 
° CI>-< Bn 
Ar Ph (62) 
(63) j "Cl, 
cy:o I N ~ ' Ph • o H }-Bn )=N~ CI-Ar Ph 
(65) Ar (64) 
Scheme 19 
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Route B: N-Protonation of N-acylimines 
Due to N-acy limines (66) being rather unstable [they tautomeri se rapidly to the 
corresponding enamide (67), Scheme 20], this method for the preparation of N-
acyliminium ions is o f more mechanistic than synthetic interest. 
(66) 
Scheme 20 
(67) 
Wurtbwein and co-workers59 have explored the N-protonation of the imine (68), via 
Lewis acid acti vation, and have reported the synthes is of the N-acy liminium ion spec ies 
(69), as shown in Scheme 2 1. 
HSbCI6 Ph 0 A <tljl 
Ph N Me 
I 
H (69) 
Scheme 21 
+ SbClij 
The second example, reported by Krow and co-workers,90 illustrates that the treatment 
of the N-acy limine (70) with fluorosulfonic acid-antimony pentafluoride ("magic acid") 
generates the species (71) via N-protonation (Scheme 22). 
S02 
(70) 
Schcmc22 
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o 
11 <tl~ 
Ph/'---N:P CCI3 I 
H 
(71) 
Route C: Electrophilic Addition to Enamidcs 
Lenz9 1 reported the synthesis of the enamide (73), via the acylation of an imine (72), 
usi ng ei ther an acid chloride or anhydride, followed by the elimination of He !. The 
synthesis of the N-acyliminium ion (74) was achieved via the protonati on of the 
enamide (Scheme 23). 
-Hel 
(72) 
Scheme 23 (74) 
Route D: Oxidation of Amidcs 
This method revolves around the removal of a hydride from the a-carbon of an amide, 
which leads to the formal synthesis of the N-acy liminium ion. Many research groups 
have reported that electrochemical methods are the most feas ible techniques to perform 
thi s ty pe of transformation92-94 
Othman and co-workers95 have reported a noteworthy example where the indo lizidine 
(75) was oxidised with 2,3-dichloro-5,6-dicyano- 1 ,4-benzoquinone (DDQ) in methanol 
and gave the expected methoxy de rivati ve (77) presumably via the N-acy liminium ion 
(76) (Scheme 24). 
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o 
OOQ 
• • 
MeOH 
(75) (76) (77) 
Scheme 24 
The mechanism for this electrochemical oxidation first involves the removal of an 
electron from the lone pair of the nitrogen atom to generate the cation radical (7S). This 
is then followed by the removal of a proton and another electron affording the N-
acyliminium ion (79) (Scheme 25). 
e 
-e 
(7S) 
Scheme 25 
<±l 
-H e -e 
1
(79) 
CH30H 
o OMe 
R)lNkR3 
I R4 
R2 
(SO) 
This electrochemical oxidation is conducted in the presence of a nuc1eophile, in this 
case methanol, which traps the N-acylirninium ion (79) generated to give u-
methoxyalkyl amide (SO). This reaction works well for a wide variety of amides and 
carbamates and has since been reviewed comprehensively (Scheme 25).48 
Introduction - 23-
Route E: Heterolysis of Amides 
Heterolysis of a-substituted amides is the most frequently used method for the 
formation of synthetically useful N-acyliminium ions. In the vast majority of cases the 
leaving group (R) is an oxygen substituent, however there are many examples where R 
is either a halogen, a nitrogen, a sulfur or a phosphorus substituent. The synthesis of the 
corresponding N-acyliminium ion (82) from a-oxyalkyl amide (81), where R is alkyl or 
hydrogen, is normally achieved by acid activation with either a Bronsted or Lewis acid 
(Scheme 26). However in the case where R is an acetyl or methanesulfonyl, no acidic 
catalysis was required.40 
o R3 
R)l~~R" acid or heat 
I e 
R2 OR 
(81) Scheme 26 (82) 
1.4 Chiral Non-racemic Lactams in Synthesis 
Meyers has extensively employed chiral, non-racemic bicyclic lactams for the synthesis 
of optically pure alkaloids and carbocycles.96,97 Two general methods have been 
developed for the construction of the bicyclic lactam system and they both involve a 
condensation of an optically pure amino alcohol and a dicarbonyl compound .97 
The first method utilises a cyclodehydration process which takes an optically pure 
alcohol (83) and a y-keto-acid (84) under Dean Stark conditions in order to generate a 
lactam such as (85) (Scheme 27). 
~OH 0 ~ CA + ~OH -H2O R n .. l n ICAI 0 ROJ NH2 
(83) (84) (85) 
CA = Chiral Auxiliary Scheme 27 n = 1. 2 
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Meyers and Wanner98 have utilised this strategy in their synthesis of the bicyclic lactam 
(86). In this example they took the chiral auxiliary, (S)-Valinol, and performed a 
cyclodehydration with levulinic acid generating the bicyclic lactam (86) as a single 
diastereomer (Scheme 28). 
~OH 
o t? + 
o 
Scheme 28 
(86) 
The second method developed to synthesise these chiral bicyclic lactams is related to 
the extensive work by Speckamp40.61 involving N-acyliminium species. Condensation of 
an optically pure amino alcohol (87) with the cyclic anhydride (88) or dicarboxylic acid 
(89) produced the imide (90), which on the addition of a hydride source generated the 
ethoxylactam (91). This intermediate was subjected to acidic conditions resulting in ring 
closure via the N-acyliminium species (92), furnishing the bicyclic lactam (93) (Scheme 
29).97.99 
~H 
NH2 
(87) 
Introduction 
~ H~ ~ o or HO 0(88) 0 (89) NaBH4 ~ EtOH ----'----. cR-o HO 
(90) 
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H 0 
(93) 
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OE! OH 
(91) 
1 
H+ 
-OEt 
cl{ 
OH 
(82) 
1.5 Applications of the Meyers bicyclic lactam substrates in Synthesis 
Introduction 
The use of chiral, nonracemic bicyclic lactams; has provided and continues to provide 
access to a wide variety of natural and unnatural carbocyclic products in high 
enantiomeric purity.96 
The versatility of the lactam template has led to the development of neW methods for 
the construction of heterocycles. In addition to the cyclopentenone, cyclohexenone (94) 
and hexahydroindenone (95) systems, products derived from the use of chiral bicyclic 
lactams now include pyrrolidines (96) and (97), pyrrolidinones (98), piperidines (99) 
and (100), pyrroloisoquinoline (101) (n = 1), pyridoisoquinoline (101) (n = 2) and 
tetrahydroisoquinoline (102) (Scheme 30). 
Meo~ 
~NH MeO 
(102) (96) 
MeO 
M 
(101) 
Scheme 30 n = 0,1 
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These favourable properties make chiral bicyclic lactams highly adaptable templates for 
asymmetric synthesis.96 
1.5.1 Synthesis of tetrahydroisoquinolines 
Routes towards the synthesis of naturally occurring tetrahydroisoquinoline alkaloids, 
such as salsoIidine (107) have recently been reviewed extensively in the Iiterature.3s 
MeyerslOO has reported an asymmetric synthesis of the simple isoquinoIine alkaloid, (-)-
salsoIidine (107). The synthesis of the required crural bicyclic lactam (104) was 
achieved by the condensation of the known acid (103) with (S)-phenylglycinol. 
( S)-phenylglycinol 
CXXOMe N I Ho{ ~ ~ OMe 
Ph " 
(106) 
~OMe 
HN~ ! OMe 
(-)-salsolidine (107) 
.. 
OMe 
~ OMe 
(104) 
o 
1 Red-AI 
O~OMe 
)l~ 
HOT ~ ~ OMe 
Ph " 
(105) 
Scheme 31 
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Treatment of (104) with sodium bis(methoxyethoxy)aluminium hydride (Red-Al)® 
generated the ring-opened lactam (105) which upon additional reduction with lithium 
aluminium hydride gave the N-benzyl substituted isoquinoline (106). Reductive 
removal of the N-benzyl group, with palladium on charcoal, afforded the natural 
product, (-)-salsolidine (107) (Scheme 31). 
1.5.2 Synthesis of substituted pyrroloisoquinolines 
Katritzky noted that there are three major routes towards the synthesis of the 
pyrroloisoquinoline template (108) (Scheme 32).101 Route (A) revolves around the 
formation of the intermediate (109). This intermediate (109) is obtained by a 1,3-dipolar 
cycloaddition of the nitrones (110) with an electron deficient ethylenes102 or 
acetylenes. lo3 Reduction of this intermediate (109) would then generate the desired 
pyrroloisoquinoline template (108) via the formation of the C3-N4 bond. Route (B) 
revolves around an intramolecular condensation of (111), forming the C3-N4 bond, with 
the eliminiation ofH20.104 
I B 
Y 0 ~U)O (108) 
(109) (112) (J 
C02R B ~ l-,~ or acetylenes 
I 0) ()) 
.&' gN"'08 
I~ 
.&' NH % 
(110) (111) C02H 
(113)1 a b c d 
OH Eta PhS R ArCH= 
Scheme 32 
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Route (C) is synthetically the most important route with regards to the synthesis of the 
pyrroloisoquinoline template (108). This route revolves around the formation of the 
CIOa-CIOb bond via an N-acyliminium ion cyclisation. The N-acyliminium ion species 
(112) is generated by the protonation of the C-C double bond of an enamide (113a),105 
or by the elimination ofa hydroxy group (1l3b),87,106.107 ethoxy group (113c),77,78.108 or 
alternatively a phenylthio group (l13d).I09 
Katritzky and co-workers 101 have reported the synthesis of the pyrroloisoquinoline 
(118) via an N-acyliminium ion cyc1isation. The pyrroloisoquinoline (118) was prepared 
via an intermolecular condensation of 3,4-dimethoxyphenethylamine (114) with the 
furan derivative (115) and benzotriazole in refluxing acetic acid. The expected N-
acyliminium ion precursor (116) was not observed as the reaction cyclised directly to 
the desired product presumably via the N-acyliminium ion intermediate (117) (Scheme 
33). 
Me~ 
,,~ NH2 MeO (114) 
+ 
.. 
M)Q) 
I # N 0 M Bt--(Y 
(116) 
j TiCI4 -B! -
8tH 
AcOH 
Me0--Q--oMe 
(115) 
MeD 
-H' [«] • MeO 
(118) (117) 
Scheme 33 
PadwallO,lll has recently described the preparation of the bicyclic lactam (101) via a 
thionium ion promoted Mannich cyc1isation. The thioacetal (119) was treated with 2 
equiv of dimethyl(methylthio )sulfonium tetrafluoroborate (DMTSF) in DCM producing 
the desired product in a one-pot cascade sequence. It is believed that the addition of 
DMTSF results in a methylthiolation of one of the thiophenyl groups which dissociates 
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to generate thioniurn ion (120). The attack of the amido nitrogen atom onto the 
cationic centre produced the phenylthio-substituted lactam (121) which cyclised 
with the addition of further DMTSF to afford the desired bicyclic lactam ring system 
via the N-acyliminiurn ion species (122) (Scheme 34). 
(!) 
£SR £SR n SR 
If):oMe DMTSF n If):oMe o NH I 
.. NH I 
# OMe # OMe 
(119) (120) j 
OMe 
~ OMe 
r,;SR Q n LDOMe o N I .. o (!)~ .. 
--
# OMe 
0 
(101) (n = 1,2) (122) (121) 
R = Ph, Et 
Scheme 34 
Li and YangIl2 have described a novel base-mediated 3,4-dihydroisoquinoline 
annulation reaction with a ro-bromo-propionate derivative leading to the synthesis of 
isoquinoline heterocyc1es. The 3,4-dihydroisoquinoline derivative (123) and the 
alkylating component, ethyl 3-bromopropionate (124) were reacted with 2 equiv of 
KO'Bu in dry DMF and this produced the desired 5-membered product in a 75% yield. 
It was believed that the initial a-alkylation intermediate (i) may undergo an 
intramolecular N-acylation through an intermediary imino benzylic anion (ii), generated 
by the deprotonation of (i). Mesomerism of (ii) followed by a 5-exo-trig ring closure of 
the corresponding enaminate led to the product (125) (Scheme 35). 
MeO 
MeO 
(126) 
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The annulated isoquinoline derivative (125) can be hydrogenated under standard 
catalytic hydrogenation conditions to the desired pyrroloisoquinoline template (126). 
MeOx::Q 
. I #' ""N 
MeO 
(123) C02Et 
Me 
"'" "'" I 
#' Me 0 
Et02C 
(125) 
-EtO' 
DMF,-600C 
MeO MeO e 
"'" OEt .. OEt 
MeO #' MeO 0 0 
(i) (ii) 
Scheme 35 
Kaluza and co-workers1l3 have reported a diastereoselective synthesis of highly 
substituted pyrroloisoquinoline derivatives from L-tartaric acid. The key intermediate in 
their synthesis was the imide (127); synthesised previously by Lee and co-workers1l4 
from L-tartaric acid. Silylation of (127) under standard conditions (TMS-CVpyridine) 
gave the bis-trimethylsilyl ether (128). The subsequent addition of the required 
Grignard reagent produced the desired hydroxyl lactarn (129). Their initial attempts to 
cyc1ise to the desired dihydroxypyrroloisoquinoline (130), using TF A in refluxing 
DCM, were successful but they only isolated the product in trace amounts. In order to 
improve the synthesis of dihydroxypyrroloisoquinoline (130) they instead prepared the 
triacetate (131). Treatmant of (129) with acetic anhydride (4 equiv) and DMAP, in 
acetonitrile, produced the triacetate (131) and a smali trace of the ring opened by-
product. Cyc1isation of the crude acetate mixture with BfJ,Et20 (4 equiv) gave the 
hexahydropyrroloisoquinoline (132) as a mixture of diastereomers (3: 1 ratio). 
Conversion to the target dihydroxypyrroloisoquinoline (130) was then achieved upon 
treatment with NaOMe in anhydrous MeOH. Separation, using flash column 
Introduction - 31 -
chromatography, resulted in a diastereoselective synthesis of both dihydroxy derivatives 
(Scheme 36). 
HO 0 H~y TMSCI, Py TMSO 0 ~y 
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• 0 
AcOII "'" f OMe 
(132) (131) 
OMe 
R = Ph, i-Pr, c-hexyl, vinyl, allyl 
Scheme 36 
1.5.3 Synthesis of substituted pyridoisoquinolines 
Bosch and co-workersll5 have reported an enantioselective approach to the synthesis of 
substituted benzo[a]quinolizidine alkaloids utilising a stereoselective cycIocondensation 
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reaction. The cycIocondensation of the racemic oxodiester (134) with 
dimethoxyphenylalaninol (133a) in refluxing toluene under Dean-Stark conditions gave 
a mixture of stereoisomeric lactams, from which the enantiopure isomer (135a) was 
isolated in 60% yield. The subsequent cyclisation of (135a) with BfJ-Et20 led to the 
desire benzo[a]quinolizidine (136a) in 40% yield (Scheme 37). 
Me02)J;0 
X 
M 
X 
MeO ~ Me02C (134) M OH .. 
# NH2 Toluene 
. .. "',,,\ 
MeO (135) (133) (a)X=H,H Me02C 
(b)X=O I BF,QE" 
DCM 
X 
MeO 
OH 
0 
MeO 
i 
'
C02Me 
Scheme 37 (136) 
They also observed that when the reaction was performed instead with the 
corresponding amimo acid (133b), with the oxodiester (134), they found that the 
synthesis of the bicyclic lactam (135b) was less efficient (15% yield). However, the 
corresponding cyclisation with BF 3.Et20 provided the benzo[ a ]quinolizidine (136b) in 
82% yield (Scheme 37). 
Lee and co-workers 74 have described a chiral synthesis of trans-l-
aminobenzo[a]quinolizidine from L-pyroglutamic acid through a stereoselective N-
acyliminium ion cyclisation. The amidoester (137) was synthesised in three steps from 
the commercially available L-pyroglutamic acid. 74,116 This was converted to the hydroxy 
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lactam (138) via the partial reduction of the methyl ester (137) with DIBAL-H 
producing an aldehyde in situ which was trapped intramolecularly by the amide group 
generating (138). The hydroxyllactam (138) was then treated with BF3.Et20 affording 
the cyciisation product (139) in 66% yield. The cyclisation product was produced as a 
single diastereomer due to the diastereoselective attack of the 3,4-demethoxyphenyl ring 
onto the more accessible side opposite the NHCbz group. The Cbz protecting group was 
then removed by catalytic hydrogenation over palladium on charcoal in MeOH 
furnishing the desired product (140) (Scheme 38). 
Me~jjN 0 Meo~O 
Me ~ 
NHCbz 
• 
Me0:D) 
1# N 0 
Me ~"y CbZ~~'''''''V 
(138) 
DtBAL-H 
(137) I BF,.E," 
MeO MeO 
"'>::: 
0 H2• PdlC I # 0 .. MeO H\\"'" 
H2N"""> CbzHN""'" 
(140) (139) 
Scheme 38 
1.6 Applications of N-acyliminium ions 
1.6.1 Intramolecular amidoalkylations with aromatic 1t-nucleophiles 
Von Braun and co-workersll7 described the first intramolecular amidoalkylations while 
investigating the ring closure of the sulfonamide glycine derivatives (141). This reaction 
proceeded via the fonnation of the corresponding acid chloride followed by the 
subsequent AICl) - catalysed decarbonylation (Scheme 39). 
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(141) Scheme 39 
The intramolecular reaction of the N-acyliminium ion has received considerable 
attention in organic chemistry, especially with respect to the synthesis of alkaloid 
natural products, even though the first intramolecular amidoalkylation did not occur 
until more than 20 years after the first reported intermolecular amidoalkylations by 
Tschemiacll8 and EinhomY9 Several isolated examples have occurred since this 
development, although the m!\ior breakthough in the synthetic application of the 
intramolecular amidoalkylation occurred in the early 1950's when BelIeau56 and 
Mondon52,8o applied this reaction to the synthesis of alkaloids. 
Einhomll9 in 1905 reported the first quenching of an N-acyliminium ion by an electron 
rich moiety contained within the same molecule (Scheme 40). The intramolecular 
alkene unit of (142) acts as a 1t-nucleophile thus generating the cyclised product (143). 
0 0 q qAR ~) R -H+ R ~ R R • R ~ R 
R 
R R 
(142) 
Scheme 40 
(143) 
It is therefore no surprise that subsequent intramolecular cyclisation reactions of this 
type have employed the use of electron rich aromatic rings as 1t-nucleophiles. Due the 
reactive nature of the benzene ring numerous polycyclic ring systems and natural 
product systems have been accessed via intramolecular amidoalkylation with 1t-
nucleophiles. 
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1.6.2 Benzenoid n-nucleophiles 
The earliest use of benzenoid It-nuc1eophiles in N-acyliminiwn ion cyclisations 
occurred in the 1950's where the methodology was used in the syntheses of erythrina 
isoquinoline alkaloids by Mondon and Belleau.52-56,80 
N-Acyliminiwn cyclisations have been widely applied to aromatic nucleophiles, and 
subsequently have been reported and reviewed many times in the 
literature_40,41,49,50,61,62,68 The increased reactivity of the N-acyliminiwn ion in 
comparison to the Mannich reagent allows cyclisations to occur even with unactivated 
benzenoids, which under Mannich reagent conditions would be relatively unreactive.41 
This was demonstrated by Belleau who reported the advantages of the N-acyliminiwn 
ion variant of the Mannich reagent in the synthesis of the erythrinane (145) (Scheme 
41). 
Me 
(a) )( .. M 
(144) 
MeO """ 0 
1.# HN 
Me 
PPA 
.. MeO 
100°C 
Scheme 41 
(145) 
As shown in Scheme 41 a, the standard iminiwn ion failed to the cyclise under "various 
conditions" to the erythrinan skeleton (144) unlike the more reactive N-acyliminiwn ion 
(Scheme 41b). The Belleau-type56 (Scheme 6 & 41b) and Mondon_type79,80 (Scheme 
15) modes of cyclisation differ only by the position of the lactam carbonyl but both 
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cyclisations solely fonn the eis-fused perhydroindole configuration. These two routes 
work smoothly with methoxy-activated or unactivated benzene rings and tolerate 
various substituents on the aliphatic skeleton. 
The benzene ring has been used in many intramolecular additions of 7t-nucleophiles to 
N-acyliminium ion centres especially in the synthesis of isoquinoline and erythrina 
alkaloids.41 However, many simpler examples, where benzene has acted as a 7t-
nucieophile in N-acyliminium ion cyclisations, have been reported and will be discussed 
below. 
Allin and co-workers'·8 have reported a novel stereoselective approach to the erythrina 
ring system via an asymmetric, intramolecular N-acyliminium mediated cyciisation. 
Treatment of the bicyclic lactarn (146) with the Lewis acid TiCI4• ring opens the N, 0-
acetal, producing the target pyrroloisoquinoline ring system (147) via the N-
acyliminium ion intennediate (148) (Scheme 42). 
P\ 
t1 »0 
(146 ) 
DCM 
OH 
° 
(147) (148) 
Scheme 42 
This methodology has since been developed and applied to the synthesis of more 
functionalised pyrroloisoquinoline derivatives (149). In the same publication Ailing also 
demonstrated the efficient removal of the pendant hydroxymethyl auxiliary generating 
the pyrroloisoquinoline template (150). 
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This methodology has since been expanded further and has been applied to our formal 
synthesis of the erythrina alkaloid, 3-demethoxyerythratidinone (3), which will be 
discussed in detail in Chapter 2.1. 
Allin and co_workers120 have also reported a two step synthesis of chiral ring-fused 
isoindolinone derivatives with high levels of diastereoselectivity. Their strategy 
required the synthesis of diastereoisomerically pure tricyclic lactam (151), prepared 
from the enantiomerically pure amino alcohol substrate, (S)-phenylalaninol as outlined 
in Scheme 43.121 
0:'" ~ ~ 
#' CHO __ H.::...2N __ O_H_.~ l?<:JPh 
Toluene 
+ 
(151) 
TMSOTf 
DCM 
o 
0) ,s,-OH 
I #' 8-/ \ 
~ 
~ j 
Scheme 43 
Cyclisation to the desired isoindolinone ring system was achieved via the Lewis acid 
induced cyclisation producing the desired product as a mixture of diastereomers. A 
number of Lewis acids were investigated, however extremely high level of 
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diastereoselectivity ~49:1) were achieved when TMSOTfwas used as the Lewis acid 
activator. 
1.6.3 The indole ring as a 7t-nucleophile 
The use of the N-acyliminium ion cyclisations has been applied to the total synthesis of 
many indole alkaloids. Wawzonek and Mamardl22 have utilised indole as a 7t-
nucIeophile in their preparation of tetrahydro[ 12H]pyrroloazepinoindoles. In this 
synthesis the key intermediate is the hydroxylactarn (152). Acid activation of this 
intermediate generates the N-acyliminium ion (153), thus providing access to this 
tetracycIic product (154), via an intramolecular cyclisation (Scheme 44). 
H 
o 3t 
H Hel 
MeOH 
(152) (153) (154) 
Scheme 44 
Heaney and co-workerl23 have reported a scandium and copper triflate mediated N-
acyliminium ion cycIisation reaction where they utilised indole as a 7t-nucIeophile. In 
this case the Il-methoxyisoindolone (155) was reacted with 10 mol% of SC(OTf)3, in 
DCM, producing the ~-carboline derivative (156) (Scheme 45). 
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Scheme 45 
They have reported that the reaction proceeds via the fonnation of the N-acyliminium 
ion intennediate. This group has since developed this methodology and has synthesised 
other p-carboline derivatives such as (157) and (158).124 
Me 
Me 
(157) (158) 
Allin and co-workers have reported a number of N-acyliminium ion cyclisations where 
indole has been used a 1t-nuc1eophile. Their strategy involves the cyclisation of an 
aromatic substituent onto N-acyliminium intennediates as the key ring-forming step.l25-
127 Their approach required the synthesis of the bicyclic lactarn (159) as precursor to the 
indolizino[8,7-b]indole system (160). 
NH2 
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(160) 
The synthesis of the required indolizino[8,7-b]indole system was achieved by taking the 
amino alcohol derivative of (S)-tryptophan and reacting it with an appropriate keto-acid, 
under Dean-Stark conditions in toluene, producing the desired product as a single 
diastereoisomer (160) (Scheme 46). The expected bicylic lactarn (159) was also isolated 
though only in 3% yield.126 
This methodology has also allowed access to the six-membered lactarn homologue 
(161) which has been cyclised to the corresponding indolo[2,3-a]quinolizine ring 
system (162). This result was highly desirable and has opened up access to a wide 
range of indole targets, including deplancheine (163), geissoschizine (164) and 
vellosimine (165). 
On this occasion the synthesis of the indolo[2,3-a]quinolizine ring system (162) was 
achieved via the expected bicylic lactarn (161). The synthesis of the lactarn was 
achieved by taking the amino alcohol derivative of (S)-tryptophan and reacting it with 
methyl 5-oxopentanoate, under Dean-Stark conditions in toluene, producing the bicyclic 
lactarn as a mixture of separable diastereoisomers (161). Treatment with 2M HCI in 
ethanol cyclised the bicyclic lactarn (161) and produced the desired indolo[2,3-
a]quinolizine (162) product as a single diastereoisomer (Scheme 47).125 
o )IN-stD 40 N 
H H 
• 
2MHCI 
EtOH 
(161) (162) 
Scheme 47 
Allin and co-workers have since developed this methodology and have reported the 
total synthesis of (R) and (S)-deplancheine (163).127 Current work within the Allin 
group is investigating access to more complex targets such as geissoschizine (164), 
vellosimine (165) and the highly functionalised template (166) which has been shown to 
act as a ~-turn mimic and display high binding affinity and selectivity for CCK1 
receptors.126,128 
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1.6.4 Heterocyclic It-nucIeophiles 
(164) OH 
(166) 
The use of heterocyclic nucleophiles in N-acyliminium ion cyclisations generally 
mirrors the reactions of benzenoid nucleophiles. It-rich heterocycles, e.g. furans, 
pyrroles and indoles, have similar reactivities to phenyl rings bearing one or two 
methoxy substituents. The reactivity of It-deficient heterocycles, e.g. pyridine, are 
however significantly weaker in comparison.41 
Furan and Thiophene 
There are several examples of N-acyliminium ion cyclisations with furan or thiophene 
nucleophiles, though this area is less developed than that of benzenoid nucleophiles. It 
was found that thiophene nucleophiles are more reactive than phenyl nucleophiles when 
the a-position is involved. However, significant regiochemical issues are raised when 
furans and thiophenes are linked to N-acyliminium segments by the 3-position.41 
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Kano and co-workersl29 have illustrated the ease at which these cyclisations proceed, as 
shown by the treatment of the thiazolidin-2-one (167) with trifluoroacetic acid 
producing the corresponding product (168) containing a seven-membered-ring (Scheme 
48). 
Me q Pd TFA S (CH2h • ~ N H~~ Me ;ro 
>=0 
S 
(167) Scheme 48 (168) 
Decroix and co_workers95,130 have reported an N-acyliminium ion cyclisation reaction 
utilising the thiophene ring in their synthesis of compound (171), a heterocyclic 
analogue of the isoquinoline alkaloid nuevamine (172). The preparation of the 
hydroxylactams (170) was achieved from the phthalimide derivative (169) by either 
reduction, or by the addition of a Grignard reagent onto the imide (R = Et, Ph). 
Subsequent treatment with TFA (or SOCh) resulted in ring closure and produced the 
expected indolizidinones (171) in good yields (Scheme 49). 
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The use of furan 1t-nucleophiles in N-acyliminium ion cyclisations has been investigated 
extensively by Tanis and co-workers. 13 I They have reported that products obtained from 
furan-based N-acyliminium ion cyclisations depend upon a number of factors: the 
position of the furan tether (2 v's 3-position), the tether length, and the substituent on 
the furan 5-position. They also observed that furans linked at the 3-position can cyclise 
to either six- or seven-membered rings, however, furans linked at the 2-positions can 
only cyclise to the six-membered rings. This reflects the lower nucIeophilicity of the 
furan ~-position relative to the ll-position. l3l 
Tanis and co-workersl3l have envisaged that a number of linearly-fused (173), 
spirocyclic (174) and bridged aza-cycIes (175) could be synthesised by simply altering 
the placement of the furan tether on the N-acyliminium ion precursor as shown in 
Scheme 50. 
o 
~ 
o 
n OH 
Scheme 50 
o 
NH 
) n 
(173) 
(174) 
(175) 
This flexibility can provide access to a number of product systems such as (±)-
epilupinine (176) and (±)-perhydrohistrionicotoxin (177). 
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(176 (177) 
Padwa and co-workers132 have also reported an electrophile-induced cyclisation of a 
tethered furan ring as a novel strategy of synthesising non-aromatic erythroidine 
alkaloids. Their approach was to take a furanyl substituted hexahydroindolinone (178) 
and perform an acid induced cyclisation to generate the tetracyclic substituted lactarn 
(179) (Scheme 51). 
0 m o I H+ ~j 
""" • Me Me 
(178) (179) 
Scheme SI 
Pyrroles, Imidazoles and Pyridines 
The use of pyrroles as 1t-nucleophiles in N-acyliminium ion cyclisation reactions has 
been reported in the literature by a number of different groupS.77,133.136 
Maryanoff and co-workers 77 have reported that N-substituted pyrroles which are linked 
to the N-acyliminium ion at the a-position can cyclise cleanly at the P-position 
producing the corresponding pyrrole lactarns (180a,b). These lactarns were generated by 
acid induced N-acyliminium ion cyclisation of the reduced imide producing the desired 
lactarns as a mixture of diastereomers (ratio 74:26) (Scheme 52). 
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However, more pyrrole cyclisations have been reported where the N-acyIiminium ion is 
linked to the pyrrole nitrogen. This has led to a number of cycIisations at the a-position 
leading to the generation of five_,134 six_,135 seven_,135,136 and even eight-membered 
rings. m The generation of an eight-membered ring is unusual in N-acyIiminium ion 
chemistry and suggest the high reactivity of the pyrrole nucleus may play an important 
role in this reaction.41 
Netchitailo and co-worker134 have reported a pyrrole cyclisation which generates a new 
five-membered ring from the hydroxyisoindole (181) using formic acid (Scheme 53). 
o 
.. 
3 days 
(181) 
Scheme 53 
Park and co-workers137 have reported an N-acyliminium ion cycIisation, with an 
imidazole 7t-nucIeophile, leading to the total synthesis of the natural products (±)-
glochidine (185) and (±)-glochidicine (186). The Grignard reaction of the imide (182) 
with n-hexylmagnesium bromide produced a mixture of the hydroxylactam (183) and 
the ring opened acyIic keto amide (184). The crude mixture was then cyclised in 
refluxing toluene affording (±)-glochidine (185). Consequently, refluxing the crude 
mixture with a catalytic amount of p-TSA in xylene yielded (±)-glochidicine (186) as 
the sole product (Scheme 54). 
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\ cat. p-TSA 
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Scheme 54 
As mentioned previously pyridine is an electron-deficient heterocycle, thus one would 
expect it to be unreactive in N-acyliminium ion cyclisations. However, activated 
pyrldine rings with 2-methoxy substitution can cyclise under these N-acyliminium ion 
conditions. Padwa and Brodneyl38 have utilised this method in the synthesis of the 
tetracyclic product (188). The cyclisation of the activated pyridine ring (187), using p-
TSA in benzene resulted in the desired product (Scheme 55).138 
oc;~M" MeO o p-TSA • Benzene 
OH (187) Scheme 55 (188) 
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1.7 Synthetic approaches for the construction of erythrina alkaloids 
Pioneering work by BelIeau,54 Mondon and co-workers8o and Prelog and co-workers139 
has shown that there are numerous synthetic approaches for the construction of the 
erythrina ring system. These alkaloids have been synthesised in a racemic form by three 
different methods:85 
(i) Diels-Alder route,13 
(ii) intramolecular cyc1isation route,11 
(iii) photochemical route.140 
If one takes the fInal step of the bond formation into consideration, the methods for the 
building up the erythrinan ring system can be loosely classifIed into seven different 
reaction types: 141 
(i) C-ring formation with the CS quaternary centre being formed by 
intramolecular cyclisation 
Early work by BelIeau 54 and Mondon 80 has paved the way for many synthetic 
approaches based around the interception of the C5 centred iminium ion by an aromatic 
nucleus (189)14 
Me~(l) 
.wV& 
X 
(189) 
Since the work of BelIeau55 the intramolecular cyclisation of an aromatic group to an N-
acyliminium ion compound has been widely investigated, by many groups,85,86,142 and 
has lead to various modifIcations of this methodology. Work reported by Mondon 80 has 
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demonstrated that cyclisations occur more readily when the lactam carbonyl is placed in 
the potential 5-membered ring instead of the 6-membered ring. The initial approaches 
have utilised the acylenamine of the endo (5-6) double bond (B), which formed the N-
acyliminium ion (A) after the addition of acid. However, Tsuda and co-workersll have 
proposed that the protonation of the double bond of the acylenamine, where the double 
bond was in the exo position would be more favourable than an endo position, due to 
stereo-electronic reasons. Thus the cycIisation of the acylenamine (C) to the erythrinan 
skeleton (D) would occur more readily than from the acylenarnine (B) (Scheme 56). 
oat H' O)(9N(f) 0 H+ mOte • R ..... f---- « R H+ 
(B) (A) (C) 
R = H or substituent j 
(0) 
(Scheme 56) 
There have been numerous synthetic approaches developed for the synthesis of the 
erythrina system. The favoured theme for the preparation of the fully substituted carbon 
centre at the BC ring fusion is based around the trapping of the N-acyliminium ion 
intermediate with an electron-rich aryl ring.143,144 
Ishibashi and co-workersl45 have utilised this N-acyliminium ion methodology to 
provide a direct synthesis to the natural product (3) via an acid-promoted double 
cycIisation. The synthesis proceeds via the key intermediate (192) which was 
generated by the condensation ofhomoveratrylamine (190) and cycIohexane-l,4-dione 
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monoethylene acetal (191) to give the imine (192). N-acylation of (192) with 
(methylthio )acetic anhydride, followed by the oxidation of the acylenamide with 
sodiwn metaperiodate gaves the sulfoxide (193). This key intennediate was then 
converted to the target erythrina skeleton (195) via the acid-promoted fonnation of the 
N-acyliminiwn ion (194). With the key tetracyclic skeleton (195) in hand, the fonnation 
of the natural product (±)-(3), albeit in a racemic fonn, was then easily achieved in three 
step procedure as reported by Ishibashi and co-workers145 (Scheme 57). 
M~ ~~Jl) NH2 MeO 
(190) 
MeOXJ) I Cl) 
MeO ~ ".N 
(194) 
! 
Me 
MeO 
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(191) 
SMe 
.. 
p-TSA 
3 steps 
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MeO 
MeO 
(±)-(3) 
Few reactions can compete with the degree of complexity achieved in a single step by 
the Diels-Alder cycloaddition; equally the N-acyliminiwn ion plays a similar role, in 
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forming carbon-carbon bonds, in the synthesis of nitrogen heterocycles. Thus a 
sequential combination of these two methods would allow a rapid, stereocontrolled 
synthesis of a variety of natural products.9 
Padwa and co-worker9 have developed a new, highly tuneable strategy for the synthesis 
of erythrina alkaloids which relies on a multi-cascade sequence of reactions. This 
cascade (or tandem) process is a group of reactions which allows the regio- and 
stereocontrolled formation of several carbon-carbon bonds (and/or ring systems) in a 
single operation. In this case, they have developed a noval approach towards the 
erythrinan skeleton, leading to the synthesis of (±)-erysotramidine, where the 
spirocyclic ABC ring was formed in a single operation. 
The key intermediate in this synthesis is the preparation of the imido sulfoxide (196), 
possessing both a dienophilic and di-activated aromatic It-tether. This was synthesied 
from a commercially available allylic bromide using a known procedure.146 The 
conversion of (196) into (200) initially proceeds via the formation of a a-thlo 
carbocation intermediate generated from the Purnmerer reaction of (196). This 
intermediate was then intercepted by the adjacent imido carbonyl to generate the a-
amido substituted furan (197). This intermediate then underwent an intramolecular 
Diels-Alder cycloaddition across the tethered It-bond to produce the cycloadduct (198). 
The subsequent formation of N-acyliminium ion intermediate (199) proceeded via the 
nitrogen-assisted ring opening of the oxabicyclic bridge, which resulted in a 1,2 
thioethyl shift and the subsequent elimination of the methoxide ion. The di-activated 
aromatic tether was then cyclised onto the N-acyliminium ion; producing the tetracyclic 
amide (200) as a single diastereomer. The enone (200) key precursor can be converted 
to the natural product (±)-erysotramidine (201), using a combination of methodologies 
reported by Padwa and co-workers9•147 and Tsuda and co-workersl48 (Scheme 58). 
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(ii) C-ring formation by electrophilic substitution 
This methodology for the synthesis of the C-ring, via an e1ectrophilic substitution, has 
been reported less in the literature;14,149 with only a couple of examples in comparison 
to the more popular intramolecular cyclisations, Desmaele and co-workersl4 have 
adopted this methodology and have generated the C-ring by utilising a Pwnmerer-based 
cyclisation, The key precursor (203) for the synthesis of the C-ring was achieved in six 
steps from the commercially available (nitro-methyl)arene derivative (202).14 With 
(203) in hand, the formation of the C-ring was then achieved by a three step procedure. 
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However, the first and most important step was the hetero Michael addition of the 
lactam anion to phenyl vinyl sulfoxide (204). This was achieved upon treatment with 
NaHMDS and excess phenyl vinyl sulfoxide (204) in the presence of HMPA. The 
subsequent cyclisation of the C-ring was then achieved by the next two steps. The 
treatment of (205) with acetic anhydride under reflux followed by the Lewis acid 
induced cyclisation of the resulting a-acetoxy thioether (206) produced the required 
tetracyclic phenylthioerythrinan-8-one intermediate (207). The desulfurization of the 
thioether (207) was achieved using tri-n-butyltin hydride and AlBN and produced the 
desired cis-8-erythrinanone (208) previously reported by Mondon53 (Scheme 59). This 
group has since adapted this methodology and have reported the synthesis of the 
naturally occurring erythrina alkaloid, (±)-dihydroerythramine (209) (Scheme 116, 
Chapter 2.5.5). 
~N02 
(202) 
+ C02Me 
cl 
• 
(206) 
j SnCI4 DCM 
SPh 
(207) 
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(203) 
(205) 
o 
• 
(208) 
o 
j NaHMDS /"--SOPh 
(204) 
~h 0 
(Hi) A-ring formation by an intramolecular aldol reaction 
This methodology requires the synthesis of an intermediate based on the structure (209) 
(Figure 2). Wasserman and Amici ISO have utilised this procedure in their synthesis of 
the erythrina alkaloid, 3-demethoxyerythratidinone (3). Their synthesis revolves around 
the formation of the A-ring via an intramolecular aldol reaction of the diketone (215). 
The key step in their synthesis was the preparation of the tricycIic pyrrolidone 
carboxylate (212). 
R 
R 
o OR = OMe, OCH20 (209) 
Figure 2 
The tricycIic intermediate (212) was generated via the reaction of 2-(3,4-
dimethoxyphenyl)ethylamine (210) with vinyl tricarbonyl ester (211) in the presence of 
the Lewis acid, POCh. This reaction is of particular interest as the two carbonyls groups 
at Cl and C3 in (211) play an important activating role in the initial reaction, however 
they also play a significant role in the conversion of the tricyclic product to the 
tetracycIic system of the erythrina alkaloids. ISO The reduction of (212) with sodium 
cyanoborohydride produced a mixture of diastereomers (ca. I: 1); the subsequent 
benzylation resulted in the formation of a single diastereomer of the corresponding 
benzyl ether. The reduction of the benzyl ether with LiAIH4 gave the aldehyde (213). 
The keto alcohol (214) was then synthesised by a Horner-Emmons reaction with the 
anion of 2-oxopropyldimethyl phosphonate, followed by the hydrogenation of the trans-
enone and the corresponding removal of the benzyl protecting group. Reduction, with 
sodium borohydride, to the diol, followed by a Swern oxidation produced the desired 
diketone intermediate (215). The subsequent treatment of (215) with NaOH in refluxing 
MeOH resulted in the intramolecular aldol condensation, along with dehydration, which 
in turn generated the natural product, (±)-3-dernethoxyerythratidinone (3) (Scheme 60). 
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(iv) A-ring formation from a benzoindolizidine fragment 
Prelog,139 Stevens1S1 and Tsuda1S2,IS3 have developed a tetracyc1ic system via the 
annulation of the A-ring onto the benzoindolizidine subunit (216).14 
RO 
Me 
R 
Me 
(216) (217) OR = OMe, OCH20 
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This methodology has been utilised by Hosoil8,19 and Sano,13 who have taken this 
dioxopyrroline derivative (217) and have converted it to the erythrina skeleton via an 
intermolecular Diels-Alder reaction. This group13 have since reported the total synthesis 
of a number of natural products, albeit in a racemic form, including erysotrine (7), 
erythraline, erysotrarnidine (201) and 8-oxoerythraline. 
Hosoi and co-workers l9 have taken the key dioxopyrroline intermediate (218), 
synthesised in three steps from the commercially available homoveratrylamine, using a 
known procedure reported by Sano and co-workersY The dioxopyrroline (218) was 
converted to the tetracyclic intermediate (219) following an intermolecular Diels-Alder 
reaction with l-methoxy-3-(trimethylsilyloxy)buta-l,3-diene. This was then reduced 
with LiB~ and then hydrolysed, in situ, with HCl to isolate the required tetracyclic 
compound (219). Mesylation and demethoxycarbonylation of the corresponding mesyl 
derivative with CaCh in DMSO gave the dienone (220). With this key intermediate in 
hand, this groupl9 have subsequently converted the dienone (220) to the natural product, 
(±)-erysotrine (7) in a three step procedure (Scheme 61). 
MeO 
""" 
(i)~ Me 0 
MeO # 0 
,?' OMe Me 
.. OH 
Me02 
(ii) LiBH4 
(iii) H+ 0 
(218) (219) 
(i) MsCl/Py 
(ii) CaCI2 
DMSO 
MeO 
""" 
MeO 
MeO # 0 
• MeO .. 
MeO""'" 
(±)-(7) (220) Scheme 61 
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(v) B-ring formation utilizing a CS spiro-isoquinoline system 
In the last few years many methods have been developed where the erythrinane skeleton 
has been constructed via the formation of the B-ring, starting from the C5 spiro-
isoquinoline systems such as (221) 5,144,154 and (222) 155. The most utilised method for 
the formation of the B-ring has been developed based around skeleton (221). 
Marianol44,156 and Danishefsky5 have exploited this methodology and this has led to the 
synthesis of the natural product, (±)-3-demethoxyerythratidinone (3). 
Me M 
NH x Me N~X MeO 
(221) (222) 
A good example of the synthesis of (±)-3-demethoxyerythratidinone (3), using this 
methodology, was reported by Irie and co-workers.154 This synthesis of the natural 
product revolves around the use of the intramolecular Wittig reaction. The key 
intermediate for the synthesis of the B-ring was the amine (224) which was synthesised 
in several steps from the previously reported spiro-amine (223).157 The amine (224) was 
then acylated with the phosphonoacetyl chloride to give the phosphonate (225). The B-
ring was then generated via an intramolecular Wittig reaction of the amine (225), with 
KOH in benzene, which produced the desired tetracyclic lactam (226). This 
intermediate (226) was then converted to the desired natural product, (±)-3-
demethoxyerythratidinone (3), in four steps as reported by Irie and co-workers (Scheme 
62).154 
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(vi) B- and C-ring formation by intramolecular annulation of dibenzazonine 
Many effective syntheses have been achieved based on the oxidative phenolic coupling 
of the bis-(arylethyl)amine subunit (227) and (228),6 
Me ,:? 
"",I 
(228) OH 
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Ito and co-workers6 have utilised this methodology in their synthesis of the natural 
product, 3-demethoxyerythratidinone (3). Their strategy was based upon the synthesis 
of the dibenzazonine derivative (232), followed by a phenol oxidation reaction. They 
took the commercially available 6-bromo-3,4-dimethoxyphenylacetic acid and reacted it 
with 3-benzyloxyphenethylamine produced the corresponding amide (229). The 
subsequent removal of the benzyl protecting group, with conc. Hel in ethanol, produced 
the amide (230). Subsequent irradiation of the amine (230) in methanol, via a 
photochemical reaction (in the presence of sodium hydroxide and a 100W high pressure 
Mercury lamp) produced the photocyclised phenolic amide (231). Reduction of (231) 
with NaBH! in THF produced the desired phenolic amine (232). With the key precursor 
(232) in hand, oxidation with Pb02 produced the desired tetracyclic skeleton of the 
erythrina alkaloids. This was followed by the catalytic hydrogenation of the resulting 
dienone (233), producing the natural product, (±)-3-demethoxyerythratidinone (3) 
(Scheme 63). 
OMe 
Me ~ M ~ 
~q MeOH R M ~ ~ ':?I .. NaOH, hv NH 
~ ':?I 
(229) R = Bn OR ~ (231) R =0 
(230) R = H OH (232) R = H2 
[-
M MeO ~ 
5% Pd/C, H2 
M ~ 
(±)-(3) 
0 (233) 0 
Scheme 63 
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(vii) Miscellaneous methods 
Apart from the methods discussed above there is also an assortment of miscellaneous 
methods for the synthesis of the erythrina ring system.158•161 A classic example will be 
discussed in detail below: 
Livinghouse and co_workers162 have reported an intramolecular cyclisation of a-keto 
iminiwn ylides (238) as a way of constructing the erythrinan skeleton. 
ex> 
I 
Figure 3 (234) CH3 
They had previously reported163,164 the successful utilisation of the intramolecular 
azomethine ylide [3+2] cycloaddition reaction for the synthesis of physostigmine ring 
system (234) (Figure 3). Hence their strategy for the synthesis of the erythrinan skeleton 
was based around the cyclisation of an appropriate substituted arene onto the highly 
reactive acylnitriliwn cation. 
° ~CI 
(235) (236) 
MeO 
MeO • 
(239) 
Scheme 64 
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M 
.. 
MeO 
MeD 
MeD 
(238) 
Me3SiCH203SCF3 
CsF 
The preparation of the required isonitrile (235) was achieved by the dehydration of the 
corresponding fonnamide with POCb in the presence of Et3N. With the preparation of 
the isonitrile (235) in hand, the synthesis of the desired l-acyl-dihydroisoquinolines 
(237) was then achieved via the cycIisation of the isonitrile (235) with the 
corresponding acyl chloride (236) in the presence of Ag+ ·OS02CF3 . The subsequent 
alkylation of this intennediate (237) with trimethylsilylmethyl triflate produced the key 
a-keto iminium ylide (238). Resulting exposure of this dihydroisoquinolinium salt (238) 
with CsF initiated an intramolecular [3+2] cycIoaddition resulting in the fonnation of 
the target erythrinan skeleton (239) (Scheme 64). 
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Chapter 2 Results and Discussion 
2.1 A formal and total synthesis of both enantiomers of the natural 
product 3-demethoxyerythratidinone 
(3) 
2.1.1 Introduction 
Data 
CIsH21N03 
m.p. lII-1I2°C 
[u]o = + 325° 
The seeds ofthe Erythrina variegata 1. (fonnerly Erythrina lithosperma BLUME) have 
previously been known to contain the biosynthetically important alkaloids, N-
norprotosinomenine (15) and erysodienone. I-3 (The use of N-norprotosinomenine (15) 
in the biosynthesis of erythrina alkaloids has been previously discussed in Chapter 
1.1.2). 
H 
Me 
~ 
Me # 
OH 
(15) 
However, other known erythrina alkaloids, e.g. erythraline and erysotrine (7) have also 
been isolated, but the discovery of two new ketonic alkaloids: erythratidinone (240) and 
more significantly, 3-demethoxyerythratidinone (3) has led to more interest in these 
alkaloids. I 
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The natural product, 3-demethoxyerythratidinone (3) was first isolated in 1973 by 
Barton and co-workers. 1 Although it is structurally one of the simplest of the erythrina 
alkaloids,4 its total synthesis, albeit in a racemic from, was not achieved until 1984 by 
Tsuda and co-workers.s This same group, almost a decade later, reported an asymmetric 
route to the enantiomeric form of the natural product, the so-called 'enantio-(-)-3-
demethoxyerythratidinone ,.6 3-Demethoxyerythratidinone (3) is a well known example 
of an alkenoid-type erythrinaalkaloids. As previously stated, in Chapter 1.1.1, the 
alkenoid-type alkaloids contain one double bond in the A-ring, as shown in structure 
(3). However, this alkaloid is unique in the erythrina genus due to the lack of a 3-
methoxy-group. It is generally believed that this alkaloid is biosynthesised from the 
known erythrina base, erythratidinone (240).7 The general theory is that a late stage 
modification occurs during the biosynthetic pathway changing the precursor, 
erythratidinone (240), into this alkaloid. Some plausible routes have been indicated in 
Scheme 65. 1 
MeO 
Me 
.. 
MeO 
(240) o 
~ 
Meo.···y 
OH 
~ MeO Me 
OH 
(3) 
Scheme 65: Biogenesis of 3-demethoxyerythratidinone (3) 0 
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2.1.2 Literature Review 
The synthesis of 3-demethoxyerythratidinone (3) has been reported many times in the 
literature, in a racemic form, however there are only a few examples of non-racemic 
syntheses of this natural product. Examples of previous racemic and non-racemic 
synthesises are discussed below. 
As discussed previously in Chapter 1.7, the erythrinan skeleton can be constructed via 
the formation of the B-ring. This methodology was exploited by Danishefsky and Panek 
who reported their total synthesis of (±)-3-demethoxyerythratidinone (3).4 Their strategy 
was based on work previously done in their group where they took a J3-oxygen-
substituted free radical, which was generated in the presence of an adjacent a,J3-
unsaturated carbonyl system, and then performed a cyclisation using an intramolecular 
Giese-type reaction. This process was developed further to incorporate a carbon radical 
bearing a vicinal nitrogen atom on the connecting chain (Scheme 66a). 
R. .... ~ln R,~ R, N ~ N Q ' Products 
0 0 0 Scheme66a 
R,~ln R'N~' R'N N Q QyJ # 
X Sn(Buh 
X Scheme66b 
In = radical initiation site; X = OAc; Y = Sn(Buh 
This method was used to generate the erythrinan skeleton (242), via an internal 
'Michael-like' free radical cyclisation, as shown in Scheme 67 (Route A). Treatment of 
(241), synthesised from known starting materials, with n-Bu3SnH in the presence of 
catalytic AlBN synthesised the key intermediate (242). This represents a formal 
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synthesis and has previously been converted to the natural product (3) by Tsuda and co-
workers.s In the same report Danishefsky and Panek4 also described a similar but more 
useful method, where they developed a site-specific enol derivative directly from a free 
radical cyclisation dynamic (Scheme 66b). The advantage gained from using this 
methodology was that it allowed direct access to the regioselectivity generated by the 
enolate, thus access to the erythrinan skeleton (244), as shown in Scheme 67 (Route B). 
Me I~ 
:'lY M 
a 
j(n-BUhsnH RouteA AIBN 
M ~ 
Me '. 
I ePh 
(241) 
a 
M ~ 
(3) a 
.. 
steps 
(i) (n-BuhSnLi 
(ii) AczO 
DMAP 
RouteB 
.. 
Scheme 67 
.. 
.. 
.. 
Me ~ 
I 
(3) a 
Mea ~ 
MeO '" 
I SePh 
(243) 
A Sn(Buh 
j (n-BuhSnH AIBN 
Mea ~ 
I 
(244) 
aAc 
Treatment of (241) with tri-n-butyllithiostannane produced the resulting 
hydroxystannane, which was immediately acetylated with acetic anhydride to afford a 
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I: I mixture of diastereoisomers (243). The subsequent reaction of (243) with n-Bu3SnH 
in the presence of catalytic AIBN afforded the single diastereoisomer (244). This was 
then converted in a three step sequence to the natural product, (±)-3-
demethoxyerytbratidinone (3).4 
lard and co-workers8 have reported a novel Ni I AcOH mediated cyc1isation leading to 
the total synthesis of the natural product, (±)-3-demethoxyerythratidinone (3). Their 
methodology follows the classic C-ring formation via an intramolecular cyclisation, 
however, on this occasion they exploited radical chemistry in its construction. In this 
reaction sequence the key precursor is the trichloroacetamide (245) which was 
generated in a two steps from the commercially available cyc1ohexane-I,4-dione 
monoethylene acetal.8 However, when this group applied its standard Ni-induced radical 
cyclisation condition to (245) it failed to produce the desired intermediate (246). 
(246) UO 
However the same reaction sequence was repeated using the more robust dithioketal 
derivative (247) prepared from (245) using 1,3-propanedithiol in the presence of 
BF3.EtzO. On this occasion the desired unsaturated lactam (248) was synthesised in 
49% yield. The subsequent acid induced cyclisation of (248) using p-TSA in refluxing 
benzene produced the desired compound (249). Finally, the natural product (3) was 
achieved in a two step sequence: reduction of the amide moiety with LiAll4-AlCi) 
combination and this was followed by the deprotection of the ketone (NCS/AgN03) 
which occurred with the simultaneous migration of the double bond (Scheme 68). 
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(245) 
Ar = 3.4-dimethoxyphenyl-
MeO 
MeO 
(3) o 
.. 
(i) LiAlH4 • A1Ch 
(ii) NCS. AgN03• 
CH3CN/H20 
Scheme 68 
Me ,::?_ 
(248) 
MeD 
M 
(249) 
o 
p-TSA 
Benzene 
S 
Ishibashi and co-workers9 have reported a Mn(II1)/Cu(II)-mediated oxidative radical 
cyclisation of a-(methylthio )acetarnides leading to the synthesis of erythrinans. In this 
particular example they treated the known intermediate (250io with Mn(OAC)3 in the 
presence of CU(OTf)2 in boiling TF A and this generated the erythrinan derivative 
(251).10 
MeD ,::? MeD 
I 0 Mn(OAch (6 equiv) 
° Cu(OTfh (1 equiv) MeD 
.. SMe 
TFA./:::;. 
(250) U
O / U O (251) 
MeO 
MeO 
(3) 
Scheme 69 o 
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This group, in a previous publication, has already converted derivative (251) to the 
natural product, (±)-3-demethoxyerythratidinone (3) (Scheme 69).10 
The following is a rare example of an asymmetric synthesis of the natural product (3). 
As previously stated, Tsuda and co-workers6 have reported an asymmetric route to the 
enantiomeric form of the natural product, the so-called 'enantio'-(-)-3-
demethoxyerythratidinone (3).6 Their strategy was based around a chiral synthesis of 
the erythrinan alkaloid via an intramolecular cyc1isation. 
M)()):C02Et E~b<>-' 
1.4' NH a-! 
MeO 2 (253) 
-------;.~ (252) 
• 
5 steps 
• 
• 
Scheme 70 
M 
M .4'~NC.OCOCI ~ C02Et 
o 
(255) '----1 
(-)-(3) 0 
The synthesis of the enamine-ester (254) was achieved via the condensation of the 
amino ester (252) with ethyl 5,5-ethylene-2-oxocyc1ohexanecarboxylate (253). 
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Treatment of (254) with oxalyl chloride gave the dioxopyrroline (255) as a mixture of 
diastereomers. This reaction proceeds in two steps: N-acylation to (255) followed by C-
acylation to give (256). Asymmetric induction occurs at the second step. The mixture of 
diastereomers (256) was then reduced with NaB14 and then cyclised with BF3.Et20 
affording the tetracyclic structure of the erythrinan alkaloids (257). With (257) in hand, 
this group successfully converted it to the enantiomer of the natural product, (-)-3-
demethoxyerythratidinone (3) in five steps (Scheme 70).6.11 
2.2 A Formal Synthesis of (-)-3-demethoxyeryfhratidinone 
Introduction 
The total synthesis of (±)-3-demethoxyerythratidinone (3) has been reported many times 
in the literature,4.S.7-1O.12-IS however asymmetric syntheses of this alkaloid are still very 
elusive.6•11 Thus, we believe that our methodology will provide a novel, highly 
stereoselective formal asymmetric synthesis of both enantiomers of this natural product. 
2.2.1 Retrosynthetic analysis 
o 
:> 
MeO (3) OMe 0 
MeO OMe 
f\ ~ o 0 ~C02H 
<: 0 + 
~OH (0 OMe MeO # NH2 MeO 
OMe Scheme 71 
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The retrosynthetic pathway shown in Scheme 71 utilises a cyc1ocondensation reaction 
leading to the synthesis of the tricyclic lactam. Then N-acyliminium ion methodology is 
required to generate the erythrinan skeleton. Simple manipulation of the ring system 
would generate the target natural product, 3-demethoxyerythratidinone (3). 
2.2.2 Synthesis of the racemic keto-acid 
In order to perform our cyclocondensation reaction we were required to synthesise the 
required keto-acid and p-amino alcohol precursors. Our initial studies focussed on the 
generation of the required keto-acid (258). 
~H 
o 
(258) 
Previous work in the Allin groupl6 had generated the keto acid (260) via the hydrolysis 
of the commercially available keto-ester (259) using LiOH in THFIH20 (Scheme 72). 
0 0 
~8 LiOH ~C02H .. THF/H20 
(259) (260) 
Scheme 72 
Unfortunately, the keto-ester we required to synthesise our target keto-acid (258) was 
not commercially available so an alternative route was required. The commercially 
available mono-protected 1,4-cyclohexanedione monoethylene ketal (261) was 
alk:ylated using enolate chemistry, to the keto-ester (262) using methyl bromoacetate 
and the base KHMDS. The reaction was stirred in dry THF at room temperature for 22 
hours, affording (262) in 63% yield (Scheme 73). 
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n n n Q KHMDS ~~ LiOH ~H .. .. Br~C02Me H20fTHF 
0 63% 0 84% 0 
(261) (262) (258) 
Scheme 73 
Conversion to the corresponding keto-acid (258) was then achieved via subsequent ester 
hydrolysis. The keto-ester (262) was hydrolysed using LiOH in TIIF1H20, at room 
temperature, for 22 hours, generating the keto-acid in a good yield of 84% (Scheme 73). 
The advantage of using LiOH in the hydrolysis step is that it does not de-protect the 
acetal protecting group. 
2.2.3 Synthesis of the chiral JJ-amino alcohol 
The P-amino alcohol component was formed via the reduction of its corresponding 
amino acid. I' The commercially available 3-(3,4-dimethoxyphenyl)-L-a1anine (263) was 
reduced to 3-(3,4-dimethoxyphenyl)a1aninol (264) using LiBJ-4 in the presence of 
Me3SiCI in dry TIIF (Scheme 74). This generated the p-amino alcohol in 97% yield. 
0 
""" 
OH LiBH4 
""" 
OH 
.. 
MeO # 
NH2 MIlJSiCI MeO # NH2 
OMe (263) 97% OMe (264) 
Scheme 74 
The reduction is suggested to proceed via the generation of the BH3-TIIF complex 
shown below. This BH3-TIIF complex acts as the reducing agent. I ' 
TIIF 
.. 
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2.2.4 Synthesis of the tricyclie taetam 
We now had the keto-acid (258) and the ~-arnino alcohol (264) in hand, so the next 
synthetic step was the preparation of the corresponding tricyclic lactarn (265). Previous 
work within the Allin group16 had produced the tricyclic lactarn (266), an analogue to 
our required substrate (265). 
OMe 
(266) OMe 
Our initial attempts to synthesis the required tricyclic lactarn (265) followed the 
methodology used to synthesis the tricyclic lactam (266). The condensation of the keto-
acid (258) and the ~-arnino alcohol (264) under Dean-Stark conditions in refluxing 
toluene for 144 hours, generated the tricyclic lactarn (265) as a single diastereoisomer, 
and in 55% yield (Scheme 75). 
(258) + (264) Toluene 
55% 
• 
Scheme 75 
o 
.# OMe 
(265) OMe 
Following the reaction, IH NMR spectroscopy, showed that the reaction had reached 
completion after only 48 hours as illustrated in Table I. We discovered that after only 1 
hour only starting material was present, with no trace of the desired product (265). After 
24 hours the IH NMR spectrum of the crude product showed that the reaction had 
nearly reached completion with only a small trace of the starting materials still present, 
however after 48 hours the reaction had reached completion with no trace of the starting 
materials. 
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Table 1: Condensation study: followed by 'H NMR Spectroscopy. 
Attempt Reaction Time Observation • 
1 1 h S.M. 
2 24h (265)+ S.M. 
3 48h (265) 
'Determined bv the 250 MHz 'H NMR spectrum of the crude product. 
With this investigation complete we repeated the reaction with this revised 
methodology. The condensation under Dean-Stark conditions, for only 48 hours, gave 
the desired lactam (265) once again as a single diastereoisomer and in an improved 
yield of 63 % (Scheme 74). The increased reaction yield is evidence that the extended 
reaction time may actually be causing some decomposition of the lactam product (265) 
during the reaction. 
The formation of the single product diastereoisomer of lactam (265) from the racemic 
keto acid (258) required the epimerization of the stereo genic centre adjacent to the 
ketone during the reaction. This observation, albeit on other substrates, has been 
reported by other groups in the preparation of polycyclic lactams for use as N-
acyliminium ion precursors.16,18,19 Ragan and Claffeyl9 have utilised this methodology 
and have reported the preparation of chiral, non-racemic, tricyclic pyrrolidinones. The 
condensation of the cyclic keto-acid (267) with the chiral amino alcohol (268) has 
generated the tricyclic pyrrolidinone (269), with high levels of diastereoselectivity, via 
the epimerisation of the keto-acid (267) (Scheme 76). 
R1 R2 
H) ~H 
(268) 
.. 
(267) Scheme 76 (269) 
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2.2.5 Synthesis of the isoquinoline alcohol 
With (265) in hand, we then turned our attention to the proposed asymmetric 
cyc1isation. The N, O-acetal carbon of the tricycIic lactarn functions as an electrophilic 
centre when treated with a strong Lewis acid, e.g. TiCI4• The electrophilic nature of this 
carbon can therefore be exploited by the addition of a nuc1eophile.2o 
In this case the cyclisation of the tricyclic lactarn (265) was achieved by using 3 equiv 
of TiCI4 as a Lewis acid activator at low temperature in dry DCM to produce the 
corresponding isoquinoline alcohol derivative (270) in 92% yield and as a 10: I mixture 
of product diastereoisomers. Analysis of the IH NMR spectrum showed that the 
cyc1isation had been successful due to the presence of two singlets at 6.60 and 6.66 
ppm, representing the two aromatic protons (Scheme 77). 
0 
0 ,,-OH 
/ 
~ TiCI4 
.. 
(0 
# OMe DCM 0 
OMe 92% 
MeO OMe 
(265) (270) 
Scheme 77 
Perhaps not surprisingly under such strong Lewis acid conditions, the cyc1isation 
proceeded with the simultaneous deprotection of the ketal protecting group. Reducing 
the number of equivalents of the Lewis acid used during this reaction did not selectively 
generate the corresponding cyc1isation product with the ketal group intact, but instead 
produced an inseparable mixture of the protected and unprotected products. Fortunately, 
the removal of the ketal protecting group at this stage of the reaction sequence was of no 
disadvantage to our future proposal. The protecting group could be reincorporated at a 
later stage in this reaction sequence as required. 
Our proposed mechanism for the Lewis acid activated cyclisation of the tricyc1ic lactarn 
(265) to the corresponding isoquinoline derivative (270) is highlighted below (Scheme 
78): 
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~ 
TiCI4 
# • 17" OMe Co OMe ~ (271) 
(:OMe 
OMe 
j 
0 !iC13 
,..--0 
.• ,/ 
Acetal 
• 
deprotection 
0 
MeD OMe 
(270) Scheme7S 
This reaction occurs via the fonnation of the N-acyliminium ion (271) followed by an 
intramolecular cyc1isation (Scheme 78). This proceeds via the fonnation of a spirocyc1e, 
followed by a subsequent rearrangement generating the required isoquinoline derivative 
(270). 
The IH NMR spectral analysis of the crude product showed the fonnation of a 10:1 
mixture of the product diastereoisomers with the major diastereoisomer (270a) shown 
below: 
MeO OMe MeO OMe 
(270a) (272) 
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Previous work by Allin and co_workersI6,21 had determined the relative stereochemistry 
of the related compound (272) prepared by analogous chemistry, by X-ray 
crystallography (Figure 3). 
Figure 3: X-ray crystal structure of the isoquinoline derivative (272).16.21 
The major diastereoisomer (270a) in this case, was isolated by flash column 
chromatography and its relative stereochemistry was determined by nOe studies, as we 
were unable to obtain suitable crystals for X-ray crystallography. The absence of an nOe 
between the protons at positions 4 and Ba supports the proposed structure indicated. In 
addition, one would not expect any significant change to occur in the stereochemistry 
with the introduction of a remote protecting group. 
The stereochemical outcome of this cyclisation can be explained with the aid of the 
conformational model shown beloW.16 The steric influence provided by the angular 
alkyl substituent R at the iminium carbon atom favours the proposed conformational 
model A that leads to the observed major diastereoisomer (270a) with overall retention 
of stereochemistry. On the other hand steric interactions between the angular alkyl 
group and the benzyl substituent will disfavour conformational model H, which would 
lead to the minor diastereoisomer (Figure 4). 
a r-Ar R LA-~ 
A 
----" (133a) 
LA-a 
a '"'1. ~ ~
H 
Figure 4: Conformational models for acyliminium cyclisations. 
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However, one cannot rule out the possible influence of chelation control caused by a 
Lewis acid such as TiC",. The presence of an asymmetric centre next to the iminium 
centre may lead to stereocontrol over the formation of a new chiraI centre upon 
cyclisation. If this is the case one can appreciate that the aromatic ring is approaching 
the planar acyliminium intermediate from the direction of the least steric hindrance 
(Figure 4).16,22 
2.2.6 Removal ofthe hydroxymethyl substituent 
It is evident from the structure of (-)-3-demethoxyerythratidinone (3) that a procedure to 
remove the pendant hydroxymethyl substituent (auxiliary) from the cyclisation product 
(270) was required (Figure 5). 
o 
MeO OMe MeO OMe 
(3) (270) 
Figure 5 
Krafft and co-workers23 have described a one-step procedure for the removal of the 
pendant hydroxymethyl substituent. They reported that in the presence of Raney nickel 
in refluxing toluene, primary aIcohols generate deoxygenated compounds that contain 
one less carbon (Scheme 79). 
o 
II - OH Mecr'"'B;~ 
(273) 
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Toluene 
3.5h 
Scheme 79 
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o 
II . Me Meo/~ 
(274) 
The authors proposed that the dehydroxymethylation procedure involved an initial 
oxidation to the aldehyde followed by an irreversible decarbonylation. For example, the 
primary alcohol (273) was heated in toluene with Raney nickel and this generated the 
decarbonylated product (274) in 73% yield (Scheme 79). 
This methodology was adapted by Martin and co-worke?4 who successfully removed 
the hydroxymethyl group from the bicyclic lactam (275) to generate the intermediate 
(276), a precursor to the indolizidine alkaloid, pumiliotoxin 52lD (277) (Scheme 80). 
Me PH ~ Me PH t Ra-Ni 0N2) l • Toluene 
0 OH 0 
""'IMe 0 (275) (276) n-Pr (277 ) 
Scheme 80 
Previous work in the Allin group21,25 have applied this methodology on a number of 
templates (278) and (162), but on both occasions the desired product was not obtained. 
o 
MeO OMe 
(278) (162) 
Although not strictly used for the removal of pendant hydroxymethyl substituents, there 
are number of examples in the literature where the equivalent carboxylic acid derivative 
have been removed via a radical decarbonylation. 
Martin and co-workers26 have reported an efficient radical decarbonylation of the 
equivalent carboxylic acid derivative. Their procedure required the formation of the acyl 
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selenide derived from (279) by a sequential reaction with isobutyl chloroformate and 
then sodium phenylselenide. This then underwent radical decarbonylation to afford 
(280) a precursor to the natural product, (+ )-geissoschizine (164) (Scheme 81). 
(280) 
(i) i-BuOCOCI, 
NMM, 
PhSeNa 
(ii) BU3SnH, 
AIBN 
Scheme 81 
• 
(281) 
Tsuda and co_workers6.11.27 have reported a decarboxylation of a similar carboxylic acid 
derivative (281) utilising the classical Barton radical decarboxylation procedure28 
(Scheme 82). 
Me C02H (i) i-BuOCOCI, 
Me)):) NMM 
I A"""", N .. Me (ii) N-hydroxy- Me ' .. 
pyridinethione 
sodium salt, 
0 
Et3N 
0 U (iii) hv, t-BuSH U 
(281) 
Scheme 82 
Using the methodology demonstrated previously by Allin and co_workers,16.29•31 we 
intend to remove the pendant hydroxymethyl substituent (auxiliary) from the tetracyclic 
product (270) via the application of a three-step procedure. 
2.2.7 Oxidation Study 
The first step in this sequence was the oxidation of the isoquinoline alcohol derivative 
(270) to its corresponding aldehyde (282). The first method used in order to achieve this 
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oxidation applied methodology already developed in the Allin group29 for the oxidation 
of the indolo[2,3-a]quinoIizidine derivative (162) to its corresponding aldehyde (283). 
The oxidation of (162) using IBX generated the aldehyde (283) as a single 
diastereoisomer and in 69% yield (Scheme 83). 
'BX,DMSO 
.. 
20h, 69% 
(162) (283) 
Scheme 83 
The use of 2-iodoxybenzoic acid (IBX) (285) in DMSO as a mild oxidant, has been 
reported by Frigerio and co_worke(l2,33 for the successful conversion of alcohols to 
aldehydes or ketones.34 
Ac~ OAc ~/~OAC I '0 Ai" 
o 
mx DMP 
IBX is the precursor to Dess-Martin periodinane (DMP) (286) and is readily prepared 
from the inexpensive, commercially available 2-iodobenzoic acid (284) and potassium 
bromate using a preparative procedure reported by Dess and Martin35,36 (Scheme 84). 
0 AcO OAc 
CC' KBr03 Cif ~-Ok I Ai" C02H HOAc I '0 .. I 0 • H2S04 Ai" AezO Ai" 
0 0 (284) (285) (286) 
Scheme 84 
When we reacted our substrate (270) with IBX (1.1 eq) in DMSO for 20 hours, we 
successfully generated the required aldehyde (282) as a single diastereoisomer, and in a 
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48% yield (Scheme 85). 'H NMR spectroscopy of the product supported our findings 
that the alcohol had been oxidised to the corresponding aldehyde (282), due to the 
presence of CHO peak at ~9.83 ppm. However, attempts to improve the yield by 
increasing the equivalents of IBX proved to be unsuccessful. Although the yields were 
consistently low the main problem however, was the co-eluting IBX by-products also 
present. Attempts to remove these co-eluting IBX by-products by flash column 
. chromatography, proved to be unsuccessful. 
0 
,,-OH 
I 
IBX, DMSO 
• 
20h,48% 
0 
MeO Me MeO OMe 
(270) Scheme 85 (282) 
Frigerio and co-workers32 have proposed a mechanism for the oxidation of alcohols 
such as (287) using IBX to the corresponding aldehyde (288) (Scheme 86). 
O\+/OH 
R H 
R1RCHO
v
O· 
o;~ + R1XOH o;~ + H2O 
(287) 0 I 0 mx 
.. ,pH 
o;~ R + )=0 + H2O 
RI 
0 (288) 
Scheme 86 
The low yield of 48% and the purification problems were unsatisfactory at this stage of 
the synthesis, so we decided an alternative method was required for this oxidation. 
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So, in order to improve this reaction we decided to use the related oxidising agent, 
Dess-Martin periodinane (286)35 due to its superior solubility (Scheme 84). The 
isoquinoline alcohol derivative (270) and the oxidising agent Dess-Martin periodinane 
were stirred in dry DCM for 24 hours and produced the required aldehyde (282) in 93 % 
yield (Scheme 87). The IH NMR spectrum of the product suggested that the aldehyde 
(282) had been synthesised, as the same CHO peak at ~9.83 ppm was present. 
2.2.8 Decarbonylation Study 
With the synthesis of the aldehyde in hand, the next step for the removal pendant 
hydroxymethyl substituent (auxiliary) was achieved via the decarbonylation of the 
aldehyde (282). 
Tsuji and Ohn037 have reported that metallic palladium is a useful catalyst for the 
decarbonylation of aldehydes and acyl halides. However, they discovered that the 
decarbonylation reaction could only be applied to aldehydes if the temperature was at 
least 200°C.38 So in order for the decarbonylation reaction to be useful in organic 
chemistry, an alternative catalyst was required, so that the reaction could be carried out 
smoothly under mild conditions. 
Tsuji and Ohn039 and Walborsky4o have reported that various aldehydes such as (289) 
can be decarbonylated under mild conditions upon treatment with the well known 
rhodium complex chlorotris(triphenylphosphine)rhodium (Wilkinson's catalyst) (290) 
(Scheme 88). 
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Cl 
(291) 
Scheme 88 
The by-product of this reaction, rhodium bis(triphenylphosphine) carbonyl chloride 
(291), was also found to be extremely useful for the decarbonylation of aldehydes and 
acyl halides under mild conditions in homogeneous systems. This complex, (291), was 
readily prepared in solution by the reaction of Wilkinson's catalyst (290) with carbon 
monoxide at room temperature and at atmospheric pressure. Tsuji and Ohno39 have also 
observed that at higher temperatures complex (291) can perform decarbonylations 
catalytically. 
The proposed mechanism39,4o for the decarbonylation of aldehydes with the rhodium 
complex (291) is illustrated in Scheme 89. The initial step is the oxidative addition of 
(291) to the aldehyde (RCHO) to form complex (292). 
CO H 
I RC~ I/PPh3 
RCHO + Ph3P-Rh-PPh3 Rh I OC ..... I ..... PPh3 
Cl Cl 
(291) (292) 
RH + 
(291) 
Scheme 89 
-co 
CO 
H 
I/PPh3 
RCO-Rh, I PPh3 Cl 
(293) 
co 
R., I ....... PPh3 
Rh H ..... I ..... CI 
PPh3 
(294) 
When heated in the absence of carbon monoxide, one mole of carbon monoxide is lost 
to produce the acyl complex (293). Complex (293) is then converted to complex (294) 
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via an acyl-alkyl rearrangement. Finally, a reductive elimination of complex (294) 
regenerates the catalyst (291) with the formation of the desired decarbonylated product 
(RH). 
Doughty and Pignolet41 have reported the decarbonation of aldehydes with cationic 
complexes of chelating diphosphine ligands. These complexes, [Rh(dppeh]Cl (dppe = 
1,3-bis(diphenylphosphino)ethane) and [Rh(dppp)2]Cl (dppp = 1,3-bis(diphenyl-
phosphino)propane) (295), were prepared by reacting RhCl(CO)(PPh3)2 (291) with an 
excess of the diphosphine ligand in toluene (Scheme 90). 
RhCI(CO)(PPh3)2 
dppp 
--'-----.... [Rh(dppp)21CI 
Toluene 
(291) (293) 
Scheme 90 
The decreased electron density of these complexes in comparison to RhCl(CO)(PPh3)2 
(291) have resulted in these complexes binding carbon monoxide less strongly due to a 
decrease in the Rh-CO 1t back-bonding. The catalylic activity of these rhodium (I) 
complexes with chelated diphosphine ligands is enhanced, in comparison to the well 
known Wilkinson's catalyst, thus decarbonylations can occur at a considerably lower 
temperature and with long-term catalyst stability. 
Meyer and Kruse 42 have utilised this methodology and have applied it in their synthesis 
of UhIe's ketone (297). In this publication they reported that they generated the active 
catalyst [Rh( dppe h]Cl in situ. 
("0 
CHO 
.. 
dppe, xylene 
Scheme 91 
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~ lX) 
H 
(297) 
The reaction proceeds readily in xylene at 140°C, using 1-5 mole % of the rhodium 
catalyst RhCl(CO)(PPh3)2 (291), and produced the desired decarbonylated product (296) 
in a near quantitative yield (Scheme 91). 
Allin and co_workers30,31 have utilised the methodology developed by Meyer and 
Kruse 42 and have applied it to the synthesis of the pyrroloisoquinoline ring system. The 
decarbonylation of the aldehyde (298) using the active catalyst [Rh(dppehlCl developed 
in situ was refluxed in p-xylene, but unfortunately the reaction only generated the 
enamide (299) with no sign of the desired decarbonylated product (300). The formation 
of the enamide has been previously observed by Tsuji and Ohn039 and occurs due to the 
f3-elimination of the aldehyde. This is accompanied by the evolution of hydrogen gas 
and forms the alkene instead of the alkane. However, the desired product (300) was 
formed in 89% yield by catalytic hydrogenation of the enamide (299) (Scheme 92). 
0 o 
Rh(PPh3l2(CO)CI H2 /Pd-C 
• .. 
dppp. p-xylene EtOH 
20h f , 
(298) (299) (300) 
Scheme 92 
We have since applied this methodology to our more complex system and our findings 
will be discussed in detail below. Our initial investigation was conducted using 5 mol% 
of the catalyst RhCl(CO)(PPh3)2 (291) and 12.5 mol% of 1,3-bis(diphenylphosphino) 
propane ligand in anhydrous p-xylene. The aldehyde (282) was refluxed under these 
conditions for 240 hours producing, once again, the corresponding enamide (301) and a 
mixture of by-products (Scheme 93). Purifucation via flash column chromatography 
enabled us to isolate the enamide in 18% yield, unfortunately it also co-eluted with an 
inseparable phosphorus by-product (Table 2: Entry I). Analysis of the IH NMR 
spectrum clearly showed that we had synthesised the enamide (301) due to the presence 
of two sets of doublets at N6.10 and 7.29 ppm. No trace of the desired decarbonylated 
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product (302) was isolated, but some recovered starting material was obtained. 
Unfortunately, the IH NMR spectrum of the recovered starting material had shown that 
the aldehyde had degraded during the reaction process. Reducing the reaction time from 
240 hours to 120 hours had no significant effect on the yield of the enamide (301), with 
again no trace of the desired amidoketone product (302) (Table 2: Entry 2). 
Rh(PPh3h(CO)CI 
• 
dppp. xylene 
0 
18-20% 
MeO OMe MeO OMe 
(282) (301) 
Scheme 93 
Numerous attempts using these conditions only produced the enamide (301) in low 
yield with no trace of the desired decarbonylated product (302). So, alternative reaction 
conditions were required to achieve our aim. 
A colleague43 was simultaneously investigating the decarbonylation reaction on the 
indolizino[8,7-b]indole derivative (303) below. Variables such as time, solvent, quantity 
of catalyst and the relative proportion of the diphosphine ligand were investigated. 
o 
(303) 
As a result of this investigation an alternative procedure was ascertained for this 
decarbonyaltion reaction. The solvent p-xylene (137-138°C) was replaced with the 
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higher boiling mesitylene (163-165°C) and 10 mol% of the catalyst (291) was used 
without the diphosphine ligand 1 ,3-bis( diphenyl-phosphino )propane (dppp). 
Table 2: Decarbonylation Study 
Entry Catalyst dppp Solvent Reaction time Product Enamide 
(mol%) (mol%) (h) (302) (301) 
1 5 12.5 xylene 240 
-
18% 
2 5 12.5 xylene 120 - 20% 
3 10 
-
mesitylene 120 Trace 38% 
4 10 25 mesitylene 120 6% 55% 
5 10 25 mesitylene 120 ~6% 48% 
We applied this revised methodology on our substrate and refluxed the aldehyde (282) 
in mesitylene with 10 mol% of the catalyst. This generated the enamide (301) (+ 
phosphorus by-products) in an improved yield of 38% but more significantly we 
successfully managed to synthesise a trace amount of the desired amidoketone (302) 
directly from the aldehyde (282) (Scheme 94) (Table 2: Entry 3). Analysis of the IH 
NMR spectrum showed two single aromatic protons at 6.58 and 6.87 ppm, with no trace 
of either the aldehyde (282) or the enamide (301). 
=0 /' 
MeO OMe 
(282) 
o o 
Rh(PPh3)2(CO)CI 
• 
+ 
dppp. mesitylene 
38-55% 0 
MeO OMe MeO OMe 
Scheme 94 
(301) ~ (302) 
10% Pd/C. EtOH 
79% 
This result supported the observation made by Tsuji and Ohn039 who reported that 
increasing the reaction temperature led to an improvement in the reactivity of the 
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rhodiwn catalyst RhCl(CO)(PPh3)2 (291). In order to be thorough we decided to repeat 
the reaction with the addition of 25 mol% of I ,3-bis( diphenylphosphino )propane ligand. 
Much to our surprise we had a significant improvement in the yield of the enamide 
(301) (55%), and although still very low, we did achieve 6% yield of the desired 
decarbonylated product (302) (Table 2: Entry 4). Nwnerous attempts using these 
conditions led to no improvement in the synthesis of the enamide (301) or more 
importantly the decarbonylated product (302). 
The fmal step in the auxiliary removal sequence could be achieved via a catalytic 
hydrogenation of the crude mixture from the previous step. Upon treatment with 
hydrogen in the presence of 10 mol% of palladiwn on charcoal we successfully 
obtained the desired amidoketone (302) in 79% yield (Scheme 94).16 
More recently, Allin and co-workers44 have reported an alternative procedure for this 
decarbonylation sequence. Due to the excessive reaction time generally required for our 
substrates, using our decarbonylation protocol, a more facile approach was developed 
utilising a decarboxylation strategy. The idea was to oxidise the aldehyde (304) to its 
corresponding carboxylic acid derivative (305) before converting it to the equivalent 
acyl selenide derivative (306). This was then followed by a tin-mediated deacylation 
affording the desired indolo[2,3-a]quinolizine template (307) (Scheme 95). 
0 
H 
NaCIO:!, NaH2P04 
OH 
• 
1-methyI-1-cyclohexene, 
-""" 
CH3CN, t-BuOH, H2O 
(304) (305) (PhSe)2 
PBU3 
DCM 
0 
SePh 
f n-Bu3SnH 
• 
-"'" AIBN 
Toluene 
(307) Scheme 95 (306) 
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2.2.9 Re-introduction of the ketal protection 
The next step in the synthesis was the re-introduction of the ketal protecting group. This 
was achieved by refluxing (302) with ethylene glycol and p-TSA in toluene, affording 
the desired product (308) in 70% yield (Scheme 96). Since compound (308) is a known 
intermediate, this now represents a formal total asymmetric synthesis of 3-
demethoxyerythratidinone (3)?2 
o 0 
Ethylene glycol 
p-TSA 
.. 
Toluene 
MeO OMe 70% MeO OMe 
(302) (308) 
Scheme 96 
In summary, we have successfully prepared the protected imidoketone (308) in a six-
step sequence as shown in Scheme 97, in an enantiomerically pure form. Although, we 
can not make a comparison to a natural compound in order to compare optical purity, 
we are confident that no degradation has occurred during the synthesis due to the fact 
that we have synthesised this intermediate as a single diastereomer. With any 
degradation one would expect to see the formation of a mixture of diastereomers. This 
intermediate (308) has previously been synthesised by Tsuda and co-workers, S albeit in 
a racemic form, and has been converted to the natural product, 3-
demethoxyerythratidinone (3) by a four-step sequence (Scheme 103). 
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2.3 A Formal Synthesis of (+)-3-demethoxyerythratidinone 
MeO OMe 
(3) 
Introduction 
Using the methodology described in Chapter 2.2, we decided to synthesise the opposite 
enantiomer of the natural product, 3-demethoxyerythratidinone (3), in order to 
demonstrate the versatility of our methodology. This was achieved by changing the (L)-
amino alcohol for the corresponding (D)-amino alcohol precursor and then following an 
identical reaction sequence. 
2.3.1 Synthesis of the chiral p-amino alcohol 
The synthesis of the required j3-amino alcohol precursor was achieved via the 
application of a two step procedure. The commercially available N-acetyl-3-(3,4-
dimethoxyphenyl)-D-alanine (309) was hydrolysed with IM HCl to generate the 
corresponding a-amino acid (310) in 95% yield.45 With the a-amino acid, 3-(3,4-
dimethoxyphenyl)-D-alanine (310) in hand, we simply reduced the acid using the 
methodology described previously. Reducing the a-amino acid using LiB& and 
Me3SiCl in dry TIIF generated p-amino alcohol, 3-(3,4-dimethoxyphenyl)-D-alaninol 
(311) in 94% yield (Scheme 98)Y 
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2.3.2 Synthesis of the lactam 
The preparation of the corresponding tricycIic lactarn (312), with opposite optical 
rotation, was achieved using the methodology described previously for the synthesis of 
the tricyclic lactarn (265) (Scheme 75).16 The condensation of ~-amino alcohol (309) 
with keto-acid (258) (Scheme 73), in refluxing toluene under Dean-Stark conditions for 
48 hours, gave the desired tricyclic lactarn (312) in 60% yield (Scheme 99). Visual 
comparison of the IH NMR spectra showed that thetricyclic lactarn (312) was virtually 
identical to tricycIic lactarn (265) and as observed previously, for the opposite 
enantiomer, the tricycIic lactarn (312) was once again produced as a single 
diastereoisomer. The optical rotation of this intermediate (312) was +56.1 compared to -
55.7 for lactarn (265). 
2.3.3 Synthesis of the isoquinoline alcohol 
With the synthesis of the tricyclic lactarn (312) in hand, the subsequent asymmetric 
cyclisation to produce the corresponding isoquinoline alcohol (313) was achieved in 
91 % yield (Scheme 99). 
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As described in Chapter 2.2.5, the asymmetric cyclisation of the tricyclic lactam (312) 
to the corresponding isoquinoline alcohol derivative (313) was achieved using 3 equiv 
of the Lewis acid TiCl4 in dry DCM (Scheme 99). The optical rotation of this 
intermediate (313) was +60.8 compared to -53.4 for the isoquinoline alcohol (270). The 
concentration of the sample may account for the slight discrepancy between the two 
optical rotation values. As reported for the opposite enantiomer, the ketal protecting 
group, once again, was removed during this synthetic step. But, as before, this posed no 
significant disadvantage to our future proposal, as it could be reincorporated at a later 
stage in the reaction sequence as required. 
2.3.4 Removal ofthe hydroxymethyl substituent 
The next step in our synthetic sequence was the removal of the pendant hydroxymethyl 
substituent from the cyclisation product (313). This was achieved by the application of 
the same three-step procedure described previously for the opposite enantiomer. I 6,30,3 I 
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(i) Oxidation 
As described previously, the initial step in the decarbonylation sequence was the 
oxidation of the isoquinoline alcohol derivative (313) to its corresponding aldehyde 
(314) (Scheme 100). 
o 
OH 
DMP, DCM 
20h,91% 
MeO OMe MeO OMe 
(313) 
Scheme 100 
(314) 
This was achieved by oxidising the primary alcohol (313) with the oxidising agent 
Dess-Martin periodinane,35 in dry DCM, for 20 hours to afford the aldehyde (314) in 
91 % yield. The IH NMR spectrum of this product verified the synthesis of the aldehyde, 
as there was clearly a CHO peak at N9,8 ppm representing the aldehyde proton. Visual 
comparison of the IH NMR spectra with the previously synthesised aldehyde (282) 
supported our observation as both spectra were virtually identical. The optical rotation 
of this intermediate (314) was + 13.2 compared to -10.2 for the aldehyde (282). 
(ii) Decarbonylation 
With the aldehyde in hand, the next step for the removal of the pendant hydroxymethyl 
substituent was achieved via the decarbonylation of the aldehyde (314). Using the best 
conditions developed for the previous enantiomer, we refluxed the aldehyde (314) in 
mesitylene in the presence of 10 mol% of the rhodium catalyst, Rh(PPh3)2COCl, and 25 
mol% of 1,3-bis(diphenylphosphino)propane ligand, dppp, for 96 hours. This produced 
a mixture of the enarnide (315) in 29% yield; and more importantly we synthesised the 
desired amidoketone (316) in a significantly improved yield (29%) (Scheme 101). This 
result was a surprise as we used the same conditions as for the opposite enantiomer 
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(Table 2: Entry 5) where we only achieved 6% yield of the desired arnidoketone (302). 
This teIls us that the quality and condition of the catalyst plays an important role in the 
synthesis of the amidoketone (316) in comparison to the enamide (315) as in this 
particular case we had a fresh batch of the rhodium catalyst. 
(iii) Hydrogenation 
The ftnal step in the auxiliary removal sequence could be achieved by catalytic 
hydrogenation of the crude mixture from the previous step. Upon treatment with 
hydrogen in the presence of 10 mol% of palladium on charcoal we successfully 
furnished the desired amidoketone (316) in 70% yield (Scheme 101).16 Visual 
comparison with the IH NMR spectrum of (301) showed that the hydrogenation had 
been successful with no trace of the enarnide (315). The optical rotation of this 
intermediate was +39.6 compared to -36.9 for the amidoketone (302). 
0 0 0 
0 
RhCI(CO)(PPh3i2 
dppp + 
Mesitylene 
MeO OMe MeO OMe MeO OMe 
(29%) (29%) 
(314) (315) (316) 
PdlC, H2 
EtOH,70% 
Scheme 101 
2.3.5 Re-introduction of the ketal protection 
Next, we focussed on the re-introduction of the ketal protecting group onto the 
amidoketone (316). This was achieved by reacting the amidoketone (316) with ethylene 
glycol and p-TSA, under Dean-Stark conditions, for 16 hours to produce the protected 
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ketone (317) in 80% yield (Scheme 102). Compound (317) gave an optical rotation of 
+21.7, compared to the opposite enantiomer (308) with a value of -26.1, thus we have 
successfully synthesised this compound in both enantiomeric forms?2 Since compound 
(317) is a known intermediate, this now represents a formal total synthesis of the 
epimeric natural product (3). 
0 
Ethylene glycol 
p-TSA 
• 
Toluene 
80% 
MeO OMe MeO OMe 
(316) (317) 
Scheme 102 
In summary, we have successfully synthesised the opposite enantiomer of the protected 
arnidoketone (308), in a six-step sequence following the same synthetic sequence shown 
in Scheme 97, in an enantiomerically pure form. As previously stated, this intermediate 
(317) has previously been synthesised by Tsuda and co-worker,s albeit in a racemic 
form, and has subsequently been converted to the natural product, 3-
demethoxyerythratidinone (3) by a four-step sequence (Scheme 103). 
2.4 Conversion to the natural product, 3-demethoxyerythratidinone (3) 
We have now achieved a formal total asymmetric synthesis of both enantiomers of the 
natural product, 3-demethoxyerythratidinone (3).22 Tsuda and co-workerss in 1984 
described five different synthetic routes to the synthesis of this natural product. The two 
reaction sequences illustrated, in Schemes 103 and 104, show the routes that could be 
taken for both enantiomers of the protected imidoketone (308) and (317), in order to 
convert them both to their equivalent natural products. 
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Treatment of the racemic protected imidoketones (308) & (317) with LDA and 
phenylselenenyl chloride afforded the intermediate (318). Oxidative elimination of the 
phenylselenenyl group introduced an a, ~-unsaturation as illustrated in (319). Reduction 
of the lactam carbonyl (319) followed by acid hydrolysis of the resulting amine (320) 
produced, with simultaneous migration of the double bond, the erythrina alkaloid (3) in 
77% yield (Scheme 103).5 
Treatment of the protected imidoketone (308) & (317) with LiAI~ afforded the amine 
(321). This was followed by acid hydrolysis which removed the ketal protecting group 
generating the ketone (322). Treatment of (322) with LDA followed by 
phenylsulfenylation with (PhSh resulted in a mixture of mono-(323a) and (323b) and 
di-(323c) phenylsulfides. This inseparable mixture of (323a) and (323b) was oxidised 
with m-CPBA and the resulting sulfoxides were heated at reflux in carbon tetrachloride 
affording the (3) and (324) (Scheme 104).5 
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2.5 Routes towards the total synthesis of natural products, (-)-
erysotrine and (-)-erythraline, and other related alkaloids 
MeO 
Me 
MeO""'" MeO""'" 
erysotrine (7) erythraline (325) 
Introduction 
Due to the success of our methodology on the fonual asymmetric synthesis of both 
enantiomers of the natural product, 3-demethoxyerythratidinone (3) (Chapter 2.1 and 
2.2) we decided to continue our work on the synthesis of related erythrina alkaloids. We 
will therefore describe our progress and application of our methodology towards the 
synthesis of the more complex erythrina alkaloids, in particular (-)-erysotrine (7) and 
(-)-erythraline (325). 
2.5.1 Retrosynthetic analysis 
RI = R2 = Me (7) 
RI + R2 = CH2 (325) 
Scheme 105 
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The retrosynthetic pathway shown in Scheme 105 utilises a cyc1ocondensation reaction 
leading to the synthesis of the tricyc1ic lactam. N-Acyliminium ion methodology is then 
applied to generate the erythrinan skeleton. Simple manipulation of the ring system 
would generate the target natural products, (-)-erysotrine (7) and (-)-erythraline (325). 
2.5.2 Attempted synthesis of the racemic keto-acid 
In order to perform our cyc1ocondensation reaction we were required to synthesise the 
required keto-acid and ~-amino alcohol precursors. Our initial studies focussed on the 
generation of the required keto-acid. 
~-
° (258) 
co ~ 
° (326) 
Our first approach was to adapt our previous methodology and synthesise a keto-acid 
derivative (326) based on our success with keto-acid (258). On this occasion we were 
required to synthesise the 1,3- instead of the 1,4-mono-protected di-ketone in order to 
get the protected ketone in the correct orientation for our desired products. 
The initial step in the synthesis of the required keto-acid (326) was the preparation of 
the corresponding mono-protected di-ketone (328). Takagi and co-workers have 
previously reported the preparation of the required mono-protected di-ketone from the 
commercially available 1,3-cyc1ohexanedione (327), using ethylene glycol (1 equiv) 
and p-TSA, refluxed in toluene under Dean-Stark conditions for 4.5 hours. We repeated 
these reaction conditions and successfully generated the desired product, 1,3-
cyc1ohexanedione monoethylene ketal (328), however in an unsatisfactory 9% yield 
(Scheme 106).46.47 Unfortunately, we also synthesised the equivalent diethylene ketal 
(329) in 17% yield, but we were able to re-isolate a significant amount of starting 
material. 
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Our attempts to improve the yield of the mono-protected ketone (328) using different 
equivalents of ethylene glycol were unsuccessful (Table 3). In each case the IH NMR 
spectrum of the crude product showed a significant amount of the di-protected ketone, 
as well as starting material. There was no specific control towards the mono-protected 
di-ketone, in comparison to the di-protected ketone. 
Table 3: Mono-protection study of l,J-cyclohexanedione (327) 
Entry Ethylene glycol Mono-protected Di-protected 
(equi';) ketone (328) ketone (329) 
1 1 9% 17% 
2 0.9 14% 15% 
3 0.75 11% 7% 
With the poor selectivity and yields observed above, we decided that a different 
approach was required in order to synthesise the required mono-protected di-ketone 
(328). 
Batty and Crich,48 have reported the synthesis of a similarly mono-protected di-ketone 
substrate (332) via a two step procedure (Scheme 107). This group took the substrate, 2-
methylcyclohexane-l,3-dione (330) and using excess ethylene glycol prepared the di-
protected ketal (331). They then performed a controlled hydrolysis of one of the ketal 
protecting groups, using 15% H2S04 and silica gel to produce the monoethylene ketal 
(332). 
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Scheme 107 
Using this methodology we took our di-ketone substrate (327) and added 4 equivalents 
of ethylene glycol, in the presence of p-rSA, and refluxed under Dean-Stark conditions 
for 16 hours, to produce the desired 1,3-cyclohexanedione diethylene ketal (329) in 78% 
yield (Scheme 108). 
15% H2S04 
n 
Ethylene glycol qj) Q UO p-TSA Silica gel • • Toluene DCM 
(327) 78% (329) 75% (328) 
Scheme 108 
Without further purification, the diethylene ketal (329) was then dissolved in DCM and 
15% H2S04 and silica gel were added. The mixture was then stirred for 2.5 hours at 
room temperature and this produced the desired mono-protected di-ketone (328) in 75% 
yield (Scheme 108). 
With the synthesis of the (328) in hand; we then focussed our attention on its conversion 
to the required keto-ester (333). Using methodology described in Chapter 2.2.2, we 
hoped to synthesise the required keto-ester (333) using the same enolate chemistry. 
Although there are two possible outcomes for this reaction, at positions (i) and (ii), we 
believed the alkylation might be directed toward position (i) rather than position (ii) due 
to the steric hindrance generated by the ketal protecting group (Figure 4). 
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With this hypothesis in hand, we attempted the alkylation using the standard conditions 
discussed previously in Chapter 2.2.2. The first attempt at the alkylation using KHMDS 
(1.1 equiv) stirred in dry THF, at -78 ·C, for 20 hours produced a mixture of compounds 
(Scheme 109). Unfortunately, further analysis of the IH NMR spectrum of the crude 
product showed that there was no trace of the desired product (333). After purification, 
using flash column chromatography, and further characterisation we discovered that the 
alkylation had occurred at the undesired, and believed to be most hindered, position 
(position (ii), Figure 4). 
~ 
o 
KHMDS 
)( .. ~M' 
o 
(328) Scheme 109 (333) 
Subsequent attempts at this alkylation using excess KHMDS (up to 1.5 equiv) did not 
produce the desired product (333). Under these conditions the IH NMR spectrum 
showed a mixture of unidentifiable products. Reducing the amount of KHMDS (down 
to 0.75 equiv) did produce a mono-alkylated product, unfortunately the IH NMR 
spectrum showed that the alkylation had again occurred at the unwanted position (ii) 
instead of position (i) as required. 
As a result of these observatiol1.s, we were now unable to synthesise the proposed keto-
acid (326), so we decided that an alternative approach was necessary to synthesise the 
required keto-acid. Our aim was to try and block position (ii) (Figure 4), thus directing 
the alkylation to the required position. To do this we needed to generate a new template 
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(Figure 5) where position (ii) is blocked, thus preventing the alkylation occurring at that 
position. 
2.S.3 Synthesis of the racemic keto-acid 
Our new approach was to synthesise a new template (Figure 5) where position (ii) is, 
effectively, blocked by a double bond. We hoped that the subsequent alkylation would 
now occur at the desired position (Position (i», (Figure 5). 
FigureS 
R = H (334), Cl (335), 
OMe (336), OEt (337) 
Four easily accessible substrate variations were considered based on this template. The 
first two substrates: 2-cyclohexen-I-one (334) and 3-ethoxy-2-cyclohexen-I-one (337) 
were commercially available, whereas the remaining two substrates: 3-chloro-2-
cyc1ohexen-I-one (33S) and 3-methoxy-2-cyc1ohexen-I-one (336) were easily 
synthesised from known literature procedures from commercially available 1,3-
cyc1ohexanedione (327). These substrates were chosen as they all had slightly different 
properties. Substrates (336) and (337) were chosen as the R substituent (R = OMe & 
OEt) could be easily hydrolysed regenerating the ketone functionality when required. It 
was hoped that the electron-withdrawing properties of substrate (33S) would direct the 
subsequent alkylation towards the required position away from position (ii) (Figure 5). 
Substrate (334) was chosen as it was the basic template with no R substituent, but the 
double bond gave us the option to add the required substituents at a later stage in the 
reaction sequence. 
Using methodology developed by Chandrasekhar and Reddy,49 commercially available 
1,3-cyclohexanedione (327) was refluxed with trimethyl orthofonnate, methanol and p-
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TSA (cat.) in toluene for 80 minutes. The desired product 3-methoxy-2-cyciohexen-l-
one (336) was obtained in 86% yield with no further purification necessary (Scheme 
110). 
(327) 
CH(OCH3h 
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MeOH, Toluene 
86% 
Scheme 110 
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Clark and Heathcockso prepared 3-chloro-2-cyciohexen-I-one (335) from the 
commercially available 1,3-cyciohexanedione (327). They dissolved (327) in 
chloroform and then added oxalyl chloride slowly due to a vigorous evolution of gas. 
The reaction mixture was stirred at room temperature for 10 minutes, before been 
refluxed for an additional 13 minutes to generate the required product (335) in 68% 
yield (Scheme 111). 
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With (334H337) in hand, we then attempted the alkylation usmg our standard 
conditions discussed previously in Chapter 2.2.2.21 
Our initial attempt at this alkylation using KHMDS (1.lequiv) and 3-methoxy-2-
cyciohexen-l-one (336) as the substrate, in dry THF at -78°C for 20 hours, generated a 
mixture of starting material and a trace amount of the desired keto-ester (338) (Table 4: 
Entry 1) (Scheme 112). Purification via flash column chromatography enabled us to 
isolate the desired product (338) and analysis of 1H NMR spectrum indicated that we 
had synthesised the desired keto-ester (338), as it clearly showed still the presence of a 
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single proton at ~5.38 ppm representing the double bond, thus indicating the alkylation 
had occurred at the correct position. 
"'ov Base MoO~ • I C02Me 
Br~C02Me 
0 0 
(336) (338) 
Scheme 112 
Attempts at improving these alkylation conditions, using a co-solvent such as 1,3-
dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU), were unsuccessful as on 
both occasions only starting materials were recovered (Table 4: Entry 2 & 6). 
This alkylation reaction was attempted with a number of different bases, as shown in 
Table 4, however changing the base from KHMDS to NaHMDS or LiHMDS only had a 
negative affect on the required alkylation (Table 4: Entry 3 & 4). On both occasions 
only starting materials were isolated with no trace of the desired product (338). 
Table 4: Attempted alkylations with (336). using a range of different bases. 
Entry Base Equivalents Observation 
1 KHMDS 1.1 Trace 
2 KHMDS& DMPU 1.1 S.M. 
3 NaHMDS 1.1 S.M. 
4 LiHMDS 1.1 S.M. 
5 LDA 1.1 Trace 
6 LDA&DMPU 1.1 S.M. 
7 LDA 1.5 30% 
8 LDA 1.8 58% 
With no real success achieved with the alternative bases used we decided to apply the 
well known base lithium diisopropylamine (LDA).51 This reaction was initially 
attempted using LDA (1.1 equiv) stirred in dry THF, at -78°C, for 24 hours and 
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produced a trace amount of the desired keto-ester (338) (Table 4: Entry 5). Again we 
had successfully synthesised our desired product (338), but as previously, the yield was 
still extremely poor. 
However, we decided to repeat the reaction again, this time using more equivalents of 
LDA. We performed the alkylation using LDA (1.5 equiv) under the same reaction 
conditions and isolated the keto-ester (338) in an improved 30% yield. Unfortunately, as 
observed previously, there was still a significant amount of starting material still present 
(Table 4: Entry 7). 
As shown in Table 4: Entry 8, we eventually managed to convert our substrate, 3-
methoxy-2-cycIohexen-l-one (336) to its equivalent keto-ester (338) in 58% yield using 
1.8 equivalents of LDA stirred in dry TIIF at -78°C for 24 hours. The IH NMR 
spectrum of the crude product showed the desired product (338) had been synthesised 
with only a trace of starting material still present (Scheme 112).51 
With these conditions in hand, we applied this methodology and successfully 
synthesised the other three keto-esters (339)-(341), where R = H, Cl, ~Et, in yields of 
52,48, 59%, respectively (Scheme 113). 
LDA 
Scheme 113 
.. 
R = H (339),CI(340), 
OEt (341) 
With all four keto-esters (338)-(341) in hand, the next step in our reaction sequence was 
to convert them to the required keto-acid. 
The synthesis of the required keto-acids was achieved via subsequent ester hydrolysis 
utilising the same methodology discussed previously in Chapter 2.2.2. The keto-esters 
(338)-(341) were hydrolysed using LiDH in THF/IIzO, at room temperature for 22 
hours, generating the keto-acids (R = OMe (342), OEt (343), Cl (344) in overall yields 
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of 79, 84 and 81%, respectively. Unfortunately, the synthesis of the required keto-acid 
(345), where R = H, was unsuccessful. The IH NMR spectrum of the crude product 
showed that we had generated the required keto-acid along with some unknown by-
products. Attempts at purification via flash column chromatography resulted in the 
decomposition of the desired product (Scheme 114). 
LiOH 
(338)-(341) 
Scheme 114 
.. 
R = OMe (342), OEt (343), 
Cl (344), H (345) 
2.6 Towards the total synthesis of the natural product, (-)-erythraline, 
and other related alkaloids 
MeO"'"'' 
erythraline (325) dihydroerythramine (346) 
Introduction 
The application of our methodology for the synthesis of more complex erythrina 
alkaloids, in particular (-)-erythraline (325) and its derivative, dihydroerythramine (or 
tetrahydroerythraline) (346) is described below. These alkaloids were isolated from the 
seeds of a number of erythrina plants including Erythrina latissima, Erythrina fosca 
Lour and even from the previously mentioned Erythrina variegata L. (formerly 
Erythrina lithosperma BLUME) (Chapter 2.2.1). 
Results & Discussion -116 -
2.6.1 Literature Review 
The synthesis of (-)-erythraline (323) and other related alkaloids including 
dihydroerythramine (or tetrahydroerythraline) (346) and erythrocarine (347) have been 
reported only a few times in the literature, albeit in a racemic form, however there are 
no examples of a non-racemic synthesis of these natural products to the best of our 
knowledge. Examples of previous racemic approaches to these natural products are 
discussed below. 
Mori and co-workers52 have reported the total synthesis of the related alkaloid 
erythrocarine (347) utilising a nickel-mediated alkylative carboxylation and a ring 
closing metathesis (RCM) of a dienyne as the key steps. The synthesis of the alkyne 
(349) was achieved in four steps from the commercially available 6-bromopiperonal 
(348) as reported by Mori and co-workers. 52 Carboxylation to the alkyne was achieved 
using a nickel complex and was followed by the addition of an alkynylzinc reagent. The 
reaction mixture was then hydrolysed before being treated with diazomethane, 
generating the desired ester (350). Deproteetion of the Boe group followed by Michael 
addition and deprotection of the silyl group afforded the bicyclic ester (351). Allylation 
of the secondary amine was followed by a Swern oxidation of the reduced ester (352). 
The addition of vinylmagnesium bromide afforded a diastereomeric mixture of products 
and the resulting alcohol was protected with an acetyl group to give the precursor (353). 
Treatment of (353) with HCI produced the dienyne hydrochloride which, in the 
presence of 10 mol% of Grubbs first-generation catalyst, produced the tetracyclic 
compound (354) in a I: I ratio of diastereomers. Finally, treatment with K2C03 in 
MeOH removed the acetyl group generating the natural product erythroearine (347) 
(Scheme I IS). 
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Desmaele and co-workerss3 reported the synthesis of the (±)-dihydroerythramine (346) 
using methodology that generates the required C-ring by utilising a Pummerer-based 
cyc1isation. The key precursor (355) for the synthesis of the C-ring via this Pummerer-
based cyc1isation was achieved in four steps from the commercially available (nitro~ 
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methyl)arene derivative (202). S3 With (355) in hand, the fonnation of the C-ring was 
then achieved by a three step procedure. The first step investigated was the two-carbon 
elongation required at the nitrogen atom of the lactam (355). 
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This elongation was achieved via a hetero Michael addition of the lactam anion to 
phenyl vinyl sulfoxide (204) upon trea1Jnent with NaHMDS. The subsequent Pummerer 
cyclisation of the C-ring was then achieved by treating sulfoxide (356) with TMSOTf in 
the presence of i-Pr2NEt. The crude product was then subjected to desilylation with n-
B\4NF producing the required tetracyclic thioether (357). The desulfurization of the 
thioether (357) was achieved using tri-n-butyltin hydride and AIBN to produce the 
desired 3-methylene-erythrinan-8-one (358). With the erythrinan system complete, 
attention turned to the functionalization of the A ring. Oxidative cleavage of the 
exocyclic double bond was achieved using the Lemieux-Iohnson oxidation conditions, 
producing the required ketone (359). Luche reduction of the carbonyl produced the 
desired alcohol (360) as a mixture of diastereomers (3: 1). Methylation of the resulting 
hydroxyl group generated the key precursor hexahydrocrytamidine (361) and fmally, 
reduction of the carbonyl group with AlH3 gave the desired natural product, (±)-
dihydroerythramine (346) (Scheme 116). 
Sano and co-workers54 have reported a regiospecific and stereoselective synthesis of the 
erythrinan skeleton utilising an intermolecular Diels-Alder reaction. The key 
intermediate is the dioxopyrroline (362), synthesised in three steps from a commercially 
available arylethylamine, using a known procedure reported by Sano and co-workers. 54 
With the dioxopyrroline derivative (362) in hand, the synthesis of the desired tetracyclic 
erythrinian skeleton (364) was then achieved via a three step procedure. The first step 
was an intermolecular Diels-Alder reaction with the activated butadiene, I-methoxy-3-
(trimethylsilyloxy)buta-I,3-diene (363). The resulting intermediate was then reduced 
with LiBH4 and then hydrolysed in situ, with HCI to isolate the required tetracyclic 
compound (364). Mesylation of the enone (364) and the subsequent 
demethoxycarbonylation of the corresponding mesyl derivative with MgCh in DMSO 
gave the dienone (365). Reduction with NaB~ gave the corresponding alcohol (359) as 
a mixture of diastereomers. Methylation of (366) with methyl iodide in the presence of 
E4N8r and KOH generated the (±)-8-oxoerythraline (367). Finally reduction with a 
LiAl~-AlCh combination afforded the natural product, (±)-erythraline (325) (Scheme 
117). 
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2.6.2 Synthesis of the enantiopure p-amino alcohol substrate 
With the synthesis of the required keto-acid (342) in hand, as discussed previously in 
Chapter 2.5.3, we turned our attention to the preparation of the required ~-amino 
alcohol. In this case, in order to access the target natural products (-)-erythraline (325) 
and its derivative, dihydroerythramine (346), we needed to synthesise the 
methylenedioxy phenyl-L-a1aninol (368). 
( 0yYY"OH ~ NH2 
(368) 
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Unfortunately, this ~-amino alcohol (368) and its corresponding amino acid parent are 
not commercially available, which was a surprise due to the number of natural products 
containing the methylenedioxy ring system. However, Ollero and co-workers55 have 
synthesised a protected amino ester (372), containing the methylenedioxy ring system, 
generated from the commercially available L-DOPA (369) using a three step procedure. 
Due to the insolubility of L-DOPA (369) it was first converted to its equivalent methyl 
ester before being subjected to further protections. The phenols were protected as tert-
butyldimethylsilyl (TBDMS) ethers, generating the amino ester (370). 
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Scheme 118 
The amino group was then protected with 9-phenylfluoren-9-yl bromide (Pmr), 
affording the protected amino ester (371). The methylenedioxy group was then 
introduced in a one-step procedure using CH2Clz and CsF in DMF and this occurred 
with the simultaneous deprotection of the silyl groups generating the desired compound 
(372) (Scheme 118). 
In the same publication, Ollero and co-workersss have also synthesised the desired (R)-
amino acid (376) via the use of a chiral auxiliary. Deprotonation of the oxazinone (373) 
with NaHMDS followed by the alkylation of the substituted benzylic bromide (374) 
afforded the alkylation adduct (375). The aIkylated oxazinone was then hydrolysed with 
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a mixture of MeOH and 3M Hel (6:1) and then hydrogenated with Pd(OH)2/C 
generating the optically pure amino acid (R)-(376) (Scheme 119). 
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Using this methodology we could generate the opposite (S)-enantiomer of the amino 
acid (376) by using the (S)-oxazinone. With the amino acid (376) in hand, we could 
then reduce it using LiAlH4, producing the desired ~-amino alcohol (368). However, we 
decided that this methodology was impractical and instead chose to synthesise the ~­
amino alcohol derivative (368) by adapting the methodology described in Scheme 118, 
as L-DOPA (369) is a cheaper and more accessible starting material. 
The first step in our synthesis was to esterify the commercially available substrate 
dihydroxyphenyl-L-alanine (L-DOPA) (369) in order to improve its solubility and 
stability. 56 This was achieved by dissolving L-DOPA in MeOH and then adding thionyl 
chloride dropwise generating the methyl ester hydrochloride salt in a quantative yield. 
The next step was to protect the phenolic groups with a TBDMS ether protecting group. 
This was achieved by using the protecting group TBDMSCl, activated in the presence 
of imidazole, to generate the desired amino ester (370) in 60% yield. 55 With compound 
(370) in hand, the amino group was then Boc-protected with di-tert-butyl dicarbonate 
and Et3N to produce the N-Boc-protected amino ester (377) in 67% yield. With the 
protecting groups in place the next step was the formation of the methylenedioxy ring 
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system using BrCH2Cl and CsF. The formation of the methylenedioxy ring proceeds via 
the simultaneous deprotection of the silyl protecting groups producing the desired 
amino ester (378) in 91% yield. Analysis of the IH NMR spectrum confirmed the 
formation of the methylenedioxy ring with a two proton peak at NS.94 ppm. With the 
synthesis of the methylenedioxy ring complete, the next step was the removal of the N-
Boc protection using TFA in dry DCM to produce the corresponding amino ester (379) 
in 69% yield. The final step in this sequence was the reduction of the amino ester (379) 
to the target ~-amino alcohol (368) using excess NaBH! in absolute ethanol (Scheme 
120). 
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Unfortunately, the IH NMR spectrum of the crude product showed that we had 
synthesised the desired product (368), along with some unknown by-products. Attempts 
at purification using flash column chromatography were unsuccessful, and we were 
unable to isolate the product (368) from the unknown by-products (Scheme 120). 
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Unfortunately due to time constraints, and a change in our synthetic target, we decided 
not to repeat this work. 
2.6.3 Future work: Our proposed synthesis of (-)-erythraline, and other related 
alkaloids 
With the keto-acid (342) (Chapter 2.5.3) and p-amino alcohol (368) in hand, our 
proposal shown in Scheme 121 was to prepare the corresponding tricyclic lactarn (380) 
using our standard condensation conditions. We would then perform an intramolecular 
cyclisation generating the tetracyclic erythrinan skeleton (381). Simple manipulation of 
this skeleton using known literature methodology would lead to the synthesis of a 
nwnber of natural products, including (-)-erythraline (325). 
M~ C()('0H I C02H """ """ NH2 (368) #' 
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Scheme 121 
Unfortunately, work done on an alternative synthetic target leading to the synthesis of 
erysotrine (7) and erysotramidine (201) and described in detail in Chapter 2.7.2 had 
shown that the standard condensation of the keto-acid (342) with a similar amino 
alcohol derivative did not produce the expected tricyclic lactarn, but instead performed a 
'Michael-like' addition of the amine. Details of this work will be discussed in Chapter 
2.7.2. 
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However, due to time constraints we were unable to amend this methodology with 
substrate (368), and our work towards the total synthesis of the natural products (-)-
erythraline (325) and dihydroerthramine (346) was abandoned at this stage. Instead we 
decided to concentrate our attention on the synthesis of the similar natural products 
erysotrine (7) and erysotramidine (201) as the amino alcohol derivative required for this 
synthesis was more readily accessible and thus more practical with the limited time 
available. 
2.7 Towards the total synthesis of the natural product (-)-erysotrine, 
and other related alkaloids 
M 
M 
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(-)-Erysotrine (7) and its 8-oxo-derivative, (-)-erysotramidine (201) have been isolated 
from the seeds of a number of erythrina plants including Erythrina latissima, Erythrina 
fusca Lour and also from the previously mentioned Erythrina variegata 1. (formerly 
Erythrina lithosperma BLUME) (Chapter 2.2.1). 
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2.7.1 Literature Review 
The synthesis of erysotrine (7) and other related alkaloids, including erysotramidine 
(201) and erythravine (382), have been reported many times in the literature, albeit in 
racemic form, however there are only a few examples of non-racemic syntheses of these 
natural products. Examples of previous racemic and non-racemic syntheses of these 
natural products are discussed below. 
Padwa and co-workers57 have reported that an intramolecular electrophilic aromatic 
substitution reaction of hexahydroindolinones allows for the rapid construction of the 
tetracyclic erythrinan skeleton. In this specific case, Padwa and co-workers have 
synthesised the bicyclic lactam (384) via condensation of 3,4-demethoxyphenethyl-
amine and keto-ester (383) in the presence oftrifluoroacetic acid (TFA). The formation 
of the n,~-unsaturated ene-amide (384) occurred with the simultaneous acid catalysed 
elimination of the phenylsulfonyl group. With the bicyclic lactam (384) in hand, the 
next step was the smooth cyclisation to the desired erythrinan skeleton (386) and this 
was achieved upon treatment with NBS in acetonitrile. This reaction proceeded via the 
formation of the N-acyliminium ion intermediate (385). Treatment of (386) with DBU 
in refluxing xylene resulted in the formation of the n, ~, y, /i-unsaturated diene-amide 
(387). This product was believed to have been formed by an initial dehydrobromination, 
followed by the isomerisation of the It-bond into the thermodynamically more stable 
position. The stereoselective a1lylic oxidation of (387) with Se02 in the presence of 
formic acid gave a 1: 1 mixture of the formate (388) and the alcohol (389) as a single 
diastereoisomer. The formate (388) was then converted to the alcohol (389) upon 
treatment with acetyl chloride in ethano1.58 The final step in the synthesis of (±)-
erysotramidine (201) is the O-methylation of the alcohol using KOHlMeI in THF using 
methodology previously reported by Tsuda and co-workers (Scheme 122).59-61 
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!MeCN 
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(387) .# I SeQlHco,H 
Me MeO 
Me KOH, Mel MeO .. 
MeO 
MeCOCI ( (388)R = CHO 
erysotramidine (201) 
EtOH (389) R = H Scheme 122 
Tsuda and co-workers27 have reported the first asymmetric synthesis of (+ )-erysotrine 
(7) from an L-DOPA derivative utilizing an asymmetric Diels-Alder reaction under 
super high pressure. The key intermediate in this synthesis is the chiral dienophile, 
dioxopyrroline (391), prepared in three steps from (S)-3,4-dimethoxyphenylalanine 
methyl ester hydrochloride (390). With (390) in hand, the subsequent Diels-Alder 
reaction with l-methoxy-3-trimethylsilyloxybutadiene (5 equiv) (392) in DCM at l30°C 
(10 kbar pressure) produced the desired erythrinan skeleton (393). The next step was the 
protection of the ketone with ethylene glycol and p-TSA in benzene, followed by the 
reduction of the corresponding intermediate with sodium borohydride in methanol 
producing the required alcohol (394). Alkaline hydrolysis of the methyl ester followed 
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by the application of the classical Barton decarboxylation protocoes on the 
corresponding carboxylic acid produced the target intennediate (395). 
MeO~C02Me 3 steps 
.. 
.# NH2·HCI MeO 
(390) 
MeO (i) ~OH HO 
Me po TSA, benzene 
.. 
(ii) NaBH4 /MeOH 
(394) 
(i) 4% NaOH-EtOH(1 :4) 
(ii) i-BuOCOCI, NMM 
(iii) N-hydroxypyridinethione 
sodium san, Et3N 
(iv) hv, t-BuSH 
Me 
MeO 5%HCI-THF(1:1) 
.. 
steps 
.. 
(+ )-erysotrine (7) 
Scheme 123 
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,;:? OMe 
Si02 [10 Kbar] 
(393) 
(i) MSCI-DMAP/Py 
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Acid hydrolysis of (395) generated the enone (396) with simultaneous deprotection of 
the ketone moiety. Mesylation of (396) followed by decarbomethoxylation with 
CaClzlDMSO gave the dienone (397). This intermediate is a known compound, albeit in 
a racemic form, and has previously been converted to the natural product erysotrine (7) 
by Tsuda and co-workers (Scheme 123).62.63 
Fukumoto and co-workers64 have reported the fIrst total synthesis of the erythrina 
alkaloid (±)-erythravine (382) utilising the tandem ring closing metathesis (RCM) 
protocol. 
MeoX)! 
I A NH MeO /./ 2 
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Me 
MeO 
TBDPS (400) 
Me 
M 
(i) TBAF 
(ii) SWem 
(iii) CH2=CHMgBr 
R 
AezO ( R = OH (401) 
DMAP R = OAc (402) 
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The diester (398) was synthesised in three steps from the commercially available 
3,4-dimethoxyphenethylamine (114), as reported by Fukwnoto and co-workers.64 The 
reduction of (398) with LiAl~ followed by selective silylation gave the TBDPS-ether 
(399). Swem oxidation of (399) and the subsequent reaction of the resulting aldehyde 
with the Bestmann's reagent65 afforded the enyne (400). Subsequent steps included 
desilylation, Swem Oxidation, and Grignard reaction using vinylmagnesium bromide, 
generating the required dienyne (401) as a 1:1 epimeric mixture. The resulting alcohol 
(401) was then converted to the corresponding acetate (402) upon treatment with acetic 
anhydride. The acetate (402) was then reacted with 10 mol% of Grubb's first generation 
catalyst, refluxed in DCM, producing the required tetracyclic intermediate, which upon 
treatment with K2C03 in methanol furnished the desired natural product, (±)-erythravine 
(382) (Scheme 124). 
2.7.2 Synthesis of the tricyclic lactam leading to an attempted synthesis of 
erysotrine 
Continuing our progress towards the synthesis of erysotrine (7) and, other related 
alkaloids including erysotramidine (201), we will now discuss the synthesis of the 
tricyclic lactam (403). With the keto-acid (342) (Chapter 2.5.3) and ~-amino alcohol 
(264) (Chapter 2.2.3) precursors in hand, the next step in this synthesis was the 
cyclocondensation of these two intermediates, using our standard methodology. 
The preparation of the tricyc1ic lactam (403) was initially attempted by refluxing the 
keto-acid (342) and the ~-amino alcohol (264) in toluene, under Dean-Stark conditions, 
for 48 hours (Scheme 125). 
~OH 0 .~ I C02H 4 NH2 MeO 
""" OMe (264) ~~ .. .# 0 Toluene OMe 
0 OMe (342) (403) 
Scheme 125 
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We hoped that under these reaction conditions we would generate the lactam as usual, 
but this would occur with the simultaneous hydrolysis of the vinyl ether, generating the 
desired ketone (403). Unfortunately, the initial analysis of the IH NMR spectrum of the 
crude product showed that the desired lactam (403) had not been synthesised due to the 
presence of a single proton peak at ~5.60 ppm, representing the double bond. We 
initially believed that we had synthesised the tricyclic lactam (404) due to the presence 
of the third methoxy peak. 
o 
OMe (404) 
# OMe 
OMe 
(405) 
OMe 
However, LCMS analysis of the crude product highlighted three major molecular 
weights (MW): 184, 345 and 539. Unfortunately, there was no peak representing the 
desired MW: 358 required for the tricyclic lactam (404). The MW: 184 represented the 
keto-acid (342) starting material, however MW: 345 interested us as it had the same 
molecular weight as the desired tricyclic lactam (403). We now believe that we 
generated the enamide (405), as this would have the same molecular weight as (403). 
This observation is supported by the IH NMR spectrum, as the single proton peak at 
~5.60 ppm was broader than expected, suggesting we had synthesised a conjugated 
ketone, and furthermore, the additional methoxy peak was later identified as keto-acid 
starting material (342). Attempted purification, using flash column chromatography, 
enabled us to isolate a trace amount of the enamide (405) and a number of other by-
products including starting material (only the keto-acid (342». Unfortunately, we were 
unable to isolate the enamide (405) cleanly as it co-eluted with an unknown by-product, 
therefore we were unable to fully characterise. 
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However, MW: 538 intrigued us as it suggested that there was a competing reaction 
occurring during the condensation. The proposed structure representing this molecular 
weight is the lactam (406) above. Unfortunately, we have no evidence to support this 
claim as we were unable to isolate this product (406) using flash column 
chromatography, as the product was unstable and decomposed on the column. 
What we think is happening is that during our standard condensation reaction some of 
the 13-arnino alcohol substrate is instead attacking the conjugated double bond, 
performing a 'Michael-like' addition. Although we have no physical evidence for the 
formation of this product (406) (or similar product), we are not surprised that such a 
product could be formed due to the conjugation present in the keto-acid derivative 
(342). Further evidence, for this theory is supported by the fact that we only managed to 
re-isolate some of the keto-acid (342) with no trace of the 13-amino alcohol (264). This 
would be expected if the 13-amino alcohol was simultaneously attacking with the keto-
acid from two different directions as the keto-acid would not be consumed during the 
reaction. 
This reaction was repeated a few times using the keto-acid (343) (Scheme 126), but 
once again, we were only able to isolate a trace amount of the enamide (405). 
OMe ~I "'" OH """ NH2 MeO OMe (264) 
.. 
Toluene 
(343) o (405) 
Scheme 126 
Increasing the number of equivalents of the 13-amino alcohol used in this reaction was 
also tried in an attempt to consume the excess keto-acid, but this had no effect on the 
overall yield of the enamide (405). Something was competing with the formation of the 
enamide (405) and we assumed it was something to do with the conjugated double 
bond. So, in order to prevent this completing side reaction we decided to try and remove 
the double bond from our keto-acid substrate (342). 
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This was attempted using methodology by Schultz and co-workers,66 who used lithium 
metal and liquid ammonia to remove a double bond from a similar vinyl ether substrate 
(407) (Scheme 127). 
Me~ rOMe_· __ L_i._N_H_3 _ _ 
. oJJOMP t-SuOH. NH4CI • 
(407) Scheme 127 
We applied this methodology in an attempt to produce the desired keto-acid substrate 
(409) where the double bond had been removed (Scheme 128). The keto-ester (338), 
synthesised in two steps from the commercially available 1,3-cyc1ohexanedione (327) 
(Chapter 2.5.2), was treated with lithium metal and liquid ammonia in dry THF at 
-78°C (Scheme 128). 
~O 2 Steps ~ .. - I C02Me (327) o (338) 
Li, NH3 
t-SuOH 
M~ ~ LiOH C02H .. C02Me THFIH20 0 0 
(409) (408) 
Scheme 128 
The 1 H NMR spectrum of the crude isolated compound showed that the single proton at 
N5.38 ppm representing the double bond had been removed, but unfortunately, the 
reaction conditions were too harsh and the resulting keto-ester (408) had totally 
decomposed and was no longer recognisable. 
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As a consequence of this observation we decided an alternative route was required in 
order to synthesise the desired erythrinan skeleton necessary to achieve our target 
synthesis of the natural products, erysotrine (7) and erysotramidine (201). 
2.7.3 An alternative synthesis of (-)-Erysotrine, and related alkaloids 
Lete and co·workers67 have reported the synthesis of the pyrroloisoquinolone (410) 
where they have utilised an amide coupling reaction, followed by a BF3.Et20 induced 
N-acyliminium ion cydisation as shown in Scheme 129. 
MeO 
""" 
~O Me 
""" 
OTBDPS OTBDPS 
M # NHz AezO, AcONa 
• #~O Me 
j-
M MeO 
""" 
OTBDPS 
BF3·EtzO #~O • M Me""'" Me 
(410) Me 
Scheme 129 
Our aim was to adapt this methodology in order to produce our target tetracyclic ring 
system of the erythrina alkaloids. 
2.7.4 Alternative retrosynthetic analysis of erysotrine 
The retrosynthetic pathway shown in Scheme 130 utilises an amide coupling reaction 
followed by a Lewis Acid induced N-acyliminium ion cyclisation leading to the 
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formation of the erythrinan skeleton. Simple manipulation of this ring system would 
generate the target natural products, (-)-erysotrine (7) and (-)-erysotramidine (201). 
M 
""" 
OH 
M .# 0 > M 
MeD\""" 
MeO 
erysotrine (7) 
~ 
MeO~OTBDMS 
I # NH OTBDMS MeO 2 0 (411) Me 
+ <: 
I C02H 
Me~ 
M 
0 (342) 
Scheme 130 
2.7.5 Synthesis ofthe protected p-amino alcohol 
Since the synthesis of the keto-acid precursor (342) has been discussed previously, we 
will therefore only describe the synthesis of the ~-amino alcohol derivative (411). The 
first step in this synthesis was the Boc-protection of the commercially available 3-(3,4-
dimethoxyphenyl)-L-alanine (263). This was achieved in 80% yield using triethylamine 
and di-tert-butyl dicarbonate, stirred in a mixture of water and 1,4-dioxane at 0 °C. With 
the N-Boc amino acid (412) in hand, we then performed a reduction of the acid, with 
LiB& and Me3SiCI in dry THF, in order to generate the required N-Boc amino alcohol 
(413). Unfortunately, the IH NMR spectrum showed that an intramolecular cyclisation 
had occurred forming the oxazolidinone (414), as there was no peak at ~1.43 ppm 
presenting the tert-butyloxy group of the Boc-protection (Scheme 131). 
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Me 
o 
MeO HN--{ 
o 
(414) 
The acid is reduced to the alcohol as expected but the lithium metal coordinates to the 
alcohol and the Boc group causing the alcohol to cycIise, thus producing the 
oxazolidinone (414). 
o 
MeO OH .. 
MeO 
(263) 
Scheme 131 
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In order to synthesise the TBDMS-protected amino alcohol (411), an alternative 
procedure was required in order to generate the amino alcohol derivative (413). We 
needed to first synthesise the N-Boc amino ester (415), before reducing it with NaB~. 
The .first step was the preparation of the a-amino ester hydrochloride salt, from the 
commercially available a-amino acid (263), using thionyl chloride and methanol, and 
this produced the a-amino ester in a quantative yield. S6 With the amino ester in hand, we 
next wanted to protect the amino group. As described above, the amino group was Boc-
protected with di-tert-butyl dicarbonate and triethylamine and this produced the N-Boc 
amino ester (415) in 58% yield. The amino ester (415) was then reduced with NaB~ (4 
equiv), stirred in absolute ethanol, and this produced the desired N-Boc amino alcohol 
(413) in 81% yield, with no trace of the unwanted oxazolidinone (414). TBDMS-
protectionSS of the N-Boc-amino alcohol (413) with tert-butyldimethylsilyl chloride 
(TBDMSCl), in the presence of imidazole, produced the TBDMS-protected amino 
alcohol (416) in 75% yield (Scheme 132). 
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The final step in this reaction sequence, in order to generate the desired substrate (411), 
was the removal of the N-Boc protection. This was attempted with excess trifluoroacetic 
acid (TFA) in dry DCM, but unfortunately, the IH NMR spectrum of the crude product 
showed that we had not synthesised the target substrate (411), but had once again 
synthesised the oxazolidinone (414) by-product. The TFA had deprotected the silyl 
ether causing it to cyclise onto the Boc protecting group producing the oxazolidinone 
ring (Scheme 133). 
Me TFA 
MeoX)'C OTBDMS 
>( I ~ OTBDMS .. 
Me 
HNYK # NH2 DCM MeO (416) 0 (411) 
Scheme 133 
In order to prevent the silyl ether cyclising onto the Boc protecting group we decided to 
change the silyl protecting group to tert-butyldiphenylsilyl chloride (TBDPSCI). We 
hoped that the two phenyl rings would increase the steric bulk of the protecting group, 
thus preventing it from cyclising onto the Boc group. 
We took the N-Boc-amino alcohol (413) and using TBDPSCI, in the presence of 
imidazole, we successfully synthesised the TBDPS-protected alcohol (417) in 60% 
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yield. With the lBDPS-protected amino alcohol (417) in hand, the final step was the 
removal of the N-Boc protection, using as before TFA in dry DeM. The IH NMR 
spectrum of the isolated product showed that the de-protection had been successful. The 
target intermediate (418) was synthesised in 63% yield, with no visible trace of the 
oxazoIidinone (414) by-product (Scheme 134). 
Me 
MeOX):(: OH I """ OTBDPS TBDPSCI 
d HNy0j< • d HN K Me Imidazole MeO 
(417) '( (413) ° 60% 
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d NH2 MeO 
Scheme 134 
(418) 
2.7.6 Synthesis ofthe bicyclic amide 
With the keto-acid (342) and the protected p-amino alcohol (418) precursors in hand, 
the next step in our synthesis was the amide coupling reaction required in order to 
generate the bicyclic amide (419), the key precursor to the desired erythrinan skeleton. 
In order to test this methodology, we decided to attempt this reaction first with the more 
readily accessible keto-acid (421). 
Me0X)X I """ OTBDPS 
d HN ° MeO ° 
MeO 
(419) 
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The commercially available keto-ester (420) was easily converted to the required keto-
acid (421) in 94% yield, using our standard hydrolysis conditions (LiOH in THF/lhO) 
(Scheme 135).16 
~8 LiOH ~H .. THF/H20 
0 94% 0 (420) (421) 
Scheme 135 
Using methodology reported by Taylor and co-workers,68 the synthesis of the bicyclic 
amide (422) was achieved by coupling the keto-acid (421) with the TBDPS-protected [3-
amino alcohol (418) using EDCI, HOABt and NMM at -15°C. This synthesised the key 
intermediate (422) in 67% yield and the analysis of the lH NMR spectrum of the crude 
product showed a mixture of product diastereoisomers (-1:1). We repeated this reaction 
with HOBt instead ofHOABt and we successfully synthesised the desired product (422) 
in 98% yield, again as a mixture of product diastereoisomers (-1: 1) We are confident 
we have synthesised the intermediate (422), since the lH NMR spectrum showed. a 
multiplet at N6.01 ppm representing the NB proton of the amide coupling (Scheme 136). 
Me 
""'" 
Me od' NH2 
+ (418) 
~ 
o (421) 
OTBDPS 
EDCI 
HOABt (or HOBt) 
NMM 
DCM 
.. 
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""'" OTBDPS 
Me od'iNjO 
(422) lJ 
Attempts at separating the diastereomers using flash column chromatography, were 
unsuccessful, so we decided to cyclise the diastereomeric mixture without separation. 
The bicyclic amide (422) was treated with BF3.Et20 (3 equiv) and refluxed in dry DCM 
for 4 days generating a mixture of the desired product (270) and starting material. This 
reaction was repeated using a larger excess of BF3.Et20 (20-30 equiv), under the same 
reaction conditions, and we successfully generated the target tetracyclic core of the 
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erythrina alkaloids (270) in 61 % yield, presumably via the formation of the N-
acyliminium ion intermediate (423). Analysis of the IH NMR spectrum of the crude 
product showed that we synthesised the desired product (270) as a mixture of product 
diastereomers (2.5:1) (Scheme 137). 
Me 
""" 
Me OTBDPS ff(f BF3·EtP MeO .. DCM MeO 
(422) 0 
54% 
(270) 
Scheme 137 
Allin and co-workersl6 have previously synthesised this intermediate (270), as a 10: I 
mixture of product diastereomers, using our standard cyclocondensation and Lewis acid 
mediated cyclisation methodology (Scheme 138). The structure of this intermediate 
(270) was confirmed by X-ray crystallography, as shown previously in Figure 3, 
Chapter 2.2.5.16 
Direct comparison of the IH NMR spectrum clearly showed that the two compounds 
were the same, thus leaving us in no doubt that we had successfully synthesised the 
target ring system, although, the diastereomeric ratio on this occasion was not as high as 
the previous synthesis of this product (270) (Scheme 138). Though disappointed with 
the diastereomeric ratio, we were encouraged by this result and decided to continue with 
this approach and applied this methodology to our substituted keto-acid substrate (342) 
(Chapter 2.5.3), in order to provide access to the erythrinan skeleton of the natural 
products, erysotrine (7) and erysotramidine (201). 
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The synthesis of the bicyclic amide (419) was achieved by coupling the keto-acid (342) 
with the TBDPS-protected ~-amino alcohol (418) using the same methodology 
described previously (EDCI, HOABt and NMM at -15°C). We successfully synthesised 
the key intermediate (419) in 81% yield and analysis of the IH NMR spectrum of the 
crude product showed a mixture of product diastereoisomers (-1: 1). We repeated this 
reaction with HOBt instead of HOABt and successfully synthesised the desired product 
(419) in 89% yield, again as a mixture of product diastereoisomers (-1:1). As observed 
previously for substrate (422), the IH NMR spectrum shows a peak at N6.20 ppm 
representing the NB proton, thus we are confident that we have synthesised 
intermediate (419) (Scheme 139). 
Me ~ OTBDPS 
MeO .# NH2 
+ (418) 
I C02H M~ 
0 (342) 
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As observed previously for substrate (422), attempts to separate the diastereomers, 
using flash column chromatography, were unsuccessful so we decided to cyclise the 
diastereomeric mixture without separation. 
2.7.7 Attempted synthesis of the tetracyclic core of the target erythrina alkaloid 
With the bicyclic amide (419) in hand, we then applied the same cyclisation 
methodology in an attempt to synthesise the equivalent tetracyclic core of the target 
erythrina alkaloid. However, upon treatment with BF3.Et20 (20-30 equiv) under reflux 
in dry DCM for 4 days, we unfortunately did not generate the desired tetracyclic 
intermediate (424) (Scheme 140). 
Me 
BF3·Et20 
M 
Me :;>< .. 0 MeD 
DCM 
MeD MeO 
(419) 
Scheme 140 
(424) 
Analysis of the IH NMR spectrum of the crude reaction product showed that there were 
three aromatic protons present. If the desired product had been synthesised one would 
expect two singlets, in the IH NMR spectrum, representing the two aromatic protons. 
Therefore, we can conclude that the aryl ring failed to cyclise and as a result we did not 
generate the desired erythrinan skeleton. However, the signal representing the NH 
proton at ~6.2 ppm is no longer present in the IH NMR spectrum suggesting maybe a 
partial cyclisation had occurred. Further characterisation and analysis has identified the 
isolated compound as the tricyc1ic lactam (404) below: 
o 
# OMe 
OMe (404) OMe 
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The reaction proceeds as expected fonning the N-acyIiminium ion intennediate (425), 
but instead of the aryl ring cyciising to generate the desired tetracyclic product (424) as 
expected. We believe that the conjugated vinyl ether donates electron density, 
stabilising the N-acyIiminium ion (425), thus generating the corresponding enamide 
(426). Next, the alcohol from the hydroxymethyl substituent then perfonns an 
intramolecular cyciisation fonning the isolated tricyciic lactam (404) (Scheme 141). 
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·u 
Me (419) (425) 
j 
:OH 
MeO I~ 
""'" • 
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In order to prevent the fonnation of the tricyciic lactam (404) we decided that it was 
necessary to hydrolyse the vinyl ether to its equivalent ketone (403). This will eliminate 
the unwanted side reaction and thus will allow us to perfonn our standard 
intramolecular N-acyIiminium ion cyclisation methodology. Using a procedure 
developed by Cook and co-workers69 we treated the tricycIic lactam (404) with 2M HCl 
in THFIH20, heated at 55°C, for 20 hours (Scheme 142). 
0 
Hel (2M) 
~ ~/ , • ""'" 
.# OMe THFIH20 .# OMe 
OMe (404) OMe 0 (403) OMe 
Scheme 142 
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Unfortunately, the expected ketone (403) was not isolated but instead we believe that 
we have generated the enamide product (405) in 62% yield. 
OMe 
o 
(405) 
The reaction proceeded as might be expected, with the vinyl ether being hydrolysed to 
fonn the corresponding ketone. Unfortunately, during the reaction, the N, O-acetal is 
simultaneously ring-opened to fonn the enamide (405), rather than the desired tricyclic 
lactam (403) (Scheme 143). 
o 
Hel (2M) OMe 
• 
(404) OMe o (405) 
l-MeOH 
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.. 
~OMe 
•• <±> 
H20 Scheme 143 
We believe that we have synthesised enamide (405) due to the fact that the IH NMR 
spectrum displays a single proton peak at ~5.30 ppm corresponding to the alkenic 
proton of the double bond. It also clearly shows that there are only two methoxy peaks, 
which indicates that the hydrolysis has been successful. This is supported by the IR 
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spectrum that shows two peaks at 1598 and 1731 cm-1 representing the conjugated 
ketone_ The presence of an OH peak at 3416 cm-1 also supports the observation that the 
reaction proceeded with the ring-opening the N, O-acetal_ 
Due to the limited time available we decided to attempt several cyclisations of the 
enamide (405) as a substrate in order to try and synthesise the desired tetracyc1ic 
product (427) (Scheme 144)_ Attempts at this cyc1isation using a Lewis Acid (or a 
Bronsted acid) were performed as shown below in Table 5. 
OMe 
o (405) 
Lewis acidl 
Bn2lnsted acid 
(428) 
Scheme 144 
MeO 
MeO 
OMe 
OH 
o 
However, all attempts to induce the cyc1isation of the enamide (405) failed to deliver 
the desired product (427) and on each occasion only starting material was re-isolated. 
The expected N-acyliminium ion intermediate (428) provides a possible explanation 
why the cyc1isation failed to generate the desired product (427). The enol is unstable 
and under acidic conditions will readily hydrolyse to produce the corresponding ketone. 
This would simultaneously stabilise the N-acyliminium ion, thus regenerating the 
enamide (405) (Scheme 144). 
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Table 5: Attempted cyclisation oftricyclic lactam (405) 
Lewis Acid! 
Entry Bronsted Acid Solvent Observation 
1 TiC'-4 DCM S.M. 
2 HCl (2M) EtOH S.M. 
3 BF3.Et20 DCM S.M. 
2.7.8 Future Work 
Although we have failed to synthesise tricyclic lactam (403) or the desired tetracyclic 
products (424) and (427), we are confident that the proposed enarnide (405) can be 
cyc1ised to generate the erythrinan skeleton (427) stereoselectively, using our standard 
N-acyliminiurn ion cyclisation methodology. Previous work by Allin and co-
workers70•71 have cyc1ised a related enarnide substrate (429) and have synthesised the 
desired xylopinine derivative (430), utilising a two step sequence, as shown in Scheme 
145. 
0 (OH 
c6 NaH,DMF • .-<7 .-<7 ,;:P Mel 
I ~ (429) OMe OMe 
OMe OMe 
/OMe / ~ /conc. Hel 
OMe (430) OMe 
Scheme 145 
With the erythrinan skeleton (427) in hand, removal of the pendant hydroxymethyl 
substituent can be achieved using our recently developed radical decarboxylation 
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protocol, which will generate the key intennediate (431). The introduction of a,~­
unsaturation can be achieved using standard literature procedures generating the known 
compound (432). Intennediate (432) has been converted by others to the natural 
products, erysotrine (7) and erysotramidine (201) (Scheme 146).27,57,61,63 
OMe 
o (405) 
Me 
MeO 
(432) 
JJ ~-steps 
M ~ 
0 
Me 
MeO'\"'" 
erysotamidine (201) 
Results & Discussion 
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MeO 
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Me 
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• 
(427) 
OH 
o 
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(431) 
MeO"'"'' 
erysotrine (7) 
2.8 Towards the synthesis of the natural product, (-)-Xylopinine 
Introduction 
MeO 
MeO 
.&' OMe 
(S)-Xylopinine (26) OMe 
Data 
C21H25N04 
m.p.173-176°C 
[ale = - 266° 
Xylopinine (26) is a typical member of the protoberberines, a large family of naturally 
occurring alkaloids characterised by a tetracyclic ring skeleton and an isoquinoline 
core.72 This tetrahydroprotoberberine alkaloid contains a tertiary amine moiety, and a 
stereogenic center at the C (14) position.72 This alkaloid has two fused phenyl rings and 
also has additional functionality present, provided by the four methoxy groups located 
on the A- and D-phenyl rings. 
Investigation ofXy/opia decreta, a member of the Annonaceae family, by Schmutz73 led 
to the isolation of the protoberberine alkaloid, (-)-xylopinine (26). The absolute 
configuration of this alkaloid was determined to be 14R by Corrodi and Hardegger.74,75 
Xylopinine (26) has also been reported to exhibit sedative effects, along with 
moderately strong and relatively long lasting adrenergic a-blocking properties. The 
physiological effects observed from these a-blocking properties include the lowering of 
blood pressure. There are various other biological properties attributed to this family of 
alkaloids including antimicrobial, antileukemic, antitumor and anti-inflammatory 
activity which has resulted in a number of synthetic applications being reported in the 
literature.75-79 
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2.8.1 Literature review 
The synthesis of xylopinine (26) have been reported many times in the literature, albeit 
in a racemic form,80-86 however there are only a handful of examples of a non-racemic 
synthesis of this natural product. 75-79 Examples of the asymmetric synthesis of this 
natural product will be discussed below. 
Munchhof and Meyers 78 have reported the total synthesis of this natural product (26) 
utilising the classical Pictet-Spengler cyclisation reaction. 
Me 
Me 
C02H 
0 ( S)-phenylglycinol 
""" (433) # OMe 
OMe 
NH LiAIH4 
MeO 
.. 
MeO 
""" 
H2! Pd-C 
MeO # (436) j HCHO, HCO,H 
MeO 
""" 
# N MeO 
# OMe 
(-)xylopinine (26) OMe 
M 
• 
MeO 
(434) 
Me 
Me 
Me 
MeO 
MeO 
Scheme 147 
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The key intermediate (434) was prepared by the condensation of the known keto-acid 
(433) with (S)-phenylglycinol under Dean-Stark conditions, producing the bicyclic 
lactarn as a single diastereomer. Treatment of (434) with Red-AI ring opens the N, 0-
acetal generating the isoquinoline (435), with no reduction of the lactam. The 
subsequent LiAl~ reduction of (435) and debenzylation with H2IPd-C, afforded the 
isoquinoline (436). Following formalin-formic acid treatment, the Pictet-Spengler 
cyclisation ensued to give the desire product, (-)-xylopinine (26) (Scheme 147). 
Davis and Mohanty72 have reported the asymmetric synthesis of the naturally occurring 
(S)-( -)-xylopinine (26) from a readily available sulfinimine derived cyclic imine. 
Me)CC:oTBDMS 
I #' "",N, + /p-Tolyl 
Me S 
+ (438) 0_ 
MeOXX 
Meol#'CN 
(437) 
MeO I~ 
MeO #' 
(441) 
I ~~ 
Me 
M 
I 
#' 
OMe 
MeO 
LDA MeO 
MeO 
MeO 
MeO 
TsCl, Py 
• M 
NaH 
OMe 
#' OMe 
xylopinine (26) OMe 
Scheme 148 
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,::? 0-
~ eN 
(439) 
jeo" MeOH 
~ OH 
I #' 0 
(440) 
#' OMe 
OMe 
The key step in this synthesis is the formation of the chiral sulfinamide (439) generated 
by the reaction of the laterally Iithiated nitrile of (437) with the o-tert-
butyldimethylsilyl-protected sulfmimine (438). The chiral sulfinamine (438) was 
synthesis in five steps from commercially available 3,4-dimethoxyphenethanol as 
reported by Davis and Mohanty.72 Treatment of(439) in aqueous MeOH with 4 equiv of 
LiOH generated the isoquinoline alcohol (440). The alcohol was then converted into the 
tosylate and treated with NaH to give the 8-oxo-xylopinine (441). Subsequent treatment 
with LiAI14 generated the natural product, (S)-(-)-xylopinine (26) (Scheme 148). 
Comins and co-workers75 have reported a chiral auxiliary mediated Pictet-Spengler 
reaction leading towards the total asymmetric synthesis of(-)-xylopinine (26). 
(444) 
Br 
t-BuLi, THF 
Potassium terl-amylate 
M MeO 
""'" 
""'" 
N # N 
MeO # MeO 
Red-AI 
,,::Y • 
~ (441) ~ OMe OMe 
xylopinine (26) OMe OMe 
Scheme 149 
The key intermediate is the chiral carbamate (442) synthesised from 3,4-
dimethoxyphenethylamine and the chiral auxiliary, (+)-trans-2-(a-cumyl)cyclohexanol. 
The Pictet-Spengler reaction of (443) and the carbamate (442) was performed using 
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trifluoroacetic acid (5 equiv) in DeM, and this generated the required 
benzylisoquinoline (444). The benzylisoquinoline (444) was then cyclised upon 
treatment with t-BuLi and potassium tert-amylate in THF, generating the desired 
precursor 8-oxo-berberine (441). With the 8-oxo-berberine (441) in hand, the final step 
of the synthesis was the reduction of the lactam carbonyl with Red-AI, utilising 
methodology by Lenz,80 generating the natural product, (-)-xylopinine (26) (Scheme 
149). 
2.8.2 Retrosynthetic analysis 
The retrosynthetic pathway shown in Scheme 150 utilises a cyc1ocondensation reaction 
leading to the synthesis of a tricyciic lactam. N-Acyliminium ion methodology is then 
required to generate the protoberberine skeleton. Simple manipulation of the ring 
system would then afford the target natural product, xylopinine (26). 
Me 
Me 
# 
xylopinine (26) OMe 
o 
Meo~o 
MeO~OH 
+ 
I """ OH M)C)C 
Me # NH2 
Results & Discussion 
OMe 
<: 
MeO ~ ",\\\-OH .. ' 
~ 0 
> M 
# OMe 
OMe 
OMe 
Me 
Me 
Scheme 150 
- 153 -
2.8.3 Towards the total synthesis of (-)-xylopinine - preliminary results 
AlIin and co-workers87 have reported the stereoselective synthesis of isoquinoline 
derivatives from bicyclic lactam templates. They recognised that a suitable substituted 
bicyclic lactam could be used as a precursor in a stereoselective synthesis of the 
tricycIic tetrahydroisoquinoline ring system, seen as a sub-unit (BCD rings) of the 
protoberberine alkaloids, e.g. xylopinine (26) and its derivatives.72 
X 
Me ~ N 
A B 
MeO # 
x = H2, xylopinine (26) 
X = 0, known precursor 
C 
,,::r 
D 
~ OMe 
OMe 
The synthesis of the required bicyclic lactarn (447) was achieved by condensation of 
commercially available (S)-phenylalaninol (446) with methyl 5-oxopentanoate (445), 
refluxed in toluene under Dean-Stark conditions, affording a 4: 1 mixture of separable 
diastereoisomers (447a) and (447b). The subsequent N-acyliminium ion cycIisation was 
then achieved upon treatment with TiCI4, stirred in DCM at _lOoC, producing the 
corresponding cycIised product (448) as a single product diastereoisomer (Scheme 151). 
&:. H N--ZPh Toluene 2 Hj -----.~ 
(445) (446) (447a) (447b) jTiCI4 DCM 
Scheme 151 (448) 
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This methodology was applied to the equivalent methoxy-substituted substrate (449) 
and has generated the tetrahydroisoquinoline (450) as a single diastereomer (Scheme 
152). 
0 (OH 
0 
6= OMe TiCI4 • DCM 
H (449) (450) OMe 
Scheme 152 OMe 
2.8.4 Current Progress: Synthesis of the lactol precursor 
The two key precursors for our proposed synthesis of the natural product, xylopinine 
(26), are the J3-amino alcohol (264) and the appropriate aldehyde (451) or its 
corresponding lactol (452) (Scheme 153). The synthesis of the J3-amino alcohol (264) 
has been discussed above, in Chapter 2.2.3, and therefore we will now only discuss the 
preparation of the required lactol precursor (452). 
0 0 
MeO I~ Me OH 
M #' ""0 MeO OH 
(451) Scheme 153 (452) 
The synthesis of the required lactol precursor (452) was achieved in five steps from the 
commercially available substrate, homoveratric acid (453). The first step in this 
sequence was the reduction of the homoveratric acid (453), using LiB~ and Me3SiCl in 
THF, to produce the corresponding homoveratryl alcohol (454) in 97% yield. The 
subsequent ring closure was then achieved upon treatment with p-forrnaldehyde and 
trifluoroacetic acid (TFA)88 affording the isochromene (455) in 83% yield.89 The next 
step was the oxidation of the isochromene (455) using KMn04 and the phase transfer 
catalyst TEBAC, refluxed in DCM, affording the corresponding isochromenone (456) 
in 89% yield.9o The subsequent ring opening of the lactone (456), using KOH, resulted 
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in the generation of the hydroxy intermediate91 (457) which, was then oxidised without 
purification to the desired lactol (452) (Scheme 154). 
Metrr°
H Me3SiCII LiBH4 MeO~OH 
1# 0 • 1# THF MeO MeO (454) (453) 97% 
(CH2O)n 
TFA 
83% 
0 
M 
"'" M)CO 
0 KMn04 • TEBAC 
• 
Me # DCM MeO # 
(456) 89% (455) j KOH, H,O 
0 0 
Me 
"'" 
DMP(SIBX) 
')C:(5 OH 1 0 .. 
MeO # OH DCM MeO # OH 
(457) 18-55% (452) 
Scheme 154 
Previous work in the Allin group/o on a similar hydroxy intermediate (459) (Scheme 
155), had tested a number of different oxidising agents as shown in Table 6. They 
discovered that the best oxidising agent for this step was Dess-Martin periodinane 
(Entry 4) (Chapter 2.2.7), as this generated the lactol (460) in 70% yield. As can be 
seen, the other oxidants PCC, PDC and IBX (Entry 1-3) generally synthesised the lactol 
(460) in poor yields and in the case of PCC only the lactone (458) was re-isolated. As 
can be appreciated, the relactonisation of the hydroxy intermediate to the equivalent 
lactone (458) is an inevitable problem due to the fact that relactonisation would lead to 
the formation of the more stable six-membered ring. 
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0 0 0 
00 KOH ~ DMP ro .. .. H2O 
.4' OH DCM .4' OH 
(458) (459) 70% (460) 
Scheme 155 
Table 6: Oxidation study-preparation of the lactol (452) 
Entry Oxidant Lactol (452) 
I PCC -
2 PDC 20% 
3 IBX Trace 
4 DMP 70% 
With this knowledge in hand, we took the hydroxy intennediate (457) and perfonned 
the oxidation with Dess-Martin periodinane (1-1.5 equiv) in dry DCM and successfully 
synthesised the required lactol (452), although the yields obtained were consistently low 
(18-55%) (Scheme 154). 
We also attempted this reaction with stabilised IBX (SIBX), a derivative of IBX and 
Dess-Martin periodinane.92,93 SIBX is a non-explosive oxidising agent composed from a 
mixture of IBX (49%), benzoic acid (22%) and isophthaIic acid (29%). We took the 
hydroxy intennediate (457) and perfonned the oxidation with SIBX (1-3 equiv) in dry 
DCM and successfully synthesised the desired lactol (452), although the maximum 
yield obtained was only 38% (Scheme 154), (Table 7). 
Table 7: Synthesis ofthe lactol (452) using SIBX 
Entry Equivalents Lactol (452) 
1 1 -
2 1.5 20% 
3 3 38% 
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As mentioned above, the major problem was that the hydroxy intermediate (457) 
reverting back to the lactone (456). As a result, we decided that an alternative procedure 
was required which did not involving the generation of the hydroxy intermediate (457), 
thus eliminating the possibility of relactonisation occurring. 
2.S.5 An alternative synthesis of the lactol precursor 
Due to the poor yields obtained for the final step in the lactol (452) synthesis shown in 
Scheme 154; we decided that an alternative procedure was required to produce the 
lactol (452) (Scheme 156). Sinhababu and Borchardt have reported the synthesis of the 
phthalaldehydic acid (462) from the commercially available o-bromobenzaldehyde 
derivative (461).94 One could then perform a Wittig reaction with Ph3P+(CI") CH20Me, 
to generate vinyl ether (463), which would be followed by the subsequent hydrolysis of 
the vinyl ether to generate the desired lactol (452). 
MXC,:;? Br ~ I 0 
M '->- "" 
(461) 
0 
Me 
Me OH 
(452) 
c) 
H 
THF 
n-BuLi, CO2 (s) 
H30 + 
Hel (2M) 
.. 
THF/H20 
.. 
Scheme 156 
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t-BuOK, Toluene 
0 
I OH 
OMe 
(463) 
Our initial attempts at synthesising the desired phthalaldehydic acid (462), using the 
methodology reported by Sinhababu and Borchardt, were unsuccessful. Unfortunately, 
due to time constraints we were unable to repeat this chemistry, but we are confident 
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that a slight adjustment of our procedure will enable us to synthesise the key 
intennediate (462). Once this has been achieved, we would then apply the Wittig 
conditions described above, in order to generate the desired lactol (452). These 
conditions have previously been applied to a similar substrate (464) and have 
successfully generated the desired lactol (460), in good yields, though problems still 
remain regarding the removal of the phosphorus by-products (Scheme 157). 
(464) 
Scheme 157 
2.8.6 Synthesis of the tricyclic lactam 
~O ~OH 
(460) 
With the lactol (452) and the p-amino alcohol (264) in hand, we perfonned our standard 
condensation reaction, refluxing in toluene under Dean-Stark conditions, to produce the 
desired tricyclic lactarn (465) in 57% yield (Scheme 158). 
o Me~OH 
M ~ __ .~H2 Me 
e (264) MeO 
• 
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We then perfonned our standard Lewis acid mediated cyclisation in an attempt to 
generate the desired protoberberine skeleton (466). The tricyclic lactam (465) was 
treated with TiCl4 (3 equiv) in dry DCM at -7SoC, but unfortunately we were unable to 
determine from the IH NMR spectrum whether or not we had successfully synthesised 
the desired product (466). Analysis of the IH NMR spectrum did show however, that we 
had not synthesised the possible by-product, the enarnide (467). 
MeO 
o (OH~OMe 
""'" N~OMe 
MeO # #H 
H (467) 
Previous work by Allin and co-workers7o had observed that during their attempted 
cyclisation of a similar tricyclic lactam (468), they synthesised the enamide (429) 
instead of the desired tetracyclic product. Presumably the N, O-acetal ring was opened 
as expected, fonning the N-acyliminium ion intennediate (469). 
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Instead of the aryl ring cyclising to fonn the desired product, the N-acyliminiurn ion 
was quenched through p-elimination to yield the enamide (429) (Scheme 159). This 
proceeds in a manner similar to the E2 elimination mechanism. 
3.8.7 Future Work 
We are confident that once we have synthesised intennediate (466) we will be able to 
convert it to the natural product, (-)-xylopinine (26) using literature methodology. Our 
recently developed radical decarboxylation protocol44 will generate the known 
intermediate, 8-oxo-xylopinine (441). Intermediate (441) has previously been converted 
to the desired natural product (26), by Davis72 and Comins,1s via Red-AI reduction 
(Scheme 160). 
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Me 
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2.9 Conclusions 
In summary, a facile and highly stereoselective approach has been developed for the 
formation of the tetracyclic template of the erythrina alkaloids, from readily available 
non-racemic substrates. The stereoselective synthesis of the N-acyliminium ion 
precursors of the erythrina (Scheme 161) and protoberberine (Scheme 162) alkaloids, 
has been achieved through the condensation of a racemic keto-acid (or lactol) and an 
appropriate chiral ~-amino alcohol. 
• Stereose1ective synthesis of the oxazolo[3,2-i]indole-5,8-dione template: 
+ 
MeO~OH 
Me~ NH2 
Toluene 
Scheme 161 
;::P OMe 
OMe 
• Stereoselective synthesis of the oxazolo[3,2-b ]isoquinoline-5-one template: 
o 
Meoro I 0 
MeO # OH 
+ 
MeO~OH 
I # NH 
MeO 2 
OMe 
Toluene 
MeO 
• 
Me 
H 
Scheme 162 
In our work towards natural product targets the key ring-forming step involves the 
cyclisation of a pendant aryl substituent onto an N-acyliminium ion intermediate 
generating the tetracyclic core of the erythrina alkaloids (Scheme 163). Key 
developments include: 
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• Stereoselective cyc1isation generating the indolo[l-a]isoquinoline-3,6-dione 
template: 
~ TiCI4 
• (0 .# DCM OMe OMe 
Scheme 163 MeO OMe 
• A potential precursor for the asymmetric synthesis of the tetracyc1ic core of the 
protoberberine alkaloids: 
MeO ~ ,,\\\-OH ... , OMe 
MeO ~ Me 
Lewisacid 
• 
H .# Me 
Scheme 164 OMe 
The potential for application of our novel methodology in target synthesis has been 
demonstrated by the removal of the hydroxymethyl substituent, generating the core of 
the erythrina alkaloids (Scheme 165). 
• Removal of the pendant hydroxymethyl substituent from the indolo[l-a] 
isoquinoline-3,6-dione template: 
o o 
Rh(PPh3l2(CO)CI 
dppp, mesitylene 
MeO OMe MeO OMe 
Scheme 165 
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We have demonstrated the versatility of this methodology and have achieved the 
asymmetric synthesis of both enantiomers of the natural product (Scheme 166). 
• Formal asymmetric synthesis of both enantiomers of the erythrina alkaloid, 3-
demethoxyerythratidinone: 
• .. 
MeO OMe MeO OMe 
3-demethoxyerythratidinone 
Scheme 166 
An alternative synthesis of the erythrina alkaloid skeleton has been investigated where 
the key ring-forming step involves the cyclisation of an aryl substituent of an amide 
precursor. Key advances include: 
• The synthesis of the bicylic amide precursor of the erythrina alkaloids: 
MeO ~ OTBDPS M ~ 
# NH2 EDCI OTBDPS Me HOABt (or HOBt) Pc7 + .. M ~H NMM DCM 
0 Scheme 167 
• Asymmetric synthesis of the indolo[l-a]isoquinolin-6-one template: 
MeoX)X I ~ OTBDPS 
# HN 
MeO 0 
MeO 
... 
DCM MeO 
Scheme 168 
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• The synthesis of a functionalised amide precursor of the erythrina alkaloids: 
MeO~OTBDPS 
,)V NH2 EDCI 
MeO HOABt (or HOBt) 
+ • 
o 
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Scheme 169 
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• Access to a potential precursor for the asymmetric synthesis of the indolo[l-a] 
isoquinoline-2,6-dione template: 
M 
MeO 
M 
OTBDPS 
o 
MeO 
• 
• MeO 
Scheme 170 
Future work will focus on extending the methodology described to other, more complex 
erythrina and protoberberine alkaloid targets. 
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Chapter 3 Experimental 
3.1 General Information 
3.1.1 Solvents 
All solvents where necessary, were dried, distilled and used immediately or stored over 
4A molecular sieves prior to use. 
Absolute Ethanol (<99.8%) 
Diethyl ether 
Dichloromethane 
N,N-Dimethylformamide (<99.8) 
Dimethylsulfoxide «99.9%) 
Ethyl Acetate 
Hexane 
Isopropyl Alcohol 
Light petroleum ether (40-60· C): 
Mesitylene (98%) 
Methanol 
Tetrahydrofuran 
Toluene 
p-Xylene (>99%) 
3.1.2 Reagents 
Used as purchased from Fisher Scientific, UK. 
Used as purchased from Fisher Scientific, UK. 
Distilled from phosphorus pentoxide. 
Used as purchased from Aldrich Chemical Co. Ltd. 
Used as purchased from Aldrich Chemical Co. Ltd. 
Distilled from calcium chloride. 
Used as purchased from Fisher Scientific, UK. 
Used as purchased from Fisher Scientific, UK. 
Distilled from calcium chloride. 
Used as purchased from AIdrich Chemical Co.Ltd. 
Used as purchased from Fisher Scientific, UK. 
Distilled from sodium and benzophenone. 
Used as purchased from Fisher Scientific, UK. 
Used as purchased from Aldrich Chemical Co. Ltd. 
Reagent chemicals were purchased from Acros (Fisher) Chemicals Ltd., Aldrich 
Chemical Company Ltd., Lancaster Chemical Synthesis Ltd., Merck Chemicals Ltd. 
and Strem Chemical UK. 
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3.1.3 Chromatographic Procedures 
Analytical thin layer chromatography (TLC) was conducted using aluminium backed 
plates coated with 0.2 mm silica gel (Merck Kiesegel 60 F254). Plates were visualised 
under UV light (254 nm) or by staining with potassium permanganate, iodine or 
phosphomolybdic acid. 
Flash column chromatography was conducted using silica gel (Merck Kiesgel 60 H). 
Samples were applied as saturated solutions in an appropriate solvent or pre-adsorbed 
onto the minimum quantity of silica. Pressure was applied to the column by the use of 
hand bellows. 
3.1.4 Spectra 
Infra-red spectroscopy (IR) was recorded on a Paragon 1000 Perkin-Elmer Fourier 
Transform Spectrophotometer (with internal calibration) in the range of 4000-600 cm'l. 
Samples were either dissolved in an appropriate solvent and run as a thin film on 
sodium chloride plates or in the form of potassium bromide disc. 
IH and BC Nuclear magnetic resonance (NMR) spectra were recorded using either a 
Broker AC-250 or DPX-400 Spectrometer. All NMR samples were prepared in 
deuterated solvents with all values quoted in parts per million (ppm) relative to 
tetramethylsilane (TMS) as an internal standard. Multiplicities were recorded as broad 
peaks (br), singlets (s), doublets (d), triplets (t), quartets (q), double of doublets (dd) and 
multiplets (m). Coupling constants (J values) are reported in Hertz (Hz). 
Diastereoisomer ratios were calculated from the integration of suitable peaks in the I H 
NMR spectrum. 
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3.1.5 Mass Spectrometry 
Mass spectra (high/low resolution) and accurate mass were recorded using a Jeol SXI02 
mass spectrometer uising electron impact (El) or fast atom bombardment (FAB) 
ionisation techniques. 
3.1.6 Other Data 
Melting points were determined using an Electrothermal 9100 melting point apparatus 
and are uncorrected. 
Elemental analyses were conducted on a Perkin-Elmer 2400 CHN Elemental Analyser 
in conjunction with a Perkin Elmer AD-4 Autobalance. 
Optical rotations were performed using an Optical Activity AA-2001 Automatic 
Polarimeter using a 0.25 dm cell. 
X-ray data was collected using a Bruker SMART 1000 CCD diffractometer with 
graphite monochromated Mo-KIl radiation operating at low temperature (150K). 
Yields (unless stated otherwise) are quoted for isolated pure products. 
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3.2 Formal asymmetric synthesis of (-)-3-demethoxyerthratidinone 
Methy 1-2-(8-oxo-l ,4-dioxaspiro[ 4,5) dec-7 -yl)ethanoate (262) 
n 
~~, 
o 
1,4-CycIohexanedione mono ethylene ketal (261) (2.00 g, 12.8 mmol) was dissolved in 
dry TIIF (20 ml) and the solution was cooled to -78°C. KHMDS (28.1 ml of a 0.5 M 
solution in toluene, 14.1 mmol) was added and the solution was stirred at-78°C for 1 h. 
Methyl bromoacetate (1.30 ml, 14.08 mmol) was added carefully to the mixture and 
stirred for a further 1 h. The mixture was then warmed to room temperature and stirred 
for an additional 20 h. The residue was quenched with 2M HCI and extracted with . 
diethyl ether (3 x 25 ml). The organic extracts were dried with anhydrous Na2S04 and 
the solvent was removed by evaporation under reduced pressure yielding a yellow oil. 
The residue obtained was purified by flash column chromatography on silica gel using a 
mixture of diethyl ether and hexanes (2:1) as eluent affording methyl-2-(8-oxo-l,4-
dioxaspiro[4,5]dec-7-yl)ethanoate (262) (1.83 g, 63%) as a colourless oil. v max 
(DCM)/cm-I 2890 (OMe), 1734 (C02Me), 1718 (CO); IiH (400 MHz; CDCh) 1.78 (lH, 
t, J 13.1, CH(H)CHCO), 1.97-2.12 (3H, m, (CH(H)CHCO and CH2CH2CO), 2.18 (lH, 
dd, J 16.7, 6.0, CHCH(H)C02Me), 2.36 (lH, ddd, J 14.3, 5.0, 2.7, CH2CH(H)CO), 
2.69-2.76 (2H, m, CH2CH(H)CO and CHCH(H)C02Me), 3.17-3.23 (lH, m, 
CH2CHCO), 3.67 (3H, s, CH30), 4.00-4.08 (4H, m, 2 x CH20); lie (100 MHz; CDCI3) 
33.67 (CH2), 34.52 (CH2), 37.78 (Gh), 40.19 (CH2), 43.06 (CH), 51.60 (CH30), 64.25 
(CH20), 64.62 (CH20), 107.05 (C-ketal), 172.43 (C02CH3), 209.38 (CO); MS (El) m/z 
228 [M" 8.3%]; (Found: M+, 228.0993. CIIHI60S requires 228.0998). 
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2-(8-0xo-l,4-dioxaspiro(4,5]dec-7-yl)ethanoic acid (258)1 
~~H 
o 
Methyl-2-(-8-oxo-l,4-dioxaspiro[4,5]dec-7-yl)ethanoate (262) (1.53 g, 7.10 nunol) was 
dissolved in a mixture of THF (70 ml) and water (30 ml). Lithium hydroxide (0.30 g, 
7.10 nunol) was added and the mixture was stirred at room temperature for 20 h. The 
mixture was then concentrated, re-suspended in water (50 ml) and acidified to pH 3 
using IM HC\. The aqueous layer was then extracted with ethyl acetate (3 x 25 ml), 
dried with anhydrous MgS04 and the solvent was removed by evaporation under 
reduced pressure affording 2-(8-oxo-l,4-dioxaspiro[4,5]dec-7-yl)ethanoic acid (258) 
(1.24 g, 84%) as a colourless solid. Further purification was not necessary. Mp 128-129; 
v max (DCM)/cm-1 3195 (OH), 1717 (CO); OH (400 MHz; CDCh) 1.78 (!H, t, J 13.6, 
CH(H)CHCO), 1.97-2.15 (3H, rn, (CH(H)CHCO and CH2CH2CO), 2.18-2.29 (lH, m, 
CHCH(H)C02H), 2.35-2.45 (lH, m, CH2CH(H)CO), 2.66-2.81 (2H, rn, CH2CH(H)CO 
and CHCH(H)C02H), 3.13-3.23 (lH, m, CH2CHCO), 3.99-4.05 (4H, rn, 2 x CH20); Cc 
(100 MHz; CDCh) 33.81 (CH2CHCO), 34.35 (CH2CH2CO), 37.63 (CH2CH2CO), 39.97 
(CH2C02H), 42.82 (CH), 64.54 (CH20), 64.78 (CH20), 107.05 (C-ketal), 177.41 
(C02H), 209.71 (CO); MS (El) rnIz 214 [M" 4.7%]; (Found: M\ 214.0837. ClOH140S 
requires 214.0841). 
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(2S)-2-Amino-3-[3,4-dim ethoxyphenyI]propan-l-oI (264)2.3 
"'" OH 
MeO 
OMe 
A solution of chlorotrimethylsilane (4.50 ml, 35.5 mmol) was added under a nitrogen 
atmosphere to a solution of lithium borohydride (8.88 ml ofa 2M solution in THF, 17.8 
mmol) in THF (25 ml) over a period of 2 min. 3-(3,4-Dimethoxyphenyl)-L-alanine 
(263) (2.00 g, 8.88 mmol) was added portionwise over 5 min, and then left to stir at 
room temperature for 24 h. Methanol (30 m!) was added slowly to the solution and the 
solvent was then removed by evaporation under reduced pressure. The residue was then 
treated with 20% aqueous potassium hydroxide solution and extracted with DCM (3 x 
20 ml). The organic extracts were dried with anhydrous Na2S04 and the solvent was 
removed by evaporation under reduced pressure affording (2S)-2-amino-3-[3,4-
dimethoxyphenyl]propan-l-01 (264) (1.82 g, 97%) as a colourless solid. Mp 81-83T; 
Lit: Mp 78_79·C;2.3 [11]D= - 22.5 (c = 1.28, EtOH); Lit: [11]D= - 21.5 (c = 8.0, EtOH);3 v 
mID< (DCM)/cm- I 3353 (OH), 2934 (Sp3 CH), 2838 (OMe), 1515 (CO); OH (400 MHz; 
CDCh) 2.44 (!H, dd, J 13.6, 8.7, CH(H)CHNH2), 2.72 (!H, dd, J 13.6, 5.2, 
CH(H)CHNH2), 3.09-3.13 (!H, m, NH2CH), 3.37 (!H, dd, J 10.6,7.1, CH(H)OH), 3.62 
(!H, dd, J 10.6, 3.9, CH(H)OH), 3.86 (3H, s, CH30), 3.87 (3H, s, CH30), 6.72-6.75 
(2H, m, ArH), 6.80-6.82 (!H, m, ArH); Oc (100 MHz; CDCh) 40.50 (Cl-hCHNH2), 
54.25 (NH2Cl-l), 55.92 (C1I30), 55.98 (C1I30), 66.46 (C1I20H), 111.48 (ArC1I), 112.45 
(ArCl-l), 121.21 (ArC1I), 131.26 (ArC), 147.75 (ArC-OCH3), 149.09 (ArC-OCH3); MS 
(El) m/z 211 [M" 15.1%]; (Found: M" 211.1211. CIIHI70 3 requires 211.1208). 
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(3S,6aS,lOaR)-3-(3,4-Dimethoxy)phenylmethyl-8-(1,3-dioxolane)perhydro[l,3] 
oxazolo[2,3-1]indol-5-one (265) 
o 
OMe 
Method A 
(2S)-2-Amino-3-[3,4-dimethoxyphenyl]propan-l-01 (264) (1.10 g, 5.00 mmol) and 2-(-
8-oxo-l,4-dioxaspiro[4,5]dec-7-yl)ethanoic acid (258) (1.10 g, 5.00 mmol) was 
dissolved in toluene (150 ml) and refluxed under Dean-Stark conditions for 144 h. The 
solution was then allowed to cool and the solvent was removed by evaporation under 
reduced pressure. The resulting yellow oil was then purified by flash column 
chromatography on silica gel using a mixture of ethyl acetate and hexanes (4: I) as 
eluent affording (3S,6aS, I OaR)-3-(3,4-dimethoxy)phenylmethyl-8-(1 ,3-dioxolane) 
perhydro[1,3]oxazolo[2,3-I]indol-5-one (265) (1.00 g, 51%) as a colourless solid. 
MethodB 
(2S)-2-Amino-3-[3,4-dimethoxyphenyl]propan-l-01 (264) (1.10 g, 5.00 mmol) and 2-(-
8-oxo-I,4-dioxaspiro[4,5]dec-7-yl)ethanoic acid (258) (1.10 g, 5.00 mmol) was 
dissolved in toluene (150 ml) and refluxed under Dean-Stark conditions for 48 h. The 
solution was then allowed to cool and the solvent was removed by evaporation under 
reduced pressure. The resulting yellow oil was then purified by flash column 
chromatography on silica gel using a mixture of ethyl acetate and hexanes (4:1) as 
eluent affording (3S,6aS, 1 OaR)-3-(3,4-dimethoxy )phenylmethyl-8-(1 ,3-dioxolane) 
perhydro[I,3]oxazolo[2,3-1]indol-5-one (265) (1.23 g, 63%) as a colourless solid. 
Mp 98-99·C; [aID = + 56.1 (c = 1.14, CHCh); v max (DCM)/cm-1 1717 (CO), 1653 
(lactam); OH (250 MHz; CDCI3) 1.68-2.05 (6H, m, NCCH2CH2, NCCH2CH2 and 
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CH2CHCH2CO), 2.39-2.53 (2H, m, CH2CHCH2CO and CHCHCH(H)CO), 2.66 (lH, 
dd, J 13.9, 9.3, CH(H)Ar), 2.90-3.07 (2H, m, CH2CHCH(H)CO and CH(H)Ar) 3.86 
(3H, s, CH30), 3.87 (3H, s, CH30), 3.91-3.97 (5H, m, 2 x CH20 and CH(H)O), 4.01-
4.08 (lH, m, CH(H)O), 4.24-4.30 (lH, m, NCHCH20), 6.70-6.77 (3H, m, ArH); Se 
(lOO MHz; CDCh) 30.44 (CH2), 30.84 (CH2), 33.71 (CH2), 39.33 (CHCH2CO),39.91 
(CH2Ar), 41.56 (CHCH2CO), 55.30 (NCHCH20), 55.83 (CH30), 55.88 (CH30), 63.92 
(CH20), 64.37 (CH20), 71.58 (NCHCH20), 98.97 (NCCH2CH2), 107.88 (C-ketal), 
111.28 (ArCH), 112.54 (ArCH), 121.31 (ArCH), 129.56 (ArC), 147.83 (ArC-OCH3), 
148.93 (ArC-OCH3), 176.28 (CO); MS (El) m/z 389 [Mt, 59.3%]; (Found: M+, 
389.1842. C21H2,N03 requires 389.1838). 
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(4S,9bS,13aS)-4-(Hydroxymethyl)-7,8-dimethoxy )-1,4,5,10,11,12,13,13a-octahydro-
2H-indolo[7a,l-a]isoquinoline-2,12-dione (270) 
o 
",-OH 
l 
MeO OMe 
(3S,6aS,1 0aS)-3-(3 ,4-Dimethoxy)phenylmethyl-8-(1 ,3 -dioxolane )perhydro [1,3 ]oxazolo 
[2,3-1]indol-5-one (265) (1.23 g, 3.16 mmol) was dissolved in dry DCM (40 ml) under 
a nitrogen atmosphere and the reaction mixture was cooled to -78°C. TiCl4 (1.04 ml, 
9.48 mmol) was added drop wise by syringe and the mixture was stirred at -78°C for 10 
min. After this time, the solution was allowed to reach room temperature before being 
stirred for an additional 20 h. The mixture was then quenched with saturated ammonium 
chloride solution (60 ml), extracted with DCM (3 x 25 ml), dried over anhydrous 
MgS04 and the solvent was removed by evaporation under reduced pressure affording a 
yellow solid. The solid was purified by flash column chromatography on silica gel using 
a mixture of 5% methanol in DCM as eluent affording (4S,9bS,13aS)-4-
(hydroxymethyl)-7 ,8-dimethoxy)-1 ,4,5, 1 0, 11,12,13, 13a-octahydro-2H-indolo[7 a, I-a] 
isoquinoline-2,12-dione (270) (1.00 g, 92%) as a colourless solid. Mp 215-21 TC; [11]D= 
- 53.4 (c = 1.22, CHCh); v max (DCM)/cm-I 3444 (OH), 1717 (CO), 1645 (Iactam); OH 
(400 MHz; CDCh) 2.24 (lH, dd, J 24.4, 7.1, CHCH(H)CO), 2.30-2.45 (4H, m, 
NCCH2CH2 and NCCH2CH2), 2.61 (2H, ddd, J 16.4, 8.7, 3.9, CHCH(H)CO and 
NCHCH(H)Ar), 2.70 (lH, dd, J 18.0, 10.9, CHCH(H)CO), 2.96 (lH, dd, J 16.1, 6.0, 
CHCH(H)CO), 3.09-3.11 (lH, m, CHCH2CO), 3.31 (lH, dd, J 16.4, 12.0, 
NCHCH(H)Ar), 3.63-3.66 (lH, m, NCHCH20H), 3.87 (3H, s, CH30), 3.88 (3H, s, 
CH30), 4.01-4.16 (2H, m, CH20H), 4.85 (lH, dd, J 9.6,4.8, OH), 6.60 (lH, s, ArH), 
6.66 (lH, s, ArH). Oc (100 MHz; CDCh) 30.25 (NCHCH2Ar), 33.42 (NCCH2CH2), 
35.21 (NCCH2CH2), 37.87 (CHCH2CO), 38.23 (CHCH2CO), 43.47 (CHCH2CO), 53.91 
(NCHCH20H), 56.00 (CH30), 56.41 (CH30), 62.18 (CH20H), 65.94 (NCCH2CH2), 
107.28 (ArCH), 111.71 (ArCH), 125.91 (ArC), 133.66 (ArC), 148.23 (ArC-OCH3), 
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148.72 (ArC-OCH3), 173.90 (NCO), 209.72 (CO); MS (El) m/z 345 [M\ 6.5%]; 
(Found: M\ 345.1581. CllH160S requires 345.1576). 
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(4S,9bS,13aS)-7 ,8-Dimethoxy-2,12-dioxo-I,4,5,1 0,11,12,13,13a-octahydro-2H-
indolo [7a,l-a) isoquinoline-4-carbaldehyde (282t·s 
MeO OMe 
IBX oxidation 
(4S,9bS, 13aS)-4-(Hydroxymethyl)-7 ,8-dimethoxy-1 ,4,5, I 0, 11,12,13, 13a-octahydro-2H-
indolo[7a,l-a)isoquinoline-2,12-dione (270) (0.40 g, 1.16 mmo1) and IBX (0.36 g, 1.28 
mmol) was dissolved in DMSO (5 ml) and the solution was stirred at room temperature 
for 20 h. The DMSO was removed by evaporation under reduced pressure producing a 
dark orange solid. The solid was then dissolved in ethyl acetate and filtered through 
celite. The solution was washed with ethyl acetate (150 m!), extracted in water (3 x 50 
ml) and dried with anhydrous MgS04. The excess solvent was removed by evaporation 
under reduced pressure affording (4S,9bS,13aS)-7,8-dimethoxy-2,12-dioxo-I,4,5,10,11, 
12,13, 13a-octahydro-2H-indolo[7a, l-a]isoquinoline-4-carbaldehyde (282) (0.11 g, 
48%) as a yellow solid. 
Dess-Martin periodinane oxidation 
(4S,9bS, 13aS)-4-(Hydroxymethyl)-7,8-dimethyloxy-1 ,4,5,1 0,11 ,12,13 ,13a-octahydro-
2H-indolo[7a,l-a]isoquinoline-2,12-dione (270) (1.15 g, 3.33 mmol) in dry DCM (30 
ml), under a nitrogen atmosphere, was added dropwise via cannula to a solution of 
Dess-Martin periodinane (1.55 g, 3.67 mmol) in dry DCM (30 m1) also under a N2 
atmosphere. The solution was then stirred at room temperature for 20 h. After this time, 
the excess solvent was removed by evaporation under reduced pressure producing a 
dark yellow solid. The solid was purified by flash column chromatography on silica gel 
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using 100% ethyl acetate as an eluent affording (4S,9bS,13aS)-7,8-dirnethoxy-2,12-
dioxo-l ,4,5, 1 0, 11,12, 13,13a-octahydro-2H-indolo[7 a, l-aJisoquinoline-4-carbaldehyde 
(282) (1.06 g, 93%) as a yellow solid. 
Mp 167-169; [a]o = - 10.2 (c = 1.08, CHCh); v max (DCM)/crn-1 1715 (CO), 1685 
(lactam); SH (250 MHz; CDCh) 2.23-2.50 (SH, m, CHCH(H)CO, NCCH2CH2 and 
NCCH2CH2), 2.60-2.86 (2H, m, CHCH(H)CO and NCHCH(H)Ar), 2.93-3.21 (4H, m, 
NCHCH(H)Ar, CHCH2CO and CHCH2CO), 3.87 (3H, s, CH30), 3.88 (3H, s, CH30), 
3.90-4.04 (lH, rn, NCHCHO), 6.65 (lH, s, Arlf), 6.70 (lH, s, Arlf), 9.84 (lH, s, CHO); 
Se (100 MHz; CDCh) 27.35 (NCHCH2Ar), 33.42 (NCCH2CH2), 35.37 (NCCH2CH2), 
36.76 (CHCH2CO), 38.84 (CHCH2CO), 43.53 (CHCH2CO), 55.91 (CH30), 56.30 
(CH30), 57.74 (NCH2CH2), 63.62 (NCCH2CH2), 107.13 (ArCH), 112.03 (ArCH), 
124.15 (ArC), 133.34 (ArC), 148.45 (ArC-OCH3), 148.67 (ArC-OCH3), 177.09 (NCO), 
196.46 (CHO), 209.57 (CO); MS (El) mJz 343 ~, 15.5%]; (Found: M", 343.1424. 
CllHl60S requires 343.1420). 
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(9bS,13aS)-7 ,8-Dimethoxy-1,1 O,11,12,13,13a-hexahydro-2H-indole (7 a,1-a) 
isoquinoline-2,12-dione (301) (+ phosphorus by-products) 
o 
MeO OMe 
Using RhCI(CO)(PPhJ)z and dppp refluxed in xylene 
Method A 
[Bis(triphenylphosphine)Jrhodium(1) carbonyl chloride (25 mg, 0.04 mmol) was added 
to anhydrous p-xylene (15 ml) under a nitrogen atmosphere. The mixture was then 
stirred at 80°C for 15 min. 1,3-Bis(diphenylphosphino)propane (38 mg, 0.91 mmol) was 
added, and the mixture was stirred at 80°C for a further 30 min. (4S,9bS, 13aS)-7 ,8-
Dimethoxy-2, 12-dioxo-l ,4,5,1 0, 11,12,13, 13a-octahydro-2H-indolo[7 a,l-aJisoquinoline 
-4-carbaldehyde (282) (0.25 g, 0.73 mmol) in anhydrous p-xylene (5 ml) was added and 
the mixture was heated at reflux for 240 h. The excess p-xylene was removed by 
evaporation under reduced pressure producing a black oil. The residue was purified by 
flash column chromatography on silica gel using a mixture of ethyl acetate and hexane 
(3:1) as eluent affording (9bS,13aS)-7,8-dimethoxy-l,1O,11,12,13,13a-hexahydro-2H-
indole[7a,l-aJisoquinoline-2,12-dione (301) (40 mg, 18%) as a yellow oil and co-
eluting phosphorus by-products. 
MethodB 
[Bis(triphenylphosphine)Jrhodium(l) carbonyl chloride (50 mg, 0.07 mmol) was added 
to anhydrous p-xylene (15 ml) under a nitrogen atmosphere. The mixture was then 
stirred at 80°C for 15 min. 1,3-Bis(diphenylphosphino)propane (75 mg, 0.18 mmol) was 
Experimental 
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added, and the mixture was stirred at 80°C for a further 30 min. (4S,9bS,I3aS)-7,8-
Dimethoxy-2, 12-dioxo-1 ,4,5, I 0, 11,12,13, 13a-octahydro-2H-indolo[7 a, I-a ]isoquinoline 
-4-carbaldehyde (282) (0.50 g, 1.46 mmol) in anhydrous p-xylene (IS ml) was added 
and the mixture was heated at reflux for 120 h. The excess p-xylene was removed by 
evaporation under reduced pressure producing a black oil. The residue was purified by 
flash column chromatography using a mixture of ethyl acetate and hexane (3:1) as 
eluent affording (9bS,I3aS)-7,8-dimethoxy-1 , 10,11,12,13 ,13a-hexahydro-2H-indole[7 a, 
l-a]isoquinoline-2,12-dione (301) (90 mg, 20%) as a yellow oil and co-eluting 
phosphorus by-products. 
Using RhCI(CO)(PPh3h refluxed in mesitylene 
[Bis(triphenylphosphine)]rhodium(I) carbonyl chloride (40 mg, 0.06 mmol) was added 
to mesitylene (20 rnI) under a nitrogen atmosphere. The mixture was then stirred at 
80°C for 20 min. (4S,9bS,I3aS)-7,8-Dimethoxy-2,12-dioxo-I,4,5,1O,11,12,I3,I3a-
octahydro-2H-indolo[7a,l-a]isoquinoline-4-carbaldehyde (282) (0.20 g, 0.58 mmol) 
was added and the mixture was heated at reflux for 120 h. The excess mesitylene was 
removed by evaporation under reduced pressure producing a dark green oil. The residue 
was purified by flash column chromatography on silica gel using a mixture of ethyl 
acetate and hexane (3:1) as eluent affording (9bS, I 3aS)-7,8-dimethoxy-I,10, 11,12, 
I3,I3a-hexahydro-2H-indole[7a,l-a] isoquinoline-2,12-dione (301) (70 mg, 38%) and 
the co-eluting phosphorus by-products as a yellow oil and a trace of the amidoketone 
(302) H mg, 6%). 
Using RhCI(CO)(PPh3h and dppp refluxed in mesitylene 
[Bis(triphenylphosphine)Jrhodium(I) carbonyl chloride (40 mg, 0.06 mmol) was added 
to mesitylene (20 rnI) under a nitrogen atmosphere. The mixture was stirred at 80°C for 
20 min. 1,3-Bis(diphenylphosphino)propane (16 mg, 0.15 mmol) was added, and the 
mixture was stirred at 80°C for a further 30 min. (4S,9bS,I3aS)-7,8-Dimethoxy-2,12-
dioxo-I ,4,5, I 0, 11,12,13, 13a-octahydro-2H-indolo[7 a, I-a Jisoquinoline-4-carbaldehyde 
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(282) (0.20 g, 0.58 mmol) was added and the mixture was heated at reflux for 120 h. 
The excess mesitylene was removed by evaporation under reduced pressure producing a 
dark green oil. The residue was purified by flash column chromatography on silica gel 
using a mixture of ethyl acetate and hexane (3: 1) as eluent affording (9bS, 13aS)-7 ,8-di 
methoxy-l, 1 0, 11,12,13, 13a-hexahydro-2H-indole[7 a, I-a ]isoquinoline-2,12-dione (301) 
(100 mg, 55%) and the co-eluting phosphorus by-products as a yellow oil, and the 
amidoketone (302) (10 mg, 6%). 
V max (DCM)/cm-I 1719 (CO), 1686 (lactam); OH (400 MHz; CDCh) 1.87-1.94 (lH, m, 
NCCH(H)CH2), 2.23-2.36 (4H, m, NCCH(H)CH2, NCCH2CH2 and CHCH(H)CO), 
2.72 (lH, dd, J 16.5, 3.6, CHCH(H)CO), 2.84 (lH, dd, J 18.2, 10.6, CHCH(H)CO), 
2.97 (lH, dd, J 16.5,6.0, CHCH(H)CO), 3.36-3.38 (lH, m, CHCH2CO), 3.89 (3H, s, 
CH30), 3.90 (3H, s, CH30), 6.10 (lH, d, J 7.5, ArCH=CHN), 6.68 (lH, s, ArH), 6.71 
(lH, s, ArH), 6.85 (lH, d, J 7.5, ArCH=CHN); oe (100 MHz; CDCh) 31.18 
(NCC1hCH2), 33.85 (NCCH2CH2), 36.07 (CHCH2CO), 37.69 (CHCH2CO), 43.02 
(CHCH2CO), 56.97 (CH30), 56.43 (CH30), 62.33 (NCCH2CH2), 106.43 (ArCH), 
109.32 (ArCH), 113.09 (CH=CH), 119.63 (CH=CH), 123.52 (ArC), 129.73 (ArC), 
148.76 (ArC-OCH3), 149.02 (ArC-OCH3), 170.82 (NCO), 209.80 (CO); MS (El) rn/z 
313 [M., 13.3%]; (Found: M., 313.1309. CIIHI60 S requires 313.1314). 
Experimental - 180-
(9bS,13aS)-7,8-Dimethoxy-l,4,5,10,11,12,13,13a-octahydro-2H-indolo[7a,l-a] 
isoquinoline-2,12-dione (302) 
o 
MeO OMe 
(9bS, 13aS)-7,8-Dimethoxy-l, 1 0, 11,12,13, 13a-hexahydro-2H-indole[7 a, I-a] 
isoquinoline-2,12-dione (301) (+ phosphorus by-products) (230 mg, 0.73 mmol) and a 
catalytic amount of 10% palladium on charcoal was dissolved in absolute ethanol (25 
ml). A 3-way tap was fitted; the sample was then de-gassed by the vacuum and then 
purged with H2 gas. This was repeated 3 times before the mixture was left to stir at room 
temperature for a further 20 h. The mixture was then filtered through celite, washed 
with DCM (3 x 20 m!) and dried with anhydrous MgS04. The excess solvent was then 
by evaporation under reduced pressure producing a dark yellow oil. The residue was 
purified by flash column chromatography on silica gel using 100% ethyl acetate as the 
eluent affording (9bS, 13aS)-7,8-dimethoxy-1,4,5, I 0,1 1,12,13,13a-octahydro-2H-indolo 
[7a,l-a] isoquinoline-2,12-dione (302) (100 mg, 43 %) as a yellow oil. [<1]D= - 36.9 (c = 
I.I6, CHCh); v max (DCM)/cm·1 17I7 (CO), 1677 (lactam); OH (400 MHz; CD Ch) 2.12 
(!H, dd, J 17.4,7.2, CHCH(H)CO), 2.25-2.43 (4H, m, NCCH2CH2 and NCCH2CH2), 
2.61-2.77 (3H, m, CHCH(H)CO, NCH2CH(H)Ar and CHCH(H)CO), 2.97-3.10 (4H, m, 
NCH2CH(H)Ar, NCH(H)CH2Ar, CHCH(H)CO and CHCH2CO), 3.87 (3H, s, CH30), 
3.88 (3H, s, CH30), 4.36-4.41 (!H, m, NCH(H)CH2Ar), 6.58 (!H, s, ArIl), 6.69 (!H, s, 
ArIl); Oc (100 MHz; CDCh) 27.58 (NCH2GhAr), 33.54 (NCCH2CH2), 34.75 
(NCH2CH2Ar), 35.25 (NCCH2CH2), 37.49 (CHCH2CO), 37.80 (CHCH2CO), 43.26 
(CHCH2CO), 55.93 (CH30), 56.35 (GbO), 62.47 (NCCH2CH2), 107.32 (ArCH), 
II 1.80 (ArCH), 125.54 (ArC), 134.35 (ArC), 148.41 (ArC-OCH3), 148.34 (ArC-
OCH3), 172.12 (NCO), 210.03 (CO); MS (El) rnIz 315 [M", 33.5%]; (Found: M., 
315.1466. C18H21N04 requires 315.1471). 
Experimental - 181 -
(9bS,13aS)-12,12-Ethylenedioxy-7 ,8-dimethoxy-l,4,S,1 0,11 ,12,13,13a-octahydro-
2H-indolo[7a,1-a] isoquinoline-2-dione (308) 
OMe 
(9bS, 13aS)-7 ,8-Dimethoxy-l ,4,5, 1 0,11,12,13, 13a-octahydro-2H-indolo[7 a,l-a] 
isoquinoline-2,12-dione (302) (50 mg, 0.16 mmol) andp-TSA (5 mg) was dissolved in 
toluene (50 ml). Ethylene glycol (0.26 ml, 0.48 mmol) was then added to this stirring 
solution and the reaction mixture was refluxed, under Dean-Stark conditions, for 20 h. 
The reaction was quenched with saturated aqueous sodium bicarbonate solution (25 ml), 
extracted with ethyl acetate (3 x 25 ml) and dried with anhydrous MgS04. The excess 
solvent was then removed by evaporation under reduced pressure affording (9bS, 13aS)-
12, 12-ethylenedioxy-7 ,8-dimethoxy-l ,4,5, I 0,11,12,13, 13a-octahydro-2H-indolo[7 a,l-
a]isoquinoline-2-dione (308) (40 mg, 70%) as a yellow oil. [aID = - 26.1 (c = 1.15, 
CHCI3); v mID< (DCM)/cm-1 2852 (OMe), 1677 (lactam), 1514 (C-O); 1)H (400 MHz; 
CDCb) 1.70-175 (2H, m, NCCH2CH2), 1.83 (lH, dd, J 14.4,3.2, CH(H)CHCH2CO), 
1.98-2.15 (3H, m, CH(H)CHCH2CO and NCCH2CH2), 2.35-2.52 (2H, m, 
CH2CHCH2CO), 2.60 (lH, ddd, J 16.4, 5.2, 2.4, NCH2CH(H)Ar), 2.77-2.80 (lH, m, 
CH2CHCH2CO), 2.98-3.07 (lH, rn, NCH2CH(H)Ar), 3.17-3.24 (lH, m, 
NCH(H)CH2Ar), 3.85 (3H, s, CH30), 3.88 (3H, s, CH30), 3.93-3.98 (4H, m, 
OCH2CH20), 4.16-4.22 (lH, m, NCH(H)CH2Ar), 6.56 (lH, s, Arlf), 6.79 (lH, s, Arlf); 
1)c (100 MHz; CDCb) 26.87 (ArCH2CH~), 30.26 (NCCH2CH2), 33.49 (NCCH2CH2), 
34.96 ArCH2CH2N), 36.74 (CH2CHCH2CO), 37.19 (CH2CHCH2CO), 37.31 
(CH2CHCH2CO), 55.85 (OCH3), 56.21 (OCH3), 62.27 (NCCH2CH2), 64.09 
(OCH2CH20), 64.44 (OCH2CH20), 107.72 (C-ketal), 108.02 (ArCH), 111.85 (ArCH), 
125.95 (ArC), 133.95 (ArC), 147.56 (ArC-OCH3), 148.02 (ArC-OCH3), 175.10 (NCO); 
MS (El) mlz 359 [M+, 5.2%]; (Found: M+, 359.1739. C20H2SNOs requires 359.1733). 
Experimental - 182-
3.3 Formal asymmetric synthesis of (+)-3-demethoxyerthratidinone 
(2R)-2-Amino-3-(3,4-dimethoxyphenyl)-D-propionic acid (310)6 
0 
I 
~ OH 
NH2 
MeO 
OMe 
Pure N-acetyl-3-(3,4-dimethoxyphenyl)-D-alanine (309) (3.00 g, 11.2 mmol) was 
dissolved in (1M) HCI (15 ml) and the mixture was heated at refluxed for 20 h. The 
excess HCl was then removed by evaporation under reduced pressure. The residue was 
then dissolved in 95% ethanol (40 ml) and then concentrated aqueous ammonia was 
added dropwise until the solution was pH 6. The solid was then filtered and washed 
with ethanol (100 ml). The excess ethanol was then removed by evaporation under 
reduced pressure affording (2R)-2-amino-3-(3,4-dimethoxyphenyl)-D-propionic acid 
(310) (2.26 g, 95 %) as a colourless solid. No further purification was necessary. Mp 
254-25TC; [U]D= - 4.8 (c = 1.09, HCl); v max(KBr)/cm-131% (C02H), 2837 (OCH3), 
1606 (NH2); liH (250 MHz; DCl) 3.15-3.36 (2H, m, CH(H)CHNH2 and CH(H)CHNH2), 
3.79 (3H, s, CH30), 3.80 (3H, s, CH30), 4.48 (lH, t, J7.2, CH2CHNH2), 6.84-6.95 (3H, 
m, Arll); Se (lOO MHz; DCl) 37.63 (C1I2CHNH2), 65.55 (C1IOH), 167.56 (C02H); MS 
(El) mlz 225 [M" 5_1%]; (Found: M'", 225.0997. C11HlS04 requires 225.1001). 
Experimental - 183 -
(2R)-2-Amino-3-[3,4-dimethoxyphenyIJpropan-l-ol (311 i 
""" 
OH 
MeO .4" 
NH2 
OMe 
A solution of chlorotrimethylsilane (4.50 ml, 35.5 mmol) was added under a nitrogen 
atmosphere to a solution oflithium borohydride (8.88 ml of a 2M solution in THF, 17.8 
nunol) in THF (25 ml) over a period of 2 min. 3-(3,4-Dimethoxyphenyl)-D-alanine 
(310) (2.00 g, 8.88 nunol) was added portionwise over 5 min, and then left to stir at 
room temperature for 24 h. Methanol (30 ml) was added slowly to the solution and the 
solvent was then removed by evaporation under reduced pressure. The residue was then 
treated with 20% aqueous potassium hydroxide solution and extracted with DCM (3 x 
20 ml). The organic extracts were dried with anhydrous Na2S04 and the solvent was 
removed by evaporation under reduced pressure affording (2R)-2-amino-3-[3,4-
dimethoxyphenyl]propan-l-01 (311) (1.77 g, 94%) as a colourless solid. Mp 82-83; Lit: 
Mp 78-79·C;2,3 [a]D= + 21.7 (c = 1.27, EtOH); v max(DCM)/cm·1 3385 (OH), 2938 (Sp3 
CH), 2838 (OMe), 1517 (C-O); OH (400 MHz; CDCh) 2.44 (lH, dd, J 13.6, 8.8, 
CH(H)CHNH2), 2.73 (lH, dd, J 13.6,5.2, CH(H)CHNH2), 3.09-3.13 (IH, m, NH2CH), 
3.42 (lH, dd, J 10.4,7.2, CH(H)OH), 3.63 (lH, dd, J 10.8,4.0, CH(H)OH), 3.87 (3H, s, 
CH30), 3.88 (3H, s, CH30), 6.72-6.75 (2H, m, ArH), 6.81-6.83 (lH, m, ArH); Oc (100 
MHz; CDCh) 40.49 (CH2CHNH2), 54.21 (NH2CH), 55.87 (CH30), 55.93 (CH30), 
66.44 (CH20H), 111.31 (ArCH), 112.27 (ArCH), 121.15 (ArCH), 131.19 (ArC), 147.64 
(ArC-OCH3), 148.98 (ArC-OCH3); MS (El) rnIz 211 [M+' 1.2%]; (Found: M" 
211.1134. CllH1603 requires 211.1130). 
Experimental - 184-
(3R,6aR,10aR)-3-(3,4-Dimethoxy)phenylmethyl-8-(l,3-dioxolane)perhydro(I,3) 
oxazolo(2,3-1)indol-5-one (312) 
(2R)-2-Amino-3-[3,4-dimethoxyphenyl)propan-l-ol (311) (0.41 g, 1.94 mmol) and 2-(-
8-oxo-l,4-dioxaspiro[4,5]dec-7-yl)ethanoic acid (258) (0.41 g, 1.94 mmol) was 
dissolved in toluene (150ml) and refluxed under Dean-Stark conditions for 48 h. The 
solution was then allowed to cool and the solvent was removed by evaporation under 
reduced pressure. The resulting yellow oil was then purified by flash column 
chromatography on silica gel using a mixture of ethyl acetate and hexanes (4:1) as 
eluent affording (3R,6aR, 1 OaR)-3-(3,4-dimethoxy)phenylmethyl-8-(1 ,3-dioxolane) 
perhydro[I,3]oxazolo[2,3-I]indol-5-one (312) (0.45 g, 60%) as a colourless solid. Mp 
98-99"C; [a]D= - 55.7 (c = 1.13, CHCh); v max(DCM)/crn·t 1717 (CO), 1653 (lactam); 
OH (400 MHz; CDCh) 1.72-2.04 (6H, rn, NCCH2CH2, NCCH2CH2 and 
CH2CHCH2CO), 2.40-2.50 (2H, rn, CH2CHCH2CO and CHCHCH(H)CO), 2.75 (lH, 
dd, J 13.9, 9.1, CH(H)Ar), 2.93-3.04 (lH, rn, CH2CHCH(H)CO and CH(H)Ar), 3.85 
(3H, s, CH30), 3.87 (3H, s, CH30), 3.91-3.96 (5H, rn, 2 x CH20 and CH(H)O), 4.03-
4.10 (lH, rn, CH(H)O), 4.24-4.30 (lH, rn, NCHCH20), 6.73-6.81 (3H, m, ArH); Oc 
(lOO MHz; CDCh) 30.45 (CH2), 30.84 (CH2), 33.71 (CH2), 39.33 (CHCH2CO),39.91 
(CH2Ar), 41.56 (CHCH2CO), 55.30 (NCHCH20), 55.83 (CH30), 55.88 (CH30), 63.92 
(CH20), 64.37 (CH20), 71.59 (NCHCH20), 98.97 (NCCH2CH2), 107.88 (C-ketal), 
111.28 (ArCH), 112.54 (ArCH), 121.31 (ArCH), 129.56 (ArC), 147.83 (ArC-OCH3), 
148.93 (ArC-OCH3), 176.28 (CO); MS (El) rnIz 389 [M+, 59.5%]; (Found: M+, 
389.1842. C2tH27N03 requires 389.1838). 
Experimental - 185 -
(4R,9bR,13aR)-4-(Hydroxymethyl)-7 ,8-dim ethoxy )-1,4,5,1 O,II,12,13,13a-
octahydro- 2H-indolo[7 a,l-a)isoquinoline-2,12-dione (313) 
o 
OH 
MeO OMe 
(3R,6aR, I OaR)-3 -(3,4-Dimethoxy )phenylmethyl-8-(I ,3-dioxolane )perhydro[ 1,3] 
oxazolo[2,3-1 ]indol-5-one (312) (1.10 g, 2.83 mmol) was dissolved in dry DCM (50 
ml) under a nitrogen atmosphere and the reaction mixture was cooled to -78°C. TiC4 
(0.93 ml, 8.48 mmol) was added drop wise by syringe and the mixture was stirred at 
-78°C for 10 min. After this time, the solution was allowed to reach room temperature 
before being stirred for an additional 20 h. The mixture was then quenched with 
saturated ammonium chloride solution (60 ml), extracted with DCM (3 x 25 ml), dried 
over anhydrous MgS04 and the solvent was removed by evaporation under reduced 
pressure affording a yellow solid. The solid was purified by flash column 
chromatography on silica gel using a mixture of 5% methanol in DCM as the eluent 
affording (4R,9bR,1 3aR)-4-(hydroxymethy1)-7,8-dimethoxy)-1 ,4,5,10,11,12, I 3, I 3a-
octahydro-2H-indolo[7a,l-a] isoquinoline-2,12-dione (313) (0.75 g, 77%) as a 
colourless solid. Mp 215-2ITC; [a]D = + 60.8 (c = 1.06, CHCh); v max (DCM)/cm-1 
3415 (OH), 1712 (CO), 1666 (lactam); BH (400 MHz; CDCh) 2.24 (IH, dd, J 18.0,7.0, 
CHCH(H)CO), 2.29-2.44 (4H, m, NCCH2CH2 and NCCH2CH2), 2.58 (IH, ddd, J 16.5, 
9.4,3.8, CHCH(H)CO and NCHCH(H)Ar), 2.70 (IH, dd, J 17.9, 10.9, CHCH(H)CO), 
2.96 (IH, dd,JI6.1, 6.1, CHCH(H)CO), 3.09-3.1 I (IH, m, CHCH2CO), 3.31 (IH, dd,J 
16.5, 12.0, NCHCH(H)Ar), 3.63-3.66 (lH, m, NCHCH20H), 3.87 (3H, s, CH30), 3.88 
(3H, s, CH30), 4.00-4.13 (2H, rn, CH20H), 4.86 (IH, dd, J 9.7,5.4, OH), 6.60 (IH, s, 
ArH), 6.66 (IH, s, ArH). Bc (100 MHz; CDCh) 30.21 (NCHCIhA), 33.34 
(NCCH2CH2), 35.18 (NCCH2CH2), 37.80 (CHCH2CO), 38.20 (CHCH2CO), 43.44 
(CHCH2CO), 53.85 (NCHCH20H), 55.96 (CH30), 56.32 (CH30), 62. I I (CH20H), 
65.94 (NCCH2CH2), 107.00 (ArCH), 111.71 (ArCH), 125.91 (ArC), 133.66 (ArC), 
Experimental - 186-
148.24 (ArC-OCH3), 148.57 (ArC-OCH3), 173.89 (NCO), 209.72 (CO); MS (El) m/z 
345 [M" 15.9%]; (Found: M., 345.1581. CI9H23NOS requires 345.1576). 
Experimental - 187-
(4R,9bR,13aR)-7,8-Dimethoxy-2,12-dioxo-l ,4,5,1 0,11 ,12,13,13a-octahydro-2H-
indolo[7a,l-a) isoquinoIine-4-carbaldehyde (314) 
MeO OMe 
(4S,9bS,13aS)-4-(Hydroxymethyl)-7,8-dimethoxy-l ,4,5, 1 0, 11,12,13, 13a-octahydro-2H-
indolo[7a,l-a)isoquinoIine-2,12-dione (313) (0.74 g, 2.14 mmol) in dry DCM (30 ml), 
under a nitrogen atmosphere, was added dropwise via cannula to a solution of Dess-
Martin periodinane (1.00g, 2.36 mmol) in dry DCM (30 ml) also under a N2 
atmosphere. The solution was then stirred at room temperature for 20 h. After this time, 
the excess solvent was removed by evaporation under reduced pressure producing a 
dark yellow solid. The solid was purified by flash column chromatography on silica gel 
using 100% ethyl acetate as an eluent affording (4R,9bR,I3aR)-7,8-dimethoxy-2,12-
dioxo-I ,4,5, 1 0,11,12, 13,13a-octahydro-2H-indolo[7 a, I-a ]isoquinoIine-4-carbaIdehyde 
(314) (0.67 g, 91%) as a yellow solid. Mp 168-170·C; [aID = + 13.2 (c = 1.06, CHCh); 
v max (DCM)/cm·1 1716 (CO), 1683 (Iactarn); OH (400 MHz; CDCh) 2.25 (lH, dd, J 
17.8, 7.4, CHCH(H)CO), 2.34-2.38 (2H, rn, NCCH2CH2), 2.45-2.49 (2H, rn, 
NCCH2CH2), 2.61 (lH, dd, J 16.0, 3.7, CHCH(H)CO), 2.67 (lH, dd, J 17.8, 10.1, 
NCHCH(H)Ar), 3.00-3.22 (4H, rn, NCHCH(H)Ar, CHCH2CO and CHCH2CO), 3.87 
(3H, s, CH30), 3.89 (3H, s, CH30), 4.01-4.04 (lH, rn, NCHCH20H), 6.66 (lH, s, ArH), 
6.71 (lH, s, ArH), 9.83 (lH, s, CHO); Oc (100 MHz; CDCh) 27.35 (NCHCH2Ar), 33.42 
(NCCH2CH2), 35.37 (NCCH2CHz), 36.84 (CHCH2CO), 38.83 (CHCH2CO), 43.21 
(CHCH2CO), 55.98 (CH30), 56.30 (CH30), 57.74 (NCH2CH2), 63.62 (NCCH2CH2), 
107.13 (ArCH), 112.03 (ArCH), 124.15 (ArC), 133.34 (ArC), 148.45 (ArC-OCH3), 
148.67 (ArC-OCH3), 174.76 (NCO), 196.46 (CHO), 209.57 (CO); MS (El) mlz 343 
[M" 11.8%]; (Found: M" 343.1414. C19H21NOs requires 343.1420). 
Experimental - 188-
(9bR,13aR)-7 ,8-Dimethoxy-l,1 0,11,12,13, 13a-hexahydro-2H-indole[7 a,l-a I 
isoquinoline-2,12-dione (315) 
MeO OMe 
[Bis(triphenylphosphine)]rhodiurn(I) carbonyl chloride (135 mg, 0.20 mmol) was added 
to mesitylene (50 ml) under a nitrogen atmosphere. The mixture was stirred at 80°C for 
20 min. 1,3-Bis(diphenylphosphino)propane (201 mg, 0.49 mrnol) was added, and the 
mixture was stirred at 80°C for a further 30 min. (4R,9bR,13aR)-7,S-Dimethoxy-2,12-
dioxo-l ,4,5, I 0, 11,12,13, 13a-octahydro-2H-indolo[7 a, I-a ]isoquinoline-4-carbaldehyde 
(314) (0.67 g, 1.95 mrnol) was added and the mixture was heated at reflux for 96 h. The 
excess mesitylene was then removed by evaporation under reduced pressure producing 
a dark green oil. The residue was purified by flash column chromatography on silica gel 
using a mixture of ethyl acetate and hexane (3:1) as eluent affording (9bR,13aR)-7,S-
dimethoxy-I, I 0,11,12, 13,13a-hexahydro-2H-indole[7 a, I-a ]isoquinoline-2, 12-dione 
(315) (ISO mg, 29%) and the co-eluting phosphorus by-products as a yellow oil, and the 
amidoketone (316) (ISO mg, 29%). v max (DCM)/cm-( 1719 (CO), 1686 (Iactam); OH 
(400 MHz; CDCh) 1.87-1.94 (lH, m, NCCH(H)CH2), 2.23-2.36 (4H, m, 
NCCH(H)CH2, NCCH2CH2 and CHCH(H)CO), 2.72 (lH, dd, J 16.5, 3.6, 
CHCH(H)CO), 2.84 (lH, dd, J 18.2, 10.6, CHCH(H)CO), 2.97 (lH, dd, J 16.5, 6.0, 
CHCH(H)CO), 3.36-3.38 (lH, m, CHCH2CO), 3.89 (3H, s, CH30), 3.90 (3H, s, CH30), 
6.10 (JH, d, J 7.5, ArCH=CHN), 6.68 (lH, s, ArH), 6.71 (lH, s, ArH), 6.85 (!H, d, J 
7.5, ArCH=CHN); Oc (100 MHz; CDCI3) 31.18 (NCCH2CH2), 33.85 (NCCH2CH2), 
36.07 (CHCH2CO), 37.69 (CHCH2CO), 43.02 (CHCH2CO), 56.97 (CH30), 56.43 
(CH30), 62.33 (NCCH2CH2), 106.43 (ArC1I), 109.32 (ArCH), 113.09 (CH=CH), 
119.63 (CH=CH), 123.52 (ArC), 129.73 (ArC), 148.76 (ArC-OCH3), 149.02 (ArC-
OCH3), 170.82 (NCO), 209.80 (CO). 
Experimental - 189-
(9bR,13aR)-7 ,8-Dimethoxy-l,4,5,l O,ll,12,13,13a-octahydro-2H-indolo [7 a,l-a I 
isoquinoline-2,12-dione (316) 
MeO OMe 
(9bR, 13aR)-7,8-Dimethoxy-1 ,I 0, 11,12,13, 13a-hexahydro-2H-indole[7 a, I-a] 
isoquinoline-2,12-dione (315) (+ phosphorus by-products) (180 mg, 0.57 mmol) and a 
catalytic amount of 10% palladium on charcoal was dissolved in absolute ethanol (25 
ml). A 3-way tap was fitted; the sample was then de-gassed by the vacuum and then 
purged with H2 gas. This was repeated 3 times before the mixture was left to stir at room 
temperature for a further 20 h. The mixture was then filtered through celite, washed 
with DCM (3 x 20 ml) and dried with anhydrous MgS04. The excess solvent was then 
by evaporation under reduced pressure producing a dark yellow oil. The residue was 
purified by flash column chromatography on silica gel using 100% ethyl acetate as the 
eluent affording (9bR, 13aR)-7 ,8-dimethoxy-1 ,4,5, I 0, 11,12,13, 13a-octahydro-2H-indolo 
[7a,l-a] isoquinoline-2,12-dione (316) (90 rng, 50 %) as a yellow oil. [a]D= + 39.6 (c = 
1.13, CHCh); v max(DCM)/crn-1 2850 (OMe), 1715 (CO), 1685 (lactam); OH (400 MHz; 
CDCh) 2.13 (!H, dd, J 17.4, 7.2, CHCH(H)CO), 2.25-2.46 (4H, rn, NCCH2CH2 and 
NCCH2CH2), 2.61-2.77 (3H, rn, CHCH(H)CO, NCH2CH(H)Ar and CHCH(H)CO), 
2.98-3.06 (4H, m, NCH2CH(H)Ar, NCH(H)CH2Ar, CHCH(H)CO and CHCH2CO), 
3.87 (3H, s, CH30), 3.88 (3H, s, CH30), 4.36-4.41 (!H, rn, NCH(H)CH2Ar), 6.58 (!H, 
s, Arl/), 6.69 (!H, s, Arl/); oe (100 MHz; CDCh) 27.59 (NCH2CH2Ar), 33.52 
(NCCH2CH2), 34_75 (NCH2CH2Ar), 35.25 (NCCH2CH2), 37.47 (CHCH2CO), 37.81 
(CHCH2CO), 43-26 (CHCH2CO), 55.92 (CH30), 56.30 (CH30), 62.47 (NCCH2CH2), 
107.13 (ArCH), 111.67 (ArCH), 125.49 (ArC), 134.33 (ArC), 148.27 (ArC-OCH3), 
148.41 (ArC-OCH3) 172.12 (NCO), 210.16 (CO); MS (El) mlz 315 [M., 12.4%]; 
(Found: M., 315.1466. C1sH21N04 requires 315.1471). 
Experimental -190 -
(9bR,13aR)-12,12-Ethylenedioxy-7 ,8-dim eth oxy-l ,4,5,1 0,11 ,12,13,13a-octahydro-
2H-indolo[7a,l-a] isoquinoline-2-dione (317) 
MeO OMe 
(9bR,13aR)-7,8-Dimethoxy-l ,4,5,1 0, 11,12,13, 13a-octahydro-2H-indolo[7 a, I-a] 
isoquinoline-2,12-dione (316) (0.24 mg, 0.76 mmol) and p-TSA (5 mg) was dissolved 
in toluene (50 ml). Ethylene glycol (0.14 ml, 2.28 mmol) was then added to this stirring 
solution and the reaction mixture was refluxed, under Dean-Stark conditions, for 20 h. 
The reaction was quenched with saturated aqueous sodium bicarbonate solution (25 ml), 
extracted with ethyl acetate (3 x 25 m1) and dried with anhydrous MgS04• The excess 
solvent was then removed by evaporation under reduced pressure affording (9bR,13aR)-
12,12-ethylenedioxy-7 ,8-dimethoxy-1 ,4,5, I 0, 11,12,13, 13a-octahydro-2H-indolo[7 a, 1-
a]isoquinoline-2-dione (317) (0.22 g, 80%) as a yellow oil. [aID = + 21.7 (c = 1.33, 
CHCh); v max (DCM)/cm-1 2852 (OMe), 1673 (Iactam), 1514 (C-O); OH (400 MHz; 
CDCh) 1.70-1.75 (2H, m, NCCH2CH2), 1.83 (lH, dd, J 14.4, 6.8, CH(H)CHCH2CO), 
1.99-2.17 (3H, m, CH(H)CHCH2CO and NCCH2CH2), 2.34-2.51 (2H, m, 
CH2CHCH2CO), 2.60 (lH, ddd, J 16.3, 5.4, 2.2, NCH2CH(H)Ar), 2.76-2.80 (lH, m, 
CH2CHCH2CO), 3.00-3.05 (IH, m, NCH2CH(H)Ar), 3.17-3.24 (lH, m, 
NCH(H)CH2Ar), 3.85 (3H, s, CH30), 3.88 (3H, s, CH30), 3.93-4.02 (4H, m, 
OCH2CH20), 4.13-4.22 (lH, m, NCH(H)CH2Ar), 6.56 (lH, s, ArH), 6.79 (lH, s, ArH); 
oe (100 MHz; CDCh) 26.86 (ArCH2C1hN), 30.45 (NCCH2C1h), 33.49 (NCCH2CH2), 
34.94 ArCH2CH2N), 36.75 (CH2CHCH2CO), 37.19 (CH2CHCH2CO), 37.30 
(CH2CHCH2CO), 55.85 (OCH3), 56.22 (OCH3), 62.25 (NCCH2CH2), 64.09 
(OCH2CH20), 64.43 (OCH2CH20), 107.77 (C-acetal), 108.02 (ArCH), 111.89 (ArCH), 
125.97 (ArC), 133.98 (ArC), 147.57 (ArC-OCH3), 148.03 (ArC-OCH3), 175.07 (NCO); 
MS (El) mlz 359 [M'", 2.1%]; (Found: M'", 359.1730. C2oH2SNOs requires 359.1733). 
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3.4 Towards the keto-acid precursor of (-)-erysotrine and (-)-
erythraline 
l,3-Cyclohexanedione monoethylene ketal (328)7,8 
Method A 
Ethylene glycol (2.49 ml, 44.6 mmol) was added to a stirring mixture of Cyclohexane-
1,3-dione (327) (5.00 g, 44.6 mmol) andp-TSA (85 mg, 0.45 mmol) in toluene (60 ml). 
The reaction mixture was then refluxed under Dean-Stark conditions for 4.5 h. After 
this time, the reaction was quenched with saturated aqueous sodium bicarbonate 
solution (40 ml) and extracted with ethyl acetate (3 x 40 ml). The organic extracts were 
dried with anhydrous MgS04 and the excess solvent was removed by evaporation under 
reduced pressure to yield a yellow solid. The solid was then purified by flash column 
chromatography on silica gel using a mixture of ethyl acetate and hexane (l : 1) as eluent 
affording 1,3-cyclohexanedione monoethylene ketal (328) (0.59 g, 9%) as a clear oil. 
MethodB 
1,3-Cyclohexanedione diethylene ketal (329) (146 mg, 0.73 mmol) was dissolved in 
DCM (20 ml) before being treated with silica gel (0.30 g) and 15% sulphuric acid (0.20 
ml). The reaction mixture was then stirred at room temperature for 2.5 h. After this 
time, the reaction mixture was then filtered, and the filtrate was washed with saturated 
aqueous sodium bicarbonate solution. The organic layer was dried with anhydrous 
MgS04 and the excess solvent was removed by evaporation under reduced pressure to 
yield a yellow oil. The residue was then purified by flash column chromatography ori 
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silica gel using a mixture of ethyl acetate and hexane (I: 1) as eluent affording 1,3-
cyclohexanedione monoethylene ketal (328) (85 mg, 75%) as a clear oil. 
V max (DCM)/cm-1 1717 (CO); OH (400 MHz; CDCh) 1-83-1-91 (4H, m, CH2CH2CHZ-
acetal and CH2CH2CH2-ketal ), 231 (2H, t, J 6.0, CH2CH2CH2CO), 2.58 (COCH2-
ketal), 3.92-3.98 (4H, m, OCH2CH20); Oc (lOO MHz; CDCh) 20.06 (CH2CH2CH2-
acetal), 34.06 (CH2CH2CH2-ketal), 40.14 (CH2CH2CH2CO), 51-56 (COCH2-ketal), 
64.58 (OCH2CH20), 109.88 (CO-ketal), 207.37 (CO). 
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l,3-Cyclohexanedione diethylene ketal (329)9 
Ethylene glycol (9.95 ml, 0.18 mol) was added to a stirring mixture of Cyclohexane-
1,3-dione (327) (5.00 g, 44.6 mmol) andp-TSA (85 mg, 0.45 mmol) in toluene (90 ml). 
The reaction mixture was then refluxed under Dean-Stark conditions for 16 h. After this 
time, the reaction was quenched with saturated aqueous sodium bicarbonate solution 
(25 ml) and extracted with ethyl acetate (3 x 25 ml). The organic extracts were dried 
with anhydrous MgS04 and the excess solvent was removed by evaporation under 
reduced pressure to yield a yellow solid. The solid was purified by flash column 
chromatography on silica gel using a mixture of ethyl acetate and hexane (l: I) as eluent 
affording 3-cyclohexanedione diethylene ketal (329) (7.02 g, 78%) as a white solid. Mp 
38-41°C; v m", (DCM)/cm-1 1656 (C-O); Ihi (400 MHz; CDCI3) 1.61-1.77 (6H, m, 
CH2CH2CH2C-ketal, CH2CH2CH2C-ketal and CH2CH2CH2C-ketal), 1.93 (2H, s, CH2C-
ketal), 3.93 (4H, s, OCH2CH20), 3.97 (4H, s, OCH2CH20); 3c (lOO MHz; CDCb) 
19.81 (CH2CH2C-ketal), 34.03 (2 x CH2CH2C-ketal), 43.68 (CH2C-ketal), 64.40 (2 x 
OCH2CH20), 109.05 (2 x C-ketal); MS (El) rnIz 200 [M\ 8.3%]; (Found: 200.1052. 
ClOH1604 requires 200.1 049). 
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Attempted preparation: Methyl-2-(7-oxo-l,4-dioxaspiro[4.5Jdec-8-yl)ethanoate 
(333) 
Method A 
1,3-CycIohexanedione monoethylene ketal (328) (210 mg, 1.23 mmol) was dissolved in 
dry TIIF (20 ml) and the solution was cooled to -78°C. KHMDS (2.72 ml of a 0.5 M 
solution in toluene, 1.36 mmol) was then added and the solution was stirred at -78°C for 
1 h. Methyl bromoacetate (0.13 ml, 1.36 mmol) was then added carefully to the reaction 
mixture and the reaction was left to stir for an additional 1 h. The mixture was then 
allowed to wann to room temperature before being stirred for a further 20 h. After this 
time, the residue was quenched with 2M HCI and extracted with diethyl ether (3 x 25 
ml). The organic extracts were dried with anhydrous NaZS04 and the excess solvent was 
removed by evaporation under reduced pressure. The residue was purified by flash 
column chromatography on silica gel using a mixture of ethyl acetate and hexane (3 :2) 
as eluent affording a light yellow oil. OH (250 MHz; CDCh): The 'H NMR spectrum of 
the crude product showed a mixture of unknown products and traces of starting 
material. 
MethodB 
1,3-CycIohexanedione monoethylene ketal (328) (0.51 g, 3.31 mmol) was dissolved in 
dry TIIF (20 m!) and the solution was cooled to -78°C. KHMDS (4.96 ml of a 0.5 M 
solution in toluene, 2.48 mmol) was added and the solution was stirred at -78°C for 1 h. 
Methyl bromoacetate (0.56 ml, 3.64 mmol) was then added carefully to the reaction 
mixture and the reaction was left to stir for an additional 1 h. The mixture was then 
allowed to wann to room temperature before being stirred for a further 20 h. After this 
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time, the residue was quenched with 2M HCI and extracted with diethyl ether (3 x 25 
ml). The organic extracts were dried with anhydrous Na2S04 and the excess solvent was 
removed by evaporation under reduced pressure affording a light yellow oil. OH (250 
MHz; CDCh): The lH NMR spectrum of the crude product showed a mixture of 
unknown alkylated products and starting material. 
Method C 
1 ,3-Cyclohexanedione monoethylene ketal (328) (0.52 g, 3.33 mmol) was dissolved in 
dry THF (20 ml) and the solution was cooled to _78°C. KHMDS (6.00 ml of a 0.5 M 
. solution in toluene, 3.00 mmol) was then added and the solution was stirred at -78°C for 
1 h. Methyl bromoacetate (0.56 ml, 3.64 mmol) was then added carefully to the reaction 
mixture and the reaction was left to stir for an additional 1 h. The mixture was then 
allowed to warm to room temperature before being stirred for a further 20 h. After this 
time, the residue was quenched with 2M HCI and extracted with diethyl ether (3 x 25 
ml).The organic extracts were dried with anhydrous Na2S04 and the excess solvent was 
removed by evaporation under reduced pressure affording a light yellow oil. OH (250 
MHz; CDCh): The lH NMR spectrum of the crude product showed a mixture of 
unknown alkylated products and starting material. 
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3-Methoxy-2-cyclohexen-l-one (336)10 
y 
o 
A mixture of Cyclohexane-l,3-dione (327) (2.00 g, 17.8 mmol), p-TSA (42 mg), 
methanol (10 ml) and trimethyl orthofonnate (1.96 ml, 17.8 mmol) was heated at reflux 
in toluene (30 ml) for 80 min. The reaction mixture was allowed to cool before being 
washed with a 10% aqueous NaOH solution (2 x 20 ml) and brine (20 ml). The solution 
was then dried with anhydrous MgS04 and the excess solvent was removed by 
evaporation under reduced pressure affording 3-methoxy-2-cyclohexen-l-one (336) 
(1.94 g, 86%) as a yellow oil. No further purification was necessary. v mID< (DCM)/cm-1 
2945 (OMe), 1665 (CO), 1603 (C=C); OH (400 MHz; CDCh) 1.96-2.03 (2H, m, 
CH2CH2CH2),2.33 (2H, t, J 5.1, CH=CCH2),2.41 (2H, t, J 6.4, COCH2), 3.71 (3H, s, 
OCH3), 5.37 (lH, s, CH=); oe (100 MHz; CDCI3) 21.41 (OJz), 28.83 (Olz), 36.76 
(CH2), 55.64 (ClI30), 102.61 (CH=), 178.76 (CH=C(OCH3», 199.64 (CO); MS (El) 
rnlz 126 [M'", 68.7%]; (Found: M'" 126.0682. C7HlO02 requires 126.0681). 
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3-Chloro-2-cyclohexen-l-one (335)11 
C'y 
o 
To a suspension ofCyc1ohexane-1,3-dione (327) (2.00 g, 17.8 mrno1) in chloroform (10 
rnI) was added slowly oxalyl chloride (3.77 rnI, 35.7 mrno1). The addition was 
accompanied by vigorous evolution of gas. After stirring at room temperature for 10 
min, the slurry was then refluxed for 13 min to give a dark yellow solution. The excess 
solvent was then removed by evaporation under reduced pressure. The residue was 
purified by flash column chromatography on silica gel using a mixture of ethyl acetate 
and light petroleum (bp 40-60°C) (1 :4) as eluent affording 3-chloro-2-cyclohexen-1-one 
(335) (1.61 g, 68%) as a yellow oil. v max (DCM)/cm-11683 (CO), 1606 (C=C); OH (400 
MHz; CDCh) 2.07-2.13 (2H, m, CH1CH1CH2CO), 2.38-2.42 (2H, m, CH2CH2CH2CO), 
2.68 (2H, dt, J 6.1, 1.5, CH2CH1CH2CO), 6.21 (lH, t, J 1.6, COCH=); Oc (100 MHz; 
CDCI3) 22.37 (CH2), 34.05 (CH2), 36.51 (CH2), 128.18 (CH=), 158.61(CH=C(Cl», 
196.78 (CO); MS (El) rn/z 130 [M" 45.7%]; (Found: ~, 130.0184. C6H7ClO requires 
130.0185). 
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MethyI2-[4-(methoxy)-2-oxocycIohex-3-enyIJethanoate (338)12 
Method A 
3-Methoxy-2-cyclohexen-I-one (336) (0.85 g, 6.74 mmol) was dissolved in dry THF 
(20 m1) and the solution was cooled to -78°C. KHMDS (14.82 ml of a 0.5 M solution in 
toluene, 7.41 mmol) was added and the solution was stirred at -78°C for 1 h. Methyl 
bromoacetate (0.69 ml, 7.41 mmol) was then added carefully to the reaction mixture and 
the reaction was left to stir for an additional 1 h. The mixture was then allowed to warm 
to room temperature before being stirred for a further 20 h. After this time, the residue 
was quenched with 2M HCI and extracted with diethyl ether (3 x 25 ml). The organic 
extracts were dried with anhydrous Na2S04 and the excess solvent was removed by 
evaporation under reduced pressure. The residue was purified by flash column 
chromatography on silica gel using a mixture of ethyl acetate and hexane (2:3) as eluent 
affording a light yellow oil. OH (250 MHz; CDCh): The IH NMR spectrum of the crude 
product showed a mixture of starting material and a small trace of the desired product 
(338). 
MethodB 
3-Methoxy-2-cyclohexen-I-one (336) (0.50 g, 3.96 mmol) was dissolved in dry THF 
(20 m1) and the solution was cooled to -78°C. NaHMDS (0.79 m1, 4.36 mmol) was 
added and the solution was stirred at -78°C for 1 h. Methyl bromoacetate (0.41 ml,4.36 
mmol) was added carefully to the reaction mixture and the reaction was left to stir for an 
additional 1 h. The mixture was then allowed to warm to room temperature before being 
stirred for a further 20 h. After this time, the residue was quenched with 2M HCI and 
extracted with diethyl ether (3 x 25 ml). The organic extracts were dried with anhydrous 
Na2S04 and the excess solvent was removed by evaporation under reduced pressure. 
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The residue was purified by flash column chromatography on silica gel using a mixture 
of ethyl acetate and hexane (1:4) as eluent affording a light yellow oil. OH (250 MHz; 
CDCh): The IH NMR spectrum of the crude product showed starting material with no 
trace of the desired product (338). 
MethodC 
3-Methoxy-2-cyc1ohexen-I-one (336) (0.50 g, 3.96 mmol) was dissolved in dry THF 
(20 ml) and the solution was cooled to -78°C. LiHMDS (0.74ml, 3.96 mmol) was added 
and the solution was stirred at -78°C for 1 h. Methyl bromoacetate (0.41 ml, 4.36 
mmol) was added carefully to the reaction mixture and the reaction was left to stir for an 
additional 1 h. The mixture was then allowed to warm to room temperature before being 
stirred for a further 20 h. After this time, the residue was quenched with saturated 
aqueous ammonium chloride solution (40ml) and extracted with diethyl ether (3 x 25 
ml). The organic extracts were dried with anhydrous Na2S04 and the excess solvent was 
removed by evaporation under reduced pressure affording a yellow Oil.OH (250 MHz; 
CDCh): The IH NMR spectrum of the crude product showed starting material with no 
trace of the desired product (338). 
MethodD 
To a stirred solution of diisopropylamine (2.59 ml, 18.31 mmol) in dry THF (10 ml), 
under a N2 atmosphere, was added n-butyllithium (2.5 M solution in hexanes) (7.32 ml, 
18.3 mmol) dropwise at 0 °C. The reaction mixture was stirred at 0 °C for IS min before 
being cooled to -78°C. A solution of 3-Methoxy-2-cyc1ohexen-l-one (336) (2.10 g, 
16.7 mmol) in dry THF (15ml) was then added via cannula and the resulting mixture 
was stirred for an additional 1 hat -78°C. Methyl bromoacetate (1.85 ml, 20.0 mmol) 
was then added dropwise via syringe and the reaction mixture was then allowed to 
warm slowly to room temperature over a period of 24 h. After this time, the reaction 
was quenched by the addition of saturated aqueous ammonium chloride solution (40 ml) 
and extracted in ethyl acetate (3 x 50 ml). The combined organic extracts were washed 
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with saturated aqueous ammonium chloride solution (100 ml), dried with anhydrous 
MgS04 and the excess solvent was then removed by evaporation under reduced 
pressure affording a yellow oil. OH (250 MHz; CDCi): The IH NMR spectrum of the 
crude product showed mainly starting material, however there was a small trace of the 
desired product (338). 
MethodE 
To a stirred solution of diisopropylamine (5.03 rnI, 35.7 mmol) in dry THF (10 ml), 
under a N2 atmosphere, was added n-butyIIithium (2.5 M solution in hexanes) (14.3 ml, 
35.7 mmol) dropwise at 0 °C. The reaction mixture was stirred at 0 °C for 15 min before 
being cooled to -78°C. A solution of 3-Methoxy-2-cycIohexen-l-one (336) (3.00 g, 
23.8 mmol) in dry THF (I5ml) was then added via cannula and the resulting mixture 
was stirred for an additional I hat -78°C. Methyl bromoacetate (2.64 ml, 28.5 mmol) 
was then added dropwise via syringe and the reaction mixture was then allowed to 
warm slowly to room temperature over a period of 24 h. After this time, the reaction 
was quenched by the addition of saturated aqueous ammonium chloride solution (40 ml) 
and extracted in ethyl acetate (3 x 50 ml). The combined organic extracts were washed 
with saturated aqueous ammonium chloride solution (100 ml), dried with anhydrous 
MgS04 and the excess solvent was then removed by evaporation under reduced 
pressure. The residue was purified by flash column chromatography on silica gel using 
5% diethyl ether in light petroleum (bp 40-60°C) as eluent affording methyl 2-[4-
(methyoxy)-2-oxocyclohex-3-enyl]ethanoate (338) (1.41 g, 30%) as a yellow oil. 
MethodF 
To a stirred solution of diisopropylamine (3.52 rnI, 25.0 mmol) in dry THF (ID ml), 
under a N2 atmosphere, was added n-butyllithium (2.5 M solution in hexanes) (3.52 ml, 
25.0 mmol) dropwise at 0 °C. The reaction mixture was stirred at 0 °C for 15 min before 
being cooled to -78°C. A solution of 3-Methoxy-2-cycIohexen-l-one (336) (1.75 g, 
13.9 mmol) in dry THF (15 ml) was then added via cannula and the resulting mixture 
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was stirred for an additional 1 hat -78°C. Methyl bromoacetate (1.41 ml, 15.3 mmol) 
was then added dropwise via syringe and the reaction mixture was then allowed to 
wann slowly to room temperature over a period of 24 h. After this time, the reaction 
was quenched by the addition of saturated aqueous ammonium chloride solution (40 ml) 
and extracted in ethyl acetate (3 x 50 ml). The combined organic extracts were washed 
with saturated aqueous ammonium chloride solution (100 ml), dried with anhydrous 
MgS04 and the excess solvent was then removed by evaporation under reduced 
pressure. The residue was purified by flash column chromatography on silica gel using 
5% diethyl ether in light petroleum (bp 40-60°C) as eluent affording 2-[4-(methoxy)-2 -
oxocycIohex-3-enyl] ethanoate (338) (1.59 g, 58%) as a yellow oil. 
v max(DCM)/cm·1 2947 (OMe), 1734 (C02Me), 1653 (CO), 1609 (C=C); BH (400 MHz; 
CDCI3) 1.75 (lH, rn, CH2CH(H)CHCO), 2.08-2.13 (lH, m, CH2CH(H)CHCO), 2.28 
(lH, dd, J 16.4, 7.7, CHCH(H)C02CH3), 2.37 (lH, ddd, J 17.6, 5.0, 2.8, 
CH(H)CH2CHCO), 2.54-2.63 (lH, m, CH(H)CH2CHCO), 2.70-2.78 (lH, m, 
CHCH2C02CH3), 2.91 (lH, dd, J 16.4, 5.2, CHCH(H)C02CH3), 3.69 (3H, s, CH30), 
3.70 (3H, s, CH30), 5.38 (lH, s, C(OCH3)=CHCO); Bc (100 MHz; CDCh) 27.14 (CH2), 
28.85 (CH2), 34.48 (CH2), 42.32 (CH2CHCO), 51.70 (CH30), 55.79 (CH30), 101.68 
(CH=), 173.20 (C02CH3), 177.90 (CH=C(OCH3», 198.79 (CO); MS (El) rnlz 198 [M+, 
10.3%]; (Found: M+, 198.0891. CIOHI40 4 requires 198.0892). 
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Methyl 2-(4-(chloro)-2-oxocycIohex-3-enyl]ethanoate (340) 
To a stirred solution of diisopropylamine (1.94 ml, 13.8 rnrnol) in dry THF (10 rnl), 
under a N2 atmosphere, was added n-butyllithium (2.5 M solution in hexanes) (5.54 rnl, 
13.8 rnrnol) dropwise at 0 °C. The reaction mixture was stirred at 0 °C for 15 min before 
being cooled to -78°C. A solution of 3-Chloro-2-cyc1ohexen-1-one (335) (1.00 g, 7.66 
rnrnol) in dry THF (15 ml) was then added via cannula and the resulting mixture was 
stirred for an additional 1 hat -78°C. Methyl bromoacetate (0.78 ml, 8.42 rnrnol) was 
then added dropwise via syringe and the reaction mixture was then allowed to warm 
slowly to room temperature over a period of 24 h. After this time, the reaction was 
quenched by the addition of saturated aqueous ammonium chloride solution (40 ml) and 
extracted in ethyl acetate (3 x 50 ml). The combined organic extracts were washed with 
saturated aqueous ammonium chloride solution (100 ml), dried with anhydrous MgS04 
and the excess solvent was then removed by evaporation under reduced pressure. The 
residue was purified by flash column chromatography on silica gel using 10% diethyl 
ether in light petroleum (bp 40-60°C) as eluent affording methyl 2-[4-( chloro )-2-
oxocyc1ohex-3-enyl]ethanoate (340) (0.74 g, 48%) as a yellow oil. v max (DCM)/cm·1 
2950 (OMe), 1734 (C02Me), 1675 (CO), 1613 (C=C); liH (400 MHz; CDCh) 1.89 (!H, 
rn, CH2CH(H)CHCO), 2.15-2.21 (!H, rn, CH2CH(H)CHCO), 2.30 (!H, dd, J 16.4,6.7, 
CHCH(H)C02CH3), 2.64 (!H, ddd, J 18.7, 5.2, 2.6, CH(H)CH2CHCO), 2.78-2.93 (3H, 
rn, CH(H)CH2CHCO, CHCH2C02CH3 and CHCH(H)C02CH3), 3.70 (3H, s, CH30), 
6.22 (!H, d, J 2.5, qCI)=CHCO); lie (100 MHz; CDCh) 27.65 (CH2), 33.34 (CH2), 
33.58 (CH2), 41.70 (CH2CHCO), 51.42 (CH30), 127.26 (CH=), 157.57 (CH=C(Cl», 
172.10 (C02CH3), 196.10 (CO); MS (El) rnJz 201 [(M - H)+, 8.3%]; (Found: W- H, 
201.0323. C9HllCI03 requires 201.0319). 
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MethyI2-[4-(ethoxy)-2-oxocyclohex-3-enyl]ethanoate (341) 
To a stirred solution of diisopropylamine (1.81 ml, 12.8 mmol) in dry THF (10 mJ), 
under a N2 atmosphere, was added n-butyllithium (2.5 M solution in hexanes) (5.14 ml, 
12.8 mmol) dropwise at 0 °C. The reaction mixture was stirred at 0 °C for 15 min before 
being cooled to -78°C. A solution of3-Ethoxy-2-cyclohexen-l-one (337) (1.00 g, 7.13 
mmol) in dry THF (15 mJ) was then added via cannula and the resulting mixture was 
stirred for an additional 1 hat -78°C. Methyl bromoacetate (0.73 ml, 7.85 mmo1) was 
then added dropwise via syringe and the reaction mixture was then allowed to wann 
slowly to room temperature over a period of 24 h. After this time, the reaction was 
quenched by the addition of saturated aqueous ammonium chloride solution (40 mJ) and 
extracted in ethyl acetate (3 x 50 mJ). The combined organic extracts were washed with 
saturated aqueous ammonium chloride solution (100 mJ), dried with anhydrous MgS04 
and the excess solvent was then removed by evaporation under reduced pressure. The 
residue was purified by flash column chromatography on silica gel using 5% diethyl 
ether in light petroleum (bp 40-60°C) as eluent affording methyl 2-[4-( ethoxy)-2-
oxocyclohex-3-enyl]ethanoate (341) (0.89 g, 59%) as a yellow oil. v max (DCM)/cm-1 
2947 (OMe), 1736 (C02Me), 1659 (CO), 1613 (C=C); OH (400 MHz; CDCh) 1.35 (3H, 
t, J 6.8, OCH2CH3), 1.74 (lH, m, CH2CH(H)CHCO), 2.07-2.14 (lH, m, 
CH2CH(H)CHCO), 2.27 (lH, dd, J 16.4, 7.6, CHCH(H)C02CH3), 2.37 (lH, ddd, J 
17.6,5.2,2.8, CH(H)CH2CHCO), 2.54-2.63 (lH, m, CH(H)CH2CHCO), 2.70-2.77 (lH, 
m, CHCH2C02CH3), 2.90 (lH, dd, J 16.4,5.2, CHCH(H)C02CH3), 3.70 (3H, s, CH30), 
3.85-3.97 (2H, m, OCH2CH3), 5.35 (lH, d, J 1.2, C(OCH2CH3)=CHCO); Oc (100 MHz; 
CDCh) 14.10 (CH3), 27.31 (CH2), 29.25 (CH2), 34.67 (CH2), 42.24 (CH2CHCO), 51.65 
(CH30), 64.34 (OCH2CH3), 101.63 (CH=), 173.20 (C02CH3), 177.16 
(CH=C(OCH2CH3», 198.92 (CO); MS (El) rn/z 212 [M" 27.2%]; (Found: M+, 
212.1050. CllHl604 requires 212.1049). 
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MethyI2-(2-oxocyclohex-3-enyl)ethanoate (339) 
To a stirred solution of diisopropylamine (2.64 ml, 18.7 mmol) in dry THF (10 ml), 
under a N2 atmosphere, was added n-butyllithium (2.5 M solution in hexanes) (2.64 ml, 
18.7 mmol) dropwise at 0 QC. The reaction mixture was stirred at 0 QC for 15 min before 
being cooled to -78 QC. A solution of2-Cyclohexen-I-one (334) (1.00 g, 10.4 mmol) in 
dry THF (15 m\) was then added via cannula and the resulting mixture was stirred for 
an additional I h at -78 QC. Methyl bromoacetate (1.06 m1, 11.4 mmol) was then added 
dropwise via syringe and the reaction mixture was then allowed to warm slowly to room 
temperature over a period of 24 h. After this time, the reaction was quenched by the 
addition of saturated aqueous ammonium chloride solution (40 ml) and extracted in 
ethyl acetate (3 x 50 m1). The combined organic extracts were washed with saturated 
aqueous ammonium chloride solution (100 ml), dried with anhydrous MgS04 and the 
excess solvent was then removed by evaporation under reduced pressure. The residue 
was purified by flash column chromatography on silica gel using 5% diethyl ether in 
light petroleum (bp 40-60QC) as eluent affording methyl 2-(2-oxocyclohex-3-
enyl)ethanoate (339) (0.91 g, 52%) as a yellow oil. v max (DCM)/cm-1 2950 (OMe), 1732 
(C02Me), 1674 (CO), 1620 (C=C); OH (400 MHz; CDCh) 1.79-1.85 (!H, m, 
CH2CH(H)CHCO), 2.11-2.15 (!H, m, CH2CH(H)CHCO), 2.26-2.32 (!H, m, 
CHCH(H)C02CH3), 2.37-2.49 (2H, m, CH2CH2CHCO), 2.83-2.93 (2H, m, 
CHCH2C02CH3 and CHCH(H)C02CH3), 3.70 (3H, s, CH30), 6.00 (!H, ddd, J 10.1, 
2.7, 1.1, CH2CH=CHCO), 6.95-7.00 (!H' m, CH2CH=CHCO); Oc (lOO MHz; CDCh) 
25.94 (CH2), 28.66 (CH2), 34.28 (CH2), 43.61 (CHCH2C02CH3), 21.70 (CH30), 129.15 
(CH2CH=CHCO), 150.12 (CH2CH=CHCO), 172.95 (C02CH3), 199.49 (CO); MS (El) 
rnlz 168 [M'", 5.3%]; (Found: M'", 168.0788. C¥Il203requires 168.0787). 
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2-[4-(Methoxy)-2-oxocycIohex-3-enyl)ethanoic acid (342) 
Methyl 2-[4-(methoxy)-2-oxocyc1ohex-3-enyl]ethanoate (338) (0.73 g, 3.68 mmol) was 
dissolved in a mixture of THF (30 ml) and water (13 ml). Lithium hydroxide (0.17g, 
4.05 mmol) was added and the mixture was stirred at room temperature for 20 h. The 
mixture was then concentrated, re-suspended in water (30 ml) and acidified to pH 3 
using I M HC!. The aqueous layer was then extracted with ethyl acetate (3 x 20 ml), 
dried with anhydrous MgS04 and the excess solvent was then removed by evaporation 
under reduced pressure affording 2-[4-(methoxy)-2-oxocyclohex-3-enyl]ethanoic acid 
(342) (0.54 g, 79%) as a yellow solid. Further purification was not necessary. Mp 132-
BYC; v max (DCM)/cm·' 2945 (OH), 1717 (C02H), 1601 (CO); OH (400 MHz; CDCh) 
1.77 (lH, m, CH2CH(H)CHCO), 2.10-2.16 (lH, m, CH2CH(H)CHCO), 2.33 (lH, dd, J 
16.1,5.8, CHCH(H)C02H), 2.40 (lH, ddd, J 17.8,5.0,2.7, CH(H)CH2CHCO), 2.55-
2.64 (lH, m, CH(H)CH2CHCO), 2.69-2.77 (lH, m, CHCH2C02H), 2.91 (lH, dd, J 
16.1, 6.9, CHCH(H)C02H), 3.73 (3H, s, CH30), 5.43 (lH, d, J 1.4, C(OCH3)=CHCO); 
Oc (100 MHz; CDCh) 27.67 (CH2), 28.90 (CH2), 35.63 (CH2), 42.01 (CH2CHCO), 
56.06 (CH30), 101.55 (CH=), 175.61 (CH=C(OCH3», 179.27 (C02H), 200.44 (CO); 
MS (El) m/z 184 [M", 16.7%]; (Found: M+, 184.0733. C9H120 4 requires 184.0736). 
Experimental - 206-
2-[ 4-(Ethoxy)-2-oxocyclohex-3-enyl] ethanoic acid (343) 
Methyl 2-[4-(ethoxy)-2-oxocyc1ohex-3-enyl]ethanoate (341) (1.53 g, 7.10 mmol) was 
dissolved in a mixture of THF (70 m!) and water (30 ml). Lithiwn hydroxide (0.30 g, 
7.10 mmol) was added and the mixture was stirred at room temperature for 20 h. The 
mixture was then concentrated, re-suspended in water (50 m!) and acidified to pH 3 
using IM HC!. The aqueous layer was then extracted with ethyl acetate (3 x 20 ml), 
dried with anhydrous MgS04 and the excess solvent was then removed by evaporation 
under reduced pressure affording 2-[4-(ethoxy)-2-oxocyclohex-3-enyl]ethanoic acid 
(343) (1.24 g, 84%) as a yellow solid. Further purification was not necessary. Mp 138-
139·C; v max (DCM)/cm-I 2984 (OH), 1731 (C02H), 1596 (CO); OH (400 MHz; CDCI3) 
1.36 (3H, t, J 7.0, OCH2CH3), 1.76 (!H, m, CH2CH(H)CHCO), 2.10-2.15 (!H, m, 
CH2CH(H)CHCO), 2.32 (!H, dd, J 16.2, 6.3, CHCH(H)C02H), 2.39 (lH, ddd, J 17.7, 
5.0, 2.7, CH(H)CH2CHCO), 2.55-2.59 (!H, m, CH(H)CH2CHCO), 2.71-2.75 (lH, m, 
CHCH2C02H), 2.92 (!H, dd, J 16.2, 6.5, CHCH(H)C02H), 3.88-3.97 (2H, m, 
OCH2CH3), 5.41 (!H, d, J 1.6, C(OCH2CH3)=CHCO); oe (100 MHz; CDCh) 14.11 
(CH3), 27.50 (CH2), 29.12 (CH2), 35.47 (CH2), 41.98 (CH2CHCO), 64.72 (OClhCH3), 
101.87 (CH=), 176.79 (CH=C(OCH2CH3», 178.38 (C02H), 200.31 (CO); MS (El) mlz 
198 [M+, 25.0%]; (Found: M+, 198.0891. CIOHI40 4 requires 198.0892). 
Experimental - 207-
2-[4-(Chloro)-2-oxocyclohex-3-enyIJethanoic acid (344) 
Methyl 2-[4-( chloro )-2-oxocycIohex-3-enyl]ethanoate (340) (0.43 g, 2.12 nunol) was 
dissolved in a mixture of THF (30 ml) and water (13 ml). Lithium hydroxide (0.10 g, 
2.33 nunol) was added and the mixture was stirred at room temperature for 20 h. The 
mixture was then concentrated, re-suspended in water (50 ml) and acidified to pH 3 
using IM HC!. The aqueous layer was then extracted with ethyl acetate (3 x 20 ml), 
dried with anhydrous MgS04 and the excess solvent was then removed by evaporation 
under reduced pressure affording 2-[4-(chloro)-2-oxocycIohex-3-enyl]ethanoic acid 
(344) (0.32 g, 81%) as a yellow oil. Further purification was not necessary. v mal( 
(DCM)/cm-1 3065 (OH), 1708 (COzH), 1674 (CO), 1620 (C=C); /)H (400 MHz; CDCh) 
1.89 (lH, m, CHzCH(H)CHCO), 2.18-2.23 (lH, m, CH2CH(H)CHCO), 2.34 (lH, dd, J 
16.8, 7.0, CHCH(H)COzH), 2.64-2_71 (lH, ddd, J 21.3, 5.1, 2.4, CH(H)CHzCHCO), 
2.77-2.92 (2H, m, CH(H)CHzCHCO and CHCHzC02H), 2.89 (lH, dd, J 16.8, 5.5, 
CHCH(H)COzH), 6.25 (lH, d, J 2.5, qCI)=CHCO); /)c (100 MHz; CDCh) 28.44 
(CH~, 34.30 (CHz), 34.44 (CH2), 42.40 (CH), 128.05 (CH=), 158.75 (CH=C(CI», 
178.12 (COzH), 197.06 (CO); MS (El) rn/z 188 [~, 0.7%]; (Found: ~, 188.0233. 
C8H9CI03 requires 188.0240). 
Experimental -208 -
Attempted preparation: 2-(2-0xocycIohex-3-enyl)ethanoic acid (345) 
~ 
o 
Methyl 2-[2-oxocyclohex-3-enyl]ethanoate (339) (0.43 g, 2.12 mmol) was dissolved in 
a mixture of THF (30 ml) and water (13 ml). Lithium hydroxide (0.10 g, 2.33 mmol) 
was added and the mixture was stirred at room temperature for 20 h. The mixture was 
then concentrated, re-suspended in water (50 ml) and acidified to pH 3 using IM HCI. 
The aqueous layer was then extracted with ethyl acetate (3 x 20 ml), dried with 
anhydrous MgS04 and the excess solvent was then removed by evaporation under 
reduced pressure affording a yellow oil. OH (400 MHz; CDCh): The IH NMR spectrum 
of the crude product showed possible traces of the desired product (345) and starting 
material. Attempts at purification resulted in decomposition. 
Experimental - 209-
3.5 Towards the amino alcohol precursor of (-)-erythraline 
Methyl (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate hydrochloride13,14 
H 
H 
o 
OMe 
NH2 
.Hel 
I-DOPA (369) (2.00 g, 10.4 mmol) was dissolved in methanol (40 ml) and cooled in an 
ice bath (0 0c). Thionyl chloride (1.11 ml, 15.2 mmol) was added dropwise to the 
solution with gentle stirring. The solution as then dried with anhydrous Na2S04 and 
filtered. The filtrate was evaporated to dryness under reduced pressure affording methyl 
(S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate hydrochloride (2.51 g, 100%) as a 
colourless solid. No further purification was necessary. (DCM)/cm-1 3355 (OH), 2978 
(OMe), 1690 (CO); OH (400 MHz; MeOD) 2.87-3.03 (2H, m, CH2CHC02CH3), 3.65 
(3H, s, CH30), 3.93-3.97 (lH, m, CH2CHC02CH3), 4.04-4.07 (2H, m, 
NH2CHC02CH3), 6.42-6.69 (3H, rn, Arll); Oc (100 MHz; MeOD) 35.25 (CH2), 52.73 
(OCH3), 53.64 (CH), 115.97 (ArCH), 117.17 (ArCH), 120.49 (ArCH), 125.46 (ArC), 
144.72 (ArC-OH), 145.33 (ArC-OH), 170.47 (C02CH3). 
Experimental - 210-
Methyl (2S)-2-amino-3-[3,4-bis(tert-butyldimethylsilyloxy)phenyl)propanoate 
(370)13,(4 
o 
TBDMS 
OMe 
TBDMSO ~ NH2 
Imidazole (4.12 g, 60.5 mmol) was added to a cold solution (0 QC) of L-DOPA methyl 
ester hydrochloride (1.00 g, 4.04 mmol) and TBDMSCI (2.13 g, 14.1 mmol) in 
anhydrous DMF (10 ml). After stirring at this temperature for 3.5 h and with the 
addition of saturated NaHC03 solution, the mixture was extracted with DCM (3 x 50 
ml). The organic layers were then washed with water, dried over anhydrous Na2S04 and 
the excess solvent was removed by evaporation under reduced pressure. The residue 
obtained was purified by flash column chromatography on silica gel using a mixture of 
ethyl acetate and hexanes (1 :4) affording methyl (2S)-2-amino-3-[3,4-bis(tert-
butyldimethylsilyloxy)phenyl]propanoate (370) as a yellow oil. (1.07 g, 60%) [a]D = + 
2.1 (c = 1.06, CHCh); v max(DCM)/cm'( 3380 (NH2), 2856 (OMe), 1741 (CO); OH (400 
MHz; CDCh) 0.21 (l2H, s, 2 x OSi(CH3hC(CH3)3), 0.98 (18H, s, 2 x 
OSi(CH3)2C(CH3h), 2.74 (lH, dd, J 13.6, 7.6, CH(H)Ar), 2.96 (lH, dd, J 8.8, 5.6, 
CH(H)Ar), 3.66 (lH, 1, J 5.2, NH2CHCH2Ar) 3.70 (3H, s, CH30), 6.56-6.76 (3H, m, 
ArH); Oc (lOO MHz; CDCh) -4.09 (4 x Cfh), 18.41 (2 x QCH3)3), 25.91 (6 x Cfh), 
40.33 (Cfb), 51.94 (OCfb), 55.82 (CH), 121.01 (ArCH), 122.21 (ArCH), 122.67 
(ArCH), 130.02 (ArC), 145.79 (ArC), 146.71 (ArC), 175.41 (C02CH3); MS (El) rnIz 
439 [M+' 4.7%]; (Found: M', 439.2580. C22~(N04Sh requires 439.2574). 
Experimental - 211 -
Methyl (2S)-3-(3,4-di {[l-(l ,l-dimethylethyl)-l ,1-dimethylsilyIJ oxy} phenyl)-2-
({[(I,I-dimethylethyl)oxyJcarbonyl}amino)propanoate (377) 
o 
TBDMSO ,::? 
TBDMS "'" 
To a stirring solution of methyl (2S)-2-Amino-3-[3,4-bis(tert-butyldimethylsilyloxy) 
phenyl]propanoate (370) (0.70 g, 1.59 mmol) and di-tert-butyl dicarbonate (0.38 g, 1.75 
mmol) in DCM (40 m!) was added triethylamine (0.22 ml, 1.59 mmol) at room 
temperature. The reaction mixture was then allowed to stir at this temperature for a 
further 24 h. After this time, the reaction mixture was diluted with diethyl ether (50 ml), 
washed with 10% hydrochloric acid and extracted with saturated aqueous NaHC03 
solution. The organic extracts were then dried with anhydrous MgS04 and the solvent 
was removed by evaporation under reduced pressure. The residue was then purified by 
flash column chromatography on silica gel using a mixture of ethyl acetate and hexane 
(1:4) to afford methyl (2S)-3-(3,4-di{[I-(I,I-dimethylethy!)-I,I-dimethylsilyl]oxy} 
phenyl)-2-( {[( 1 , I-dimethy lethyl)oxy] carbonyl} amino )propanoate (377) (0.58 g, 67%) 
as a yellow oil. [(1]D = + 8.6 (c = l.l2, DCM); Lit: [(1]D = + 5.0 (c = 1.0, DCM); v max 
(DCM)/cm·1 3441 (NCO), 2857 (OMe), 1748 (CO); liH (400 MHz; CDCh) 0.17-0.20 
(12H, m, 2 x OSi(CH3)2C(CH3)3), 0.97 (9H, s, OSi(CH3)2C(CH3)3), 0.99 (9H, s, 
OSi(CH3)2C(CH3h), 1.43 (9H, s, NHC02C(CH3)3), 2.94 (2H, d, J 5.7, CH2Ar), 3.69 
(3H, s, CH30), 4.50-4.55 (lH, m, NHCHC02CH3), 4.94 (lH, d, J 7.9, -
NHCHC02CH3), 6.53 (!H, dd, J 8.1,2.1, ArH), 6.61 (lH, d, J2.2, ArH), 6.72 (!H, d, J 
8.1, ArH); lie (100 MHz; CDCh) -3.99 (4 x CH3), 18.44 (2 x C), 25.94 (2 x C(CH3)3), 
28.32 (3 x CH3), 37.53 (CH2), 52.12 (OCH3), 54.37 (CH), 85.16 (C), 121.05 (ArCH), 
122.20 (2 x ArCH), 128.90 (ArC), 145.97 (ArC-O), 146.76 (ArC-O), 155.07 
(NHC02(CH3)3), 172.37 (C02CH3); MS (El) mlz 539 [M" 11.0%]; (Found: M" 
539.3102 C27&9N06Sh requires 539.3198). 
Experimental - 212-
Methyl (2S)-3-(I,3-benzodioxol-5-yl)-2-( n (I ,I-dimethylethyl)oxy) carbonyl} amino) 
propanoate (378) 
o 
Bromochloromethane (1.97 ml, 29.3 mmol) was added to a stirring solution of cesium 
fluoride (7.13g, 47.0 mmol) and Methyl (2S)-3-(3,4-di{[I-(I,I-dimethylethyl)-I,I-
dimethylsilyl)oxy} phenyl)-2-( {[(1, I-dimethylethyl)oxy )carbonyl } amino )propanoate 
(377) (6.33 g, 11.7 mmol) in anhydrous DMF (30 ml) under an nitrogen atmosphere. 
The mixture was heated at 110°C for 2.5 h. Upon cooling, the mixture was diluted with 
DCM and filtered. The filtrate, along with the DCM washings of the residue was 
washed with H20 (6 x 50 ml), dried with anhydrous MgS04 and the solvent was 
removed by evaporation under reduced pressure. The residue was purified by flash 
column chromatography on silica gel using a mixture of ethyl acetate and light 
petroleum (bp 40-60°C) (1:5) to afford methyl (2S)-3-(1,3-benzodioxol-5-yl)-2-({[(I,I-
dimethylethyl)oxy ]carbonyl } amino )propanoate (378) (3.46 g, 91 %) as a yellow oil. [a]D 
= + 26.2 (c = 1.14, CHCh); v max (DCM)/cm-1 3383 (NCO), 2930 (OMe), 1743 (CO), 
1714 (CO); SH (400 MHz; CDCh) 1.43 (9H, s, NHC02C(CH3)3), 2.95-3.06 (2H, m, 
CH2AI), 3.73 (3H, s, CH30), 4.51-4.55 (lH, m, -NHCHC02CH3), 4.98 (lH, d, J7.6, -
NHCHC02CH3), 5.93 (2H, q, J2.8, -OCH20-), 6.55-5.61 (2H, m, AIl!), 6.72 (lH, d, J 
8.0, AIl!); Sc (100 MHz; CDCh) 28.30 (3 x CfIJ), 38.00 (Cfh), 52.26 (OCH3), 54.51 
(Cf!), 79.97 (C), 100.96 (CH2), 108.32 (AICf!), 109.60 (AICH), 122.39 (AICfI), 
129.58 (AIC), 146.62 (AIC-O), 147.71 (AIC-O), 155.08 (NHC02(CH3)3), 172.28 
(C02CH3); MS (El) m/z 323 [M., 3.7%]; (Found: 11'" 323.1365 C16H21N06 requires 
323.1369). 
Experimental -213 -
Methyl (2S)-2-amino-3-(1,3-benzodioxol-5-yl)propanoate (379) 
(
0 ~ 
o I .4' 
o 
OMe 
To a stirring solution of methyl (28)-3-(1,3-Benzodioxol-5-yl)-2-( {[(I,I-dimethylethyl) 
oxy]carbonyl}amino)propanoate (378) (3.46 g, 10.7 mmol) in DCM (30 ml) was added 
TFA (16.5 ml, 0.21 mol). The reaction mixture was stirred at room temperature for a 
further 3 h. After this time, saturated NaHC03 was added until the effervescence 
subsided. The two layers were separated and the aqueous layer was extracted with DCM 
(3 x 25 ml). The combined organic layers were dried with anhydrous MgS04 and the 
solvent was removed by evaporation under reduced pressure affording methyl (28)-2-
amino-3-(l,3-benzodioxol-5-yl)propanoate (379) (1.65 g, 69%) as a yellow oil. [a]D= + 
25.4 (c = 1.12, CHCh); v max (DCM)/cm·\ 3383 (NH2), 2950 (OMe), 1737 (CO); OH 
(400 MHz; CDCh) 2.76 (lH, dd, J 13.6, 7.6, CH(H)Ar), 2.98 (lH, dd, J 13.6, 4.8, 
CH(H)Ar), 3.67 (lH, m, NH2CHC02CH3), 3.73 (3H, s, CH30), 5.94 (2H, s, -OCH20-), 
6.63-6.76 (3H, m, ArH); oe (lOO MHz; CDCh) 40.70 (CH2), 52.03 (OCH3), 55.90 
(CH), 100.94 (CH2), 108.32 (ArCH), 109.50 (ArCH), 122.33 (ArCH), 130.79 (ArC), 
146.47 (ArC-O), 147.75 (ArC-O), 175.43 (C02CH3); MS (FAB) mlz 224 [(M + It, 
4.2%]; (Found: M' + 1,224.0925. Cl1H\3N04 requires 224.0923). 
Experimental - 214-
Attempted preparation: (S)-2-Amino-3-(1,3-benzodioxoI-6-yI)propan-l-oI (368)IS 
To a stirring solution of Methyl (2S)-2-amino-3-(1,3-benzodioxol-5-yl)propanoate (379) 
(1.64 g, 7.35 mmol) in absolute ethanol (40 ml) at O°C was added sodium borohydride 
(2.78 g, 73.5 mmol) portion wise over a period of 2 min. The solution was allowed to 
warm to room temperature overnight, before being re-cooled back down to O°C. The 
reaction mixture was then quenched with successive additions of conc. HCI (2 mJ) and 
water (15 ml). The excess ethanol was then removed by evaporation under reduced 
pressure and the resulting residue was taken up in ethyl acetate (40 ml), extracted with 
brine (40 ml) and dried with anhydrous MgS04. The solvent was then removed by 
evaporation under reduced pressure affording (S)-2-amino-3-(I,3-benzodioxol-6-
yl)propan-I-ol (368) (1.16 g, 81%) as a yellow oil. Lit: Mp 87-9TC;IS I5H(250 MHz; 
CDCI3): The IH NMR spectrum of the crude product showed that the ~-amino alcohol 
had been synthesised, unfortunately a number of impurities were also present. Attempts 
at purification were unsuccessful. 
Experimental - 215-
3.6 Towards the amino alcohol precursor of (-)-erysotrine 
(S)-2-[(l,l-Dimethylethyloxycarbonyl)aminoJ-3-(3,4-dimethoxyphenyl)propanoic 
acid (413) 
o 
M 
MeO 
3-(3,4-Dimethoxyphenyl)-L-alanine (263) (0.50 g, 2.22 mmol) was dissolved in H20 
(20 ml) and triethylamine (0.37 ml, 2.66 mmol) was added at O°C. To this solution was 
added di-tert-butyl dicarbonate (O.5lg, 2.33 mmol) as a solution in 1,4-dioxane (20 ml). 
The solution was then allowed to stir overnight whilst attaining ambient temperature. 
After this time, the excess 1,4-dioxane was removed by evaporation under reduced 
pressure yielding an aqueous residue. This aqueous residue was then acidified with 1 M 
HCI to ca. pH 2-3, extracted with ethyl acetate (3 x 50 ml), washed with saturated 
NaHC03 solution (1 x 50 ml) and brine (1 x 50 ml). The organic fractions were then 
dried with anhydrous Na2S04 and the solvent was removed by evaporation under 
reduced pressure. The residue was then purified by flash column chromatography on 
silica gel using a mixture of ethyl acetate and light petroleum (bp 40-60°C) (2: I) as the 
eluent affording (S)-2-[(1, I-dimethylethyloxycarbonyl)arnino ]-3-(3,4-dimethoxyphenyl) 
propanoic acid (413) (0.58 g, 80%) as an colourless solid. Mp 265-267°C; [aID = - 28.2 
(c = 1.25, CHCh); (Found: C, 58.96; H, 7.37; N, 4.78. Cl6HnN06requires C, 59.06; H, 
7.13; N, 4.31 %); v max (DCM)/cm-1 3332 (OH), 2836 (OMe), 1715 (CO), 1516 (C-O); 
/)H (400 MHz; CDCh) 1.31 (3H, s, NHC02C(CH3)J), 1.42 (6H, s, NHC02C(CH3)3), 
2.99 (2H, br dd, J 14.1,5.6, ArCH2CHC02H), 3.85 (3H, s, CH30), 3.86 (3H, s, CH30), 
4.56 (lH, m, ArCH2CHC02H), 4.95 (lH, d, J 8.0, NHC02C(CH3)3), 6.71-6.73 (2H, m, 
Arll), 6.79-6.81 (lH, m, Arll); /)c (100 MHz; CDCh) 28.00 (CH3), 28.29 (2 x CH3), 
37.33 (CH2), 54.36 (CH), 55.78 (OCH3), 55.85 (OCH3), 80.33 (C(CH3)3), 111.20 
(ArCH), 112.35 (ArCH), 121.43 (ArCH), 128.16 (ArC), 148.09 (ArC-OCH3), 148.85 
(ArC-OCH3), 155.38 (NCO), 176.57 (C02H); MS (El) rnIz 325 [M\ 3.4%]; (Found: 
M\ 325.1529. CI~nN06 requires 325.1525)_ 
Experimental - 216-
(S)-MethyI2-arnino-3-(3,4-dirnethoxyphenyl)propanoate hydrochloride 
o 
MeO 
.OMe 
MeO 
.Hel 
3-(3,4-Dimethoxyphenyl)-L-alanine (263) (2.00 g, 8.88 mmol) was dissolved in 
methanol (10 rnl) and cooled in an ice bath (O°C). Thionyl chloride (0.97 ml, 13.3 
mmol) was added dropwise to the solution with gentle stirring. The solution as then 
dried with anhydrous Na2S04 and filtered. The filtrate was evaporated to dryness under 
reduced pressure affording (S)-methy 1-2-amino-3-(3 ,4-dirnethoxypheny l)propanoate 
hydrochloride (2.40 g, 98%) as a colourless gum. No further purification was necessary. 
(DCM)/cm·1 2938 (OMe), 1714 (CO), 1516 (NH2); OH (400 MHz; MeOD) 3.09-3.25 
(2H, rn, CH2CHC02CH3), 3.35 (3H, s, CH30), 3.82 (3H, s, CH30), 3.84 (3H, s, CH30), 
4.23-4.27 (lH, rn, CH2CHC02CH3), 4.31-4.34 (2H, m, NH2CHC02CH3), 6.79-6.88 
(3H, m, Arll); oe (100 MHz; MeOD) 36.87 (Gh), 53.65 (CH), 55.19 (OCH3), 56.45 
(OCH3), 56.48 (OCH3), 113.32 (ArCH), 114.04 (ArCH), 123.09 (ArCH), 127.98 (ArC), 
150.19 (ArC-OCH3), 150.80 (ArC-OCH3), 171.31 (C02CH3); MS (El) rn/z 239 [M\ 
2.3%]; (Found: M+, 239.1156. CI2H17N04 requires 239.1158). 
Experimental - 217-
tert-Butyl (S)-1-(methoxycarbonyl)-2-(3,4-dimethoxyphenyl)ethylcarbamate (416)16 
o 
(S)-Methyl 2-amino-3-(3,4-dimethoxyphenyl)propanoate hydrochloride (2.45 g, 10.2 
mmol) was dissolved in H20 (40 ml) and triethylamine (1.71 ml. 12.3 mmol) was added 
at O°C. To this solution was added di-tert-butyl dicarbonate (2.35 g, 10.8 mmol) as a 
solution in 1,4-dioxane (40 ml). The solution was then allowed to stir overnight whilst 
attaining ambient temperature. After this time, the excess 1,4-dioxane was removed by 
evaporation under reduced pressure yielding an aqueous residue. This aqueous residue 
was then acidified with IM HCI to ca. pH 2-3, extracted with ethyl acetate (3 x 50 ml), 
washed with saturated NaHC03 solution (I x 50 ml) and brine (I x 50 ml). The organic 
fractions were then dried with anhydrous Na2S04 and the solvent was removed by 
evaporation under reduced pressure yielding a colourless solid. The solid was purified 
by flash column chromatography on silica gel using a mixture of ethyl acetate and light 
petroleum (bp 40-60°C) (1 :4) as the eluent affording tert-butyl (S)-I-
(rnethoxycarbonyl)-2-(3,4-dimethoxyphenyl)ethylcarbamate (416) (1.93 g, 58%) as a 
clear oil. [a]D = - 65.6 (c = 1.28, CHCh); v max (OCM)/cm'l 3362 (NH), 2834 (OMe), 
1743 (C02tBu), 1700 (C02Me); OH (400 MHz; COCI3) 1.43 (9H, s, NHC02C(CH3)3), 
2.98-3.09 (2H, rn, ArCH2CHC02CH3), 3.72 (3H, s, CH30), 3.85 (3H, s, CH30), 3.86 
(3H, s, CH30), 4.54 (lH, m, ArCH2CHC02CH3), 4.99 (lH, d, J 7.9, NHC02C(CH3)3), 
6.64-6.80 (3H, rn, ArH); Oc (100 MHz; COCh) 28.31 (3 x rn3), 37.87 (rn2), 52.23 
(OCl:I), 54.49 (rn), 55.78 (Orn3), 55.84 (Orn3), 79.95 (CCCH3)3), 111.16 (Arm), 
112.31 (Arm), 121.35 (ArCl:l), 128.39 (ArC), 148.05 (ArC-OCH3), 148.81 (ArC-
OCH3), 155.09 (NCO), 172.45 (C02CH3); MS (FAB) m/z 339 [M\ 47.1%]; (Found: 
M\ 339.1686. C17H2SN06 requires 339.1682). 
Experimental - 218-
(S)-2-[ (1,1-Dimethylethyloxycarbonyl)amino )-3-(3,4-dim eth oxyphenyl)propan-l-ol 
(414)16 
Meorr:c. ~ OH 
I # HN~O MeO I 
~ 
Method A 
Chlorotrimethylsilane (1.98 ml, 4.50 rnmol) was added under nitrogen atmosphere to a 
stirring solution of lithium borohydride (5.10 ml of a 2M solution in THF, 2.25 rnmol) 
in THF (15 ml) over a period of2 min. (S)-2-[(1,I-Dimethylethyloxycarbonyl)aminoJ-3-
(3,4-dimethoxyphenyl)propanoic acid (413) (0.35 g, 1.12 rnmol) was added portionwise 
over a period of 5 min and the reaction mixture was allowed to stir at room temperature 
for a further 24 h. After this time, methanol (30 ml) was added slowly to the reaction 
mixture and the excess solvent was removed by evaporation under reduced pressure. 
The residue was then dissolved in 10% potassium hydroxide solution (40 ml); extracted 
with DCM (3 x 30 ml) and dried with anhydrous MgS04• The excess solvent was then 
removed by evaporation under reduced pressure to yield a clear oil. OH (250 MHz; 
CDCh): The IH NMR spectrum of the crude product indicated that we had not 
generated the desired product (414), but had instead synthesised the corresponding 
oxazolidinone (415). 
MethodB 
To a stirring solution of tert-Butyl (S)-I-(methoxycarbonyl)-2-(3,4-dimethoxyphenyl) 
ethyl carbamate (416) (2.27 g, 7.00 rnmol) in absolute ethanol (50 ml) at O°C was added 
sodium borohydride (2.65 ml, 70.0 mmol) portion wise over a period of 2 min. The 
solution was allowed to warm to room temperature overnight, before being re-cooled 
back down to ooe. The reaction mixture was then quenched with successive additions of 
conc. HCl (2 ml) and water (IS ml). The excess ethanol was then removed by 
Experimental - 219-
evaporation under reduced pressure and the resulting residue was taken up in ethyl 
acetate (40 ml), extracted with brine (40 ml) and dried with anhydrous MgS04. The 
excess solvent was then removed by evaporation under reduced pressure yielding an off 
white solid. The solid was purified by flash column chromatography on silica gel using 
100% ethyl acetate as the eluent affording (S)-2-[(1,I-dimethylethyloxycarbonyl) 
amino]-3-(3,4-dimethoxyphenyl)propan-l-01 (414) (1.77 g, 81%) as a colourless solid. 
Mp 92-93°C; [a]D = - 16.9 (c = 1.28, MeOH); (Found: C, 61.51; H, 8.07; N, 4.46. 
ClJi2sNOs requires C, 61.72; H, 8.09; N, 4.50 %); v max (DCM)/cm·1 3355 (OH), 2932 
(OMe), 1700 (CO), 1521 (C-O); OH (400 MHz; CDCh) 1.42 (9H, s, NHC02C(CH3)3), 
2.78 (2H, d, J 7.6, ArCH2CHCH20H), 3.54 (m, dd, J 11.2, 5.6, ArCH2CHCH(H)OH), 
3.65 (m, dd, J 11.2,3.6, ArCH2CHCH(H)OH), 3.81-3.88 (m, m, ArCH2CHCH20H), 
3.85 (3H, s, CH30), 3.87 (3H, s, CH30), 4.74-4.75 (m, m, NHC02C(CH3)3), 6.74-6.82 
(3H, m, ArH); Oc (100 MHz; CDCh) 28.36 (3 x Cl!), 36.98 (Clh), 53.71 (CH), 55.85 
(OCH3), 55.90 (OCl!), 64.45 (CH2), 79.75 (C(CH3)3), 111.22 (ArCH), 112.23 (ArCH), 
121.26 (ArCH), 130.23 (ArC), 147.71 (ArC-OCH3), 148.93 (ArC-OCH3), 156.19 
(NCO); MS (El) mlz 311 [M\ 4.7%]; (Found: M\ 311.1736. CI6H2sNOs requires 
311.1733). 
Experimental - 220-
(2S)-1-[(1,1-Dimethylethyl)-1,1-dimethylsiIyIJoxy)-2-[(1,1-dimethylethyl)oxy) 
carbonyl)amino )-3-(3,4-dimethoxyphenyl)propanoate (417) 
Meo)():C I ""'" OTBDMS 
#' HNyO MeO 
~ 
Imidazole (0.82 g, 12.0 mmol) was added to a cold solution (O°C) of (S)-2-[(1,1-
Dimethylethyloxycarbonyl)amino ]-3-(3,4-dimethoxyphenyl)propan-l-01 (414) (0.50 g, 
1.61 mmol) and TBDMSCI (0.48 g, 3.21 mmol) in dry DCM (20 ml). After stirring at 
this temperature for 16 h, the reaction was quenched with the addition of saturated 
NaHC03 solution and extracted with DCM (3 x 50 ml). The organic layers were then 
washed with water, dried over anhydrous Na2S04 and the excess solvent was removed 
by evaporation under reduced pressure. The residue was then purified by flash column 
chromatography on silica gel using 100% ethyl acetate as the eluent affording (2S)-1-
[(1, I-dimethylethyl)-I, l-dimethylsilyl]oxy)-2-[(1, I-dimethylethyl) oxy)carbonyl)amino] 
-3-(3,4-dimethoxyphenyl)propanoate (417) (0.51 g, 75%) as a clear oil. [11]D = - 24.3 (c 
= 1.35, CHCh); v max (DCM)/cm'l 3367 (NH), 2952 (ArH), 2855 (OMe), 1712 (CO), 
1515 (C-O); OH (400 MHz; CD Ch) 0.10 (6H, s, OSi(CH3hC(CH3)3), 0.92 (6H, s, 
OSi(CH3)2C(CH3)3), 1.43 (9H, s, NHC02C(CH3)3), 2.76-2.78 (2H, m, ArCH2CHCH2), 
3.50-3.52 (2H, m, ArCH2CHCH2), 3.86 (3H, s, CH30), 3.87 (3H, s, CH30), 4.74-4.75 
(lH, m, ArCH2CHCH2), 6.76-6.80 (3H, m, ArH); Bc (lOO MHz; CDCh) -3.58 (2 x 
CH3), 18.28 (C(CH3)3), 25.90 (3 x CH3), 28.41 (3 x CH3), 36.78 (CH2), 52.93 (CH), 
55.77 (OCH3), 55.87 (OCH3), 62.71 (CH2), 79.19 (C(CH3)3), 111.05 (ArCH), 112.40 
(ArCH), 121.44 (ArCH), 130.86 (ArC), 147.45 (ArC-OCH3), 148.73 (ArC-OCH3), 
156.41 (NCO); MS (El) rnIz 425 [M+, 5.6%]; (Found: M., 425.2594. C22H39NOsSi 
requires 425.2598). 
Experimental - 221 -
(2S)-I-[ (1,1-Dimethylethyl)-I,I-dimethylsilyl) oxy)-2-amino-3-(3,4-dimethoxy-
phenyl)propanoate (412) 
MeoX)(' I "'" OTBDMS 
.<:9 NH2 MeO 
To a stirring solution of (2S)-1-[(I,I-Dimethylethyl)-1,1-dimethylsilyl]oxy)-2-[(1,1-
dimethylethyl)oxy)carbonyl)amino 1-3-(3,4-dimethoxyphenyl)propanoate (417) (0.50 g, 
1.17 mmol) in dry DCM (25 ml) was added trifluoroacetic acid (2.68 ml, 23.5 mmol). 
The mixture was stirred at room temperature for 80 min and after this time saturated 
NaHC03 solution was added until the effervescence had subsided. The layers were 
separated and the aqueous layer was extracted with DCM (3 x 25 ml). The combined 
organic layers were dried with anhydrous MgS04 and the excess solvent was removed 
by evaporation under reduced pressure affording a yellow oil. 1)H (250 MHz; CDCh): 
The IH NMR spectrum of the crude product showed that the desired product (412) has 
not been generated, but instead we had synthesised again the corresponding 
oxazolidinone (415). 
Experimental - 222-
(2S)-I-[(I,I-Dimethylethyl)-I,I-diphenylsilyl]oxy)-2-[(I,1-dimethylethyl)oxy) 
carbonyl)amino 1-3-(3,4-dimethoxyphenyl)propanoate (418) 16 
Me0X):C I ~ OTBDPS 
#' HN'y"0y 
MeO 11 1"-
° 
Imidazole (0.82 g, 12.04 mmol) was added to a cold solution (O°C) of (8)-2-[(1,1-
Dimethylethyloxycarbonyl)amino]-3-(3,4-dimethoxyphenyl) propan-l-01 (414) (0.50 g, 
1.61 mmol) and TBDPSCI (0.84 ml, 3.21 mmol) in dry DCM (2OmI). After stirring at 
this temperature for 3.5 h, and with the addition of saturated NaHC03 solution, the 
mixture was extracted with DCM (3 x 50ml). The organic layers were then washed with 
water, dried over anhydrous Na2S04 and the excess solvent was removed by 
evaporation under reduced pressure. The residue was then purified by flash column 
chromatography on silica gel using a mixture of ethyl acetate and light petroleum (bp 
40-60°C) (3:2) as the eluent affording (2S)-I-[(I,I-dimethylethyJ)-I,I-diphenyJsilyl] 
oxy)-2-[ (1 ,1-dimethylethy I)oxy )carbonyl)amino]-3-(3 ,4-dimethoxypheny I)propanoate 
(418) (0.52 g, 60%) as a clear oil. [aID = - 22.9 (c = 1.24, CHCh); v max (DCM)/cm·1 
3365 (NH), 2930 (ArH), 2856 (OMe), 1718 (CO), 1517 (C-O); OH (400 MHz; CDCh) 
1.1 1 (9H, s, OSi(C6Hs)2C(CH3)3), 1.43 (9H, s, NHC02C(CH3)3), 2.86 (2H, d, J 7.0, 
ArCH2CHCH2), 3.57-3.63 (2H, m, ArCH2CHCH2), 3.79 (3H, s, CH30), 3.83 (3H, s, 
CH30), 3.92-3.96 (lH, m, ArCH2CHCH2), 4.78 (lH, d, J 8.8, NHC02C(CH3)3), 6.70-
6.75 (3H, m, Arlf), 7.34-7.43 (6H, m, OSi(C~s)2C(CH3)3), 7.63-7.66 (4H, m, 
OSi(C~s)2C(CH3)3); Oc (100 MHz; CDCh) 19.42 (C(CH3)3), 26.66 (3 x CH3), 28.48 (3 
x CH3), 37.16 (CH2), 53.04 (CH), 55.77 (OCH3), 55.91 (OCH3), 64.09 (CH2), 79.13 
(OC(CH3)3), 111.22 (ArCH), 112.49 (ArCH), 121.50 (ArCH), 127.80 (phCH), 129.85 
(PhCH), 130.74 (ArC), 133.30 (phC), 135.59 (PhCH), 147.57 (ArC-OCH3), 148.85 
(ArC-OCH3), 155.37 (NCO); MS (FAB) rn/z 549 [M" 1.3%]; (Found: M+, 549.2920. 
C32~3NOsSi requires 549.2911). 
Experimental - 223-
(2S)-I-( (1,I-Dimethylethyl)-I,I-diphenylsilyl) oxy)-2-amino-3-(3,4-dimeth oxy 
phenyl)propanoate (419)16 
Meo)()'C I ~ OTBDPS 
.<:9 NH2 MeO 
To a stirring solution of (2S)-1-[(1,1-Dimethylethyl)-1,1-diphenylsilyl]oxy)-2-[(1,1-
dimethylethyl)oxy)carbonyl)amino ]-3-(3,4-dimethoxyphenyl)propanoate (418) (0.20 g, 
0.36 mmol) in dry DCM (10 ml) was added trifluoroacetic acid (0.56 ml, 7.28 mmol) 
and the reaction mixture was stirred at room temperature for 3 h. After this time, 
saturated NaHC03 solution was added until the effervescence had subsided. The 
mixture was then extracted with DCM (3 x 25 ml), dried with anhydrous MgS04 and 
the excess solvent was removed by evaporation under reduced pressure. The residue 
obtained was purified by flash column chromatography on silica gel using a mixture of 
ethyl acetate and light petroleum (bp 40-60°C) (l :4) as the eluent affording (2S)-1-[(1 ,1-
dimethylethyl)-I, I-diphenylsiIyl ]oxy)-2-amino-3-(3 ,4-dimethoxypheny I)propanoate 
(419) (0.10 g, 63%) as a clear oil. [aID = - 18.1 (c = 1.32, CHCI3); v max (DCM)/cm-1 
3373 (NH2), 2930 (ArH), 2855 (OMe), 1515 (C-O); OH (400 MHz; CDCh) 1.09 (9H, s, 
OSi(C6Hs)2C(CH3)3), 2.45 (IH, dd, J 13.6, 8.4, CH(H)CHNH2)' 2.72 (lH, dd, J 13.2, 
5.2, CH(H)CHNH2), 3.11-3.15 (lH, m, CH2CHNH2), 3.52 (lH, dd, J 10.0, 6.8, 
CH2CHCH(H)OH), 3.63 (lH, dd, J 9_6, 4.4, CH2CHCH(H)OH), 3.82 (3H, s, CH30), 
3.84 (3H, s, CH30), 6.70-6.78 (3H, m, ArH), 7.35-7.43 (6H, m, OSi(C~shC(CH3)3), 
7.66-7.69 (4H, m, OSi(C~s)2C(CH3)3); Oc (100 MHz; CDCh) 19.49 (C(CH3)3), 26.80 
(3 x CH3), 39.92 (CH2), 54.47 (CH), 55_80 (OCH3), 55.92 (OCH3), 68.35 (CH2), 
111.22 (ArCH), 112.35 (ArCH), 121.22 (ArCH), 127.77 (PhCH), 129.51 (PhCH), 
131.57 (ArC), 133.53 (2 x PhC), 135.63 (PhCH), 147.46 (ArC-OCH3), 148.83 (ArC-
OCH3). MS (El) m/z 449 [M., 0.6%]; (Found: M+, 449.2381. C27H3sN03Si requires 
449.2386). 
Experimental - 224-
3.7 Towards the asymmetric synthesis of (-)-erysotrine 
2-(2-0xocycIohexyl)ethanoic acid (422)1 
~C~H 
o 
Ethyl-2-cyclohexanone acetate (421) (0.50 g, 2.70 rnmol) was dissolved in a mixture of 
lHF (18 ml) and water (8 ml). Lithium hydroxide (0.17 g, 4.07 rnmol) was added and 
the mixture was stirred at room temperature for 20 h. The reaction was concentrated, re-
suspended in water (30 ml) and acidified to pH 3 with IM HCI. The aqueous layer was 
then extracted with ethyl acetate (3 x 20 ml), dried with anhydrous MgS04 and the 
excess solvent was then removed by evaporation under reduced pressure affording 2-(2-
oxocyclohexyl)ethanoic acid (422) (0.40 g, 94%) as a colourless oil. No further 
purification was necessary. v max (DCM)/cm-1 3200 (OH), 1709 (CO); OH (400 MHz; 
CDCb) 1.37-1.48 (lH, m, CH(H)CHCO), 1.59-1.79 (2H, m, CH(H)CH2CHCO and 
CH2CH(H)CH2CO), 1.86-1.93 (lH, m, CH(H)CH2CHCO), 2.08-2.24 (3H, m, 
CH2CH(H)CH2CO, CH(H)CHCO & CHCH(H)C02H), 2.33-2.48 (2H, m, CH2CH2CO), 
2.79-2.89 (2H, m, CHCH(H)C02H & CH2CHCO); Oc (100 MHz; CDCb) 25.16 (CH2), 
27.77 (CH2)' 33.82 (CH2), 34.28 (CH2), 41.78 (CH2), 46.90 (CH), 178.48 (C02H), 
211.14 (CO); MS (El) mlz 156 ~,24.7%]; (Found: M., 156.0785. CgH1203 requires 
156.0787). 
Experimental - 225-
N-(S}-I-[(1,1-Dimethylethyl)-I,I-diphenylsilyl] oxy)-3-(3,4-dimethoxyph enyl) 
propan-2-yl)-2-(2-oxocyclohexyl)acetamide (423)17 
MeO 
OTBDPS 
Me 
Method A 
2-(2-0xocyclohexyl)ethanoic acid (422) (0.18 g, 1.18 mmol) was dissolved in dry DCM 
(30 m1), under a N2 atmosphere, and cooled to - ISoC. HOABt (0.16 g, 1.18 mmol) and 
EDCI (0.23 g, 1.18 mmol) was then added and the reaction was stirred at - ISoC for a 
further 20 min. N-methylmorpholine (0.13 ml, 1.18 mmol) and (2S)-I-[(I,I-Dimethyl 
ethyl)-I ,1-diphenylsilyl]oxy)-2-amino-3-(3 ,4-dimethoxyphenyl)propanoate (419) (0.S3 
g, 1.18 mmol) was then added and the reaction was stirred at - ISoC for an additional 3 
h. After this time, the reaction was quenched with ice cold (1 M) HCI and the reaction 
was extracted in DCM (3 x 30 ml). The organic extracts were washed with saturated 
NaHC03, dried with anhydrous MgS04 and the solvent was removed by evaporation 
under reduced pressure. The residue obtained was purified by flash column 
chromatography on silica gel using a mixture of ethyl acetate and light petroleum (bp 
40-60°C) (1:3) as the eluent affording N-(S)-I-[(I,I-dimethylethyl)-I,I-diphenylsilyl] 
oxy)-3-(3,4-dimethoxyphenyl)propan-2-yl)-2-(2-oxocyclohexyl)acetamide (423) (0.46 
g, 67%) as a yellow oil. 
MethodB 
2-(2-0xocyclohexyl)ethanoic acid (422) (O.3S g, 2.22 mmol) was dissolved in dry DCM 
(40 ml), under a N2 atmosphere, and cooled to - ISoC. HOBt (0.30 g, 2.22 mmol) and 
EDCI (0.23 g, 2.22 mmol) was then added and the reaction was stirred at - ISoC for a 
further 20 min. N-methylmorpholine (0.24 ml, 2.22 mmol) and (2S)-I-[(I,I-Dimethyl 
Experimental - 226-
ethyl)-I, l-diphenylsilyl]oxy)-2-amino-3-(3,4-dimethoxyphenyl)propanoate (419) (1.00 
g, 2.22 mmol) was then added and the reaction was stirred at - 15°C for an additional 3 
h. After this time, the reaction was quenched with ice cold (lM) HCI and the reaction 
was extracted in DCM (3 x 30 ml). The organic extracts were washed with saturated 
NaHC03, dried with anhydrous MgS04 and the solvent was removed by evaporation 
under reduced pressure affording N-(S)-I-[(I,I-dimethylethyl)-1 ,1-diphenylsilyl]oxy)-3-
(3,4-dimethoxyphenyl)propan-2-yl)-2-(2-oxocyc1ohexyl)acetamide (423) (1.28 g, 98%) 
as a yellow oil. 
[a]D = +26.3 (c = 1.28, CHCb); v max (DCM)/cm-1 3314 (NCO), 2931 (ArH), 2856 
(OMe), 1707 (CO), 1654 (NCO), 1515 (C-O); SH (400 MHz; CDCb) 1.09 (9H, s, 
OSi(C6Hs)2C(CH3)3), 1.17-1.34 (2H, m, CH2CH(H)CHCO and CH(H)CH2CH2CO), 
1.56-1.71 (2H, m, CH2CH2CH2CO), 1.79-2.13 (3H, m, NHCOCH(H)CHCO, 
CH2CH(H)CHCO and CH(H)CH2CH2CO), 2.30-2.40 (2H, m, CH2CH2CH2CO), 2.53 
(lH, ddd, J 14.4,6.4,2.4, NHCOCH(H)CHCO), 2.76-2.88 (3H, m, NHCOCH2CHCO 
and ArCH2CHCH2), 3.57-3.64 (2H, m, ArCH2CHCH2), 3.80 (3H, s, CH30), 3.84 (3H, 
s, CH30), 4.18-4.24 (lH, m, ArCH2CHCH2), 5.98 (lH, m, NHCOCH2CHCO), 6.67-
6.76 (3H, m, ArB), 7.35-7.45 (6H, m, OSi(C~s)zC(CH3)3), 7.61-7.65 (4H, m, 
OSi(C~s)zC(CH3)3); Se (100 MHz; CDCb) 19.38 (C(CH3)3), 26.96 (3 x CH3), 28.01 
(CH2), 34.03 (CH2), 34.64 (CH2), 36.72 (CH2), 36.94 (CH2), 42.03 (CfIz), 47.82 (CH), 
51.60 (CH), 55.78 (OCH3), 55.86 (OCH3), 63.88 (CH2), 111.02 (ArCH), 112.43 
(ArCH), 121.43 (ArCH), 127.83 (PhCH), 129.88 (PhCH), 130.62 (ArC), 133.26 (2 x 
PhC), 135.57 (PhCH), 147.50 (ArC-OCH3), 148.78 (ArC-OCH3), 171.20 (NCO), 
212.27 (CO); MS (FAB) m1z 588 [(M' + 1), 11.4%]; (Found: M'+ 1, 588.3161. 
C3s~sNOsSi requires 588.3165). 
Experimental -227 -
(13bS)-1,2,3,4,4a,5,8,9-0ctahydro-8-(hydroxymethyI)-11,12-dimethoxyindolo[l-aJ 
isoquinoIin-6-one (270)1,16 
MeO 
MeO 
N-(S)-I-[(I, I-Dimethylethyl)-I, I-diphenylsilyl]oxy )-3-(3,4-dimethoxyphenyl)propan-2-
yl)-2-(2-oxocyc1ohexyl)acetamide (423) (50 mg, 0.09 mmol) was dissolved in dry DCM 
(10 ml) and BF3.Et20 (0.03 ml, 0.26 mmol) was added drop wise via syringe. The 
reaction mixture was heated at reflux for 96 h. After this time, the reaction was 
quenched with saturated NaHC03 solution, extracted with ethyl acetate (3 x 25 ml) and 
dried anhydrous MgS04• The excess solvent was removed by evaporation under 
reduced pressure affording (13bS)-1,2,3,4,4a,5,8,9-0ctahydro-8-(hydroxymethyl)-
11, 12-dimethoxyindolo[l-a ]isoquinoline-6-one (270) (18 mg, 61 %) as a yellow oil. The 
diastereoselectivity of the reaction was determined by IH NMR spectroscopy on the 
crude reaction mixture (2.5:1). Mp 192-193; v max (DCM)/cm'1 3383 (OH), 2931 (ArH), 
2855 (OMe), 1655 (lactam); SH (400 MHz; CDCb) 1.40-1.43 (lH, m, NCCH2CH(H», 
1.50-1.67 (5H, m, NCCH2CH2, CH2CH2CH and CH(H)CH2CH), 1.75-2.08 (10H, m, 
NCCH2CH(H), 2 x CH2CH2CH, NCCH2CH2, CHCH2CO and CH(H)CH2CH), 2.35-
2.42 (3H, m, NCCH(H)CH2 and CHCH2CO), 2.62-2.66 (2H, m, NCCH(H)CH2 and 
CHCH2CO), 2.75-2.85 (2H, m, NCHCH(H)Ar and NCHCH(H)Ar), 2.91(lH, J 
NCHCH(H)Ar), 3.09 (lH, J NCHCH(H)Ar), 2.68-3.94 (5H, m, 2 x NCHCH20H and 
NCHCH20H), 3.86 (3H, s, CH30), 3.88 (3H, s, CH30), 4.00-4.04 (lH, m, 
NCHCH20H'), 6.65 (lH, s, ArH), 6.72 (lH, s, ArHJ, 6.88 (lH, s, ArH), 6.99 (lH, s, 
ArH'); Se (100 MHz; CDCb) 20.34 and 20.84 (NCCH2Cfh), 20.89 and 21.06 ( 27.36 
and 27.51 (CH2CH2CH), 29.93 and 30.14 (NCHCH2Ar), 35.70 and 36.15 (NCCH2CH2), 
36.81 and 37.02 (CHCH2CO), 38.07 and 38.14 (CHCH2CO), 52.57 and 54.38 
(NCHCH20H), 55.93 and 56.02 (CH30), 56.27 and 56.41 (CH30), 64.73 and 65.26 
(NCCH2CH2), 64.00 and 69.30 (CH20H), 108.34 and 108.53 (ArCH), 111.73 and 
112.30 (ArCH), 125.51 and 125.99 (ArC), 133.96 and 134.26 (ArC), 147.40 and 147.58 
(ArC-OCH3), 148.05 and 148.15 (ArC-OCH3), 175.76 and 176.09 (CO). 
Experimental - 228-
N-(S)-l-[ (1 ,1-Dimethylethyl)-1 ,1-diphenylsilyIJ oxy)-3-(3,4-d imeth oxyph enyl) 
propan-2-yl)-2-( 4-methoxy-2-oxocyclohex -3-enyl)acetamide (420) 17 
Meoxx;c: I ~ OTBDPS 
#' HN 0 MeO 0 
MeO 
Method A 
2-[4-(Methoxy)-2-oxocyclohex-3-enyl]ethanoic acid (342) (0.22 g, 1.18 rnmol) was 
dissolved in dry DCM (30 ml), under a N2 atmosphere, and cooled to - 15°C. HOABt 
(0.16 g, 1.18 rnmol) and EDCI (0.23 g, 1.18 rnmol) was then added and the reaction 
mixture was stirred at - 15°C for an additional 20 min. N-methylmorpholine (0.13 ml, 
1.18 rnmol) and (2S)-I-[(1 ,1-Dimethylethyl)-I,I-diphenylsilyIJoxy)-2-amino-3-(3,4-
dimethoxyphenyl)propanoate (419) (0.53 g, 1.18 rnmol) was then added and the 
reaction was stirred at - 15°C for an additional 3 h. After this time, the reaction was 
quenched with ice cold (IM) HCI and the reaction was extracted in DCM (3 x 25 ml). 
The organic extracts were washed with saturated NaHC03, dried with anhydrous 
MgS04 and the solvent was removed by evaporation under reduced pressure. The 
residue obtained was purified by flash column chromatography on silica gel using a 
mixture of ethyl acetate and light petroleum (bp 40-60°C) (I :2) as the eluent affording 
N-(S)-I-[(I, I-dimethylethyl)-I, l-diphenylsilyl]oxy)-3-(3,4-dimethoxyphenyl)propan-2-
yl)-2-(4-methoxy-2-oxocyc1ohex-3-enyl)acetamide (420) (0.59 g, 81 %) as a yellow oil. 
MethodB 
2-[ 4-(Methoxy)-2-oxocyclohex-3-enyl]ethanoic acid (342) (0.45 g, 2.22 mmol) was 
dissolved in dry DCM (40 ml), under a N2 atmosphere, and cooled to - 15°C. HOBt 
(0.30 g, 2.22 mmol) and EDCI (0.43 g, 2.22 rnmol) was then added and the reaction was 
stirred at - 15°C for an additional 20 min. N-methylmorpholine (0.24 ml, 2.22 rnmol) 
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and (28)-1-[(1, I-Dimethylethyl)-I, l-diphenylsilyl]oxy)-2-amino-3-(3,4-dimethoxy 
phenyl)propanoate (419) (1.00 g, 2.22 mmol) was then added and the reaction was 
stirred at - 15°C for a further 3 h. After this time, the reaction was quenched with ice 
cold (I M) HCI and the reaction was extracted in DCM (3 x 30 ml). The organic extracts 
were washed with saturated NaHC03, dried with anhydrous MgS04 and the solvent was 
removed by evaporation under reduced pressure affording N-(S)-I-[(I,I-dimethylethyl)-
I, I-di phenylsil yl]oxy)-3-(3 ,4-dimethoxyphenyl )propan-2-yl )-2-(2-oxocycl ohexyl) 
acetamide (420) (1.22 g, 89%) as a yellow oil. 
[a]D = - 21.6 (c = 1.22, CHCh); v max (DCM)/cm-1 3311 (NCO), 2931 (ArH), 2855 
(OMe), 1650 (CO), 1607 (NCO), 1515 (C-O); OH (400 MHz; CDCh) 1.11 (9H, s, 
OSi(C6Hs)2C(CH3)3), 1.50-1.71 (2H, m, CH2CH2CHCO), 1.94-2.06 (!H, m, 
CH(H)CH2CHCO), 2.19 (lH, dd, J 14.0,6.0, NHCOCH(H)CHCO), 2.28-2.37 (!H, m, 
NHCOCH2CHCO), 2.44-2.93 (4H, m, NHCOCH(H)CHCO, CH(H)CH2CHCO and 
ArCH2CHCH2), 3.60-3.64 (2H, m, ArCH2CHCH2), 3.70 (3H, s, CH30), 3.81 (3H, S, 
CH30), 3.84 (3H, s, CH30), 4.20-4.27 (!H, m, ArCH2CHCH2), 5.33 (!H, d, J 7.6, 
CH=C(CH30», 6.20 (!H, d, J 9.2, NHCOCH2CHCO), 6.70-6.75 (3H, m, ArH), 7.35-
7.45 (6H, m, OSi(C~shC(CH3)3), 7.61-7.65 (4H, m, OSi(C~S)2C(CH3)3); iic (100 
MHz; CDCh) 19.38 (C(CH3)3), 26.96 (3 x CH3), 27.63 (CH2), 28.89 (CH2), 36.80 
(Cfh), 37.14 (CH2), 42.99 (CH), 51.61 (CH), 55.84 (3 x OCH3), 64.16 (CH2), 101.80 
(CH=), 1l0.99 (ArCH), 112.40 (ArCH), 121.39 (ArCH), 127.80 (PhCH), 129.84 
(PhCH), 130.66 (ArC), 133.27 (2 x PhC), 135.59 (PhCH), 147.45 (ArC-OCH3), 148.74 
(ArC-OCH3), 171.31 (NCO), 178.23 (CH=C(CH30», 200.08 (CO); MS (FAB) mlz 616 
[(M" + 1),7.0%]; (Found: M"+ I, 616.3088. C36~sN06Si requires 616.3094). 
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(3S,6aS)-3-(3,4-Dimethoxyphenyl)-2,3,6,6a,7 ,8-hexahydro-9-methoxyoxazolo[3,2-ll 
indol-5-one (405)16 
OMe 
N-(S)-I-[(l, I-Dimethylethyl)-I, 1-diphenylsilyl]oxy )-3-(3,4-dimethoxyphenyl)propan-2-
yl)-2-(4-methoxy-2-oxocyclohex-3-enyl)acetamide (420) (1.95 g, 3.17 mmol) was 
dissolved in dry DCM (50 ml) and BF3.Et20 (12.0 ml, 95.0 mmol) was added drop wise 
via syringe. The reaction mixture was heated at reflux for 96 h. After this time, the 
reaction was quenched with saturated NaHC03 solution, extracted with ethyl acetate (3 
x 25 ml) and dried anhydrous MgS04• The excess solvent was removed by evaporation 
under reduced pressure producing a yellow oil. The residue was then purified by flash 
column chromatography on silica gel using 5% methanol in ethyl acetate as the eluent 
affording (3S,6aS)-3-(3,4-dirnethoxyphenyl)-2,3,6,6a,7,8-hexahydro-9-methoxyoxazolo 
[3,2-iJindol-5-one (405) (0.81 g, 71 %) as a yellow oil. The diastereoselectivity of the 
reaction was determined by 1 H NMR spectroscopy on the crude reaction mixture (~1: 1). 
[a]D = - 27.5 (c = 1.38, CHCb); v max (DCM)/cm-1 2938 (ArH), 2836 (OMe), 1651 
(lactam); OH (400 MHz; CDCb) 1.54-1.80 (4H, m, 2 x CHCH2CH2), 2.20-2.27 (lH, m, 
CHCH(H)CO), 2.29-2.40 (2H, m, CHCH2CH2), 2.46-2.57 (5H, rn, 2 x CHCH(H)CO, 
CHCH2CH2 and CHCH2CO), 2.65-2.87 (6H, m, 2 x NCHCH2Ar, CHCH(H)CO and 
CHCH2CO), 3.51-3.76 (4H, m, 2 x NCHCH20), 3.70 (3H, s, CH30), 3.84 (3H, s, 
CH30), 3.86 (3H, s, CH30), 4.11-4.23 (2H, m, 2 x NCHCH2Ar), 5.31 (lH, s, 
NCCH=C(OCH3», 5.35 (lH, s, NCCH=C(OCH3», 6.71-6.77 (6H, m, ArH); Oc (100 
MHz; CDCb) 27.32 and 27.50 (CHCH2CH2), 28.82 and 28.91 (CHCH2CH2), 36.48 and 
36.56 (NCHClhAr), 37.17 and 37.33 (CHCH2CO), 43.07 (CHCH2CO), 52.76 and 
53.05 (NCHCH20), 55.82, 55.85 and 55.97 (3 x CH30), 63.94 and 64.15 (NCHCH20), 
101.53 and 101.57 (CH=C(CH30», 111.09 (2 x ArCH), 112.35 (2 x ArCH), 121.16 and 
121.23 (ArCH), 130.42 (2 x ArC), 147.58 (2 x ArC-OCH3), 148.84 (2 x ArC-OCH3), 
179.09 (2 x CH=C(OCH3», 200.88 and 201.06 (NCO); MS (FAB) mlz 360 [(M' + I), 
2.9%]; (Found: M'+ 1,360.1819. C20H25NOS requires 360.1811). 
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(S)-3,3a,4,5-Tetrahydro-l-( (S)-1-hydroxy-3-(3,4-dimethoxyphenyl)propan-2-yI)-
IH-indole-2,6-dione (406)18 
OMe 
OMe 
o 
(3S,6aS)-3-(3,4-Dimethoxybenzyl)-2,3,6,6a,7,8-hexahydro-9-methoxyoxazolo[3,2-i] 
indol-5-one (405) (0.68 g, 1.89 mmol) was dissolved in a mixture of THF (20 m!) and 
H20 (20 ml). To the resulting solution was added (2M) HCl (20 ml) via syringe. The 
reaction mixture was then stirred at 55°C (oil bath temperature) overnight. After this 
time, the excess THF was removed by evaporation under reduced pressure. The 
resulting solution was then quenched with saturated NaHC03 solution, extracted with 
ethyl acetate (3 x 30 ml), washed with H20 (15 rnl) and dried with anhydrous MgS04. 
The excess ethyl acetate was then removed by evaporation under reduced pressure 
producing a yellow oil. The residue was then purified by flash column chromatography 
on silica gel using 100% ethyl acetate as the eluent affording (S)-3,3a,4,5-tetrahydro-l-
«S)-I-hydroxy-3-(3,4-dimethoxyphenyl)propan-2-yl)-IH-indole-2,6-dione (406) (0.41 
g, 62%) as a colourless solid. Mp 101-103T; [a]D = - 59.8 (c = 1.27, CHCb); v max 
(DCM)/cm-1 3417 (OH), 2936 (ArH), 2836 (OMe), 1731 (CO), 1737 (lactam), 1598 
(C=C); OH (400 MHz; CDCb) 1.54-1.88 (2H, m, 2 x CHCH(H)CH2), 2.12-2.35 (6H, m, 
2 x CHCH(H)CH2, 2 x CHCH2CH(H) and 2 x CHCH(H)CO), 2.50-2.54 (2H, m, 2 x 
CHCH2CH(H», 2.60-2.73 (2H, rn, 2 x CHCH(H)CO), 2.79-2.95 (2H, rn, 2 x 
CHCH2CO), 2.98-3.12 (4H, rn, NCHCH2Ar), 3.84 (3H, s, CH30), 3.86 (3H, s, 
CH30),387-3.90 (2H, m, 2 x NCHCH(H)O), 4.01-4.15 (2H, rn, 2 x NCHCH(H)O), 
4.16-4.32 (2H, m, 2 x NCHCH2Ar), 5.52 (lH, s, NC=CHCO), 5.60 (lH, s, NC=CHCO), 
6.69-6.78 (6H, m, ArH); oe (100 MHz; CDCb) 27.79 and 27.84 (CHCI'hCH2), 32.70 
(CHCH2CH2), 33.78 (NCHCH2Ar), 35.01 and 35.06 (CHCH2CO), 35.29 and 35.48 
(CHCH2CO), 37.15 (NCHCH20), 55.89 and 55.97 (2 x CH30), 61.24 and 62.07 
(NCHCH20), 103.14 (CIICO), 111.16 (2 x ArCH), 112.06 (2 x ArCH), 121.09 and 
121.13 (ArCH), 129.17 and 129.27 (2 x ArC), 147.94 (2 x ArC-OCH3), 148.79 (2 x 
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ArC-OCH3), 176.68 and 176.87 (NCO), 197.31 and 197.46 (2 x CO); MS (FAB) mJz 
346 [M" 32.4%]; (Found: M+, 346.1653. Cl9H235NOsrequires 346.1655). 
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3.8 Towards the lactol precursor of (-)-xylopinine 
2-(3,4-Dimethoxyphenyl)ethanol (Homoveratryl alcohol) (455)2,19 
MeO~OH 
Meo~ 
Chlorotrimethylsilane (3.96 ml, 40.8 mmol) was added under nitrogen atmosphere to a 
stirring solution of lithium borohydride (10.2 ml of a 2M solution in THF, 20.4 mmol) 
in THF (20 ml) over a period of 2 min. Homoveratric acid (454) (2.00 g, 10.2 mmol) 
was then added portionwise over a period of 5 min and the reaction mixture was 
allowed to stir at room temperature for a further 24 h. After this time, methanol (30 ml) 
was added slowly to the reaction mixture and the excess solvent was removed by 
evaporation under reduced pressure. The residue was then dissolved in 10% potassium 
hydroxide solution (40 ml); extracted with DCM (3 x 30 ml) and dried with anhydrous 
MgS04.The solvent was then removed by evaporation under reduced pressure 
affording 2-(3,4-dimethoxyphenyl)ethanol (Homoveratryl alcohol) (455) (1.80 g, 97%) 
as a colourless solid. Mp 48-49°C; Lit: Mp 47_79°C;2,19 (Found: C, 65.85; H, 7.71. 
CtoHI403 requires C, 65.92; H, 7.74 %); v max (DCM)/cm·1 3394 (OH), 2936 (Sp3 CH), 
2834 (OCH3), 1516 (C-O); liH (400 MHz; CDCh) 1.51 (lH, br s, OH), 2.81 (2H, t, J 
6.4, CH2CH20H), 2.83 (2H, 1, J 6.4, CH2CH20H), 3.87 (3H, s, OCH3), 3.88 (3H, s, 
OCH3), 6.76-6.84 (3H, m, ArH); lie (100 MHz; CDCh) 38.73 (CH2), 55.82 (OCH3), 
55.91 (OCH3), 63.75 (CH2), 111.29 (ArCH), 112.11 (ArCH), 120.91 (ArCH), 130.91 
(ArC), 147.66 (ArC-OCH3), 148.96 (ArC-OCH3); MS (El) m1z 182 [~, 26.5%]; 
(Found:~, 182.0944. CloHI40 3 requires 182.0943). 
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3,4-Dihydro-6,7-dimethoxy-lH-isochromene (456)20 
Me0XX) I ° 
MeO # 
To a stirring solution of2-(3,4-Dimethoxyphenyl)ethanol (Homoveratryl alcohol) (455) 
(2.00 g, 11.0 mmol) in trifluoroacetic acid (10 ml) was added para-formaldehyde (0.40 
g) at room temperature. This suspension was allowed to stir at this temperature for a 1 
h. The mixture was then diluted with the addition of ethyl acetate (30 ml) and washed 
with saturated sodium carbonate solution and brine (30 ml). The organic layer was 
separated, dried with anhydrous MgS04 and the excess solvent was removed by 
evaporation under reduced pressure. The residue was purified by flash column 
chromatography on silica gel using a mixture of ethyl acetate and light petroleum (bp 
40-60°C) (1:4) as the eluent affording 3,4-dihydro-6,7-dimethoxy-IH-isochromene 
(456) (1.77 g, 83%) as an colourless solid. Mp 80-83'C; Lit: Mp 82_83'C;20 (Found: C, 
68.07; H, 7.23. CllHl40 3 requires C, 68.02; H, 7.27 %); v max (DCM)/cm-1 2934 (Sp3 
CH), 2834 (ArOCH3), 1783 (C-O), 1124, 1097 (CH20CH2); OH (400 MHz; CDCh) 2.76 
(2H, t, J 5.6, CH2CH20H), 3.84 (3H, s, OCH3), 3.86 (3H, s, OCH3), 3.94 (2H, t, J 5.6, 
CH2CH20H), 4.70 (2H, s, ArCH20), 6.48 (lH, s, ArH), 6.62 (lH, s, ArH); Se (lOO 
MHz; CDCh) 27.84 (Cfh), 55.931 (2 x OCfiJ), 65.44 (Cfh), 67.65 (Cfh), 107.31 
(ArCfl), 111.67 (ArCfl), 125.03 (ArC), 126.67 (ArC), 147.52 (ArC-OCH3), 147.64 
(ArC-OCH3); MS (El) rnlz 194 [M+, 100%]; (Found: M" 194.0942. CllHl40 3 requires 
194.0943). 
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3,4-Dihydro-6,7-dimethoxy-lH-isochromen-l-one (457i1,22 
Memo I 0 MeO # 
To a stirring solution of 3,4-Dihydro-6,7-dimethoxy-lH-isochromene (456) (1.00 g, 
5.15 mmol) and triethylbenzylammonium chloride (TEBAC) (3.52 g, 15.5 mmol) in dry 
DCM (100 ml) was added finely ground potassium permanganate (2.44 g, 15.5 mmol). 
This mixture was then heated at reflux for 20 h. Upon cooling in an ice/salt bath, 
sodium bisulphite (10 g) in water (25 ml) was added with vigorous stirring until the 
purple colour had completely discharged. The aqueous layer was then separated and 
extracted with chloroform (3 x 20 ml). The combined organic layers were then washed 
with water (2 x 50 ml), dried with anhydrous MgS04 and the excess solvent was 
removed by evaporation under reduced pressure. The residue was purified by flash 
column chromatography on silica gel using a mixture of ethyl acetate and light 
petroleum (bp 40-60°C) (1:4) as the eluent affording 3,4-dihydro-6,7-dimethoxy-IH-
isochromen-l-one (457) (0.95 g, 89%) as an colourless solid. Mp 139-141·C; Lit: Mp 
140_141·C;21.22 (Found: C, 62.95; H, 5.74. CllH1204 requires C, 63.45; H, 5.81 %); v max 
(DCM)/cm·1 2945 (Sp3 CH), 2834 (OCH3), 1716 (CO); OH (400 MHz; CDCh) 2.98 (2H, 
t, J 6.0, CH2CH20CO), 3.93 (3H, s, OCH3), 3.95 (3H, s, OCH3), 4.51 (2H, t, J 6.0, 
CH2CH20CO), 6.69 (lH, s, ArH), 7.56 (lH, s, ArH); Oc (100 MHz; CDCh) 27.50 
(CH2), 56.18 (OCH3), 56.19 (OCH3), 67.38 (CH2), 109.09 (ArCH), 111.81 (ArCH), 
117.42 (ArC), 133.96 (ArC), 148.48 (ArC-OCH3), 153.61 (ArC-OCH3), 165.23 (CO); 
MS (El) rn/z 208 [M., 100%]; (Found: M., 208.0734. CllH120 4 requires 208.0736). 
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3,4-Dihydro-3-hydroxy-6,7-dimethoxy-1H-isochromen-l-one (453i3 
o 
Meoro I 0 
MeO #' OH 
To a stirring mixture of water (50 ml) and 3,4-Dihydro-6,7-dimethoxy-lH-isochromen-
I-one (457) (1.00 g, 4.81 mmol) was added potassium hydroxide (0.40 g, 7.21 mmol). 
This mixture was allowed to stir at room temperature for 24 h. The resulting yellow 
solution was then acidified (PH 1-2) with 2M sulphuric acid, extracted with diethyl 
ether (3 x 30 ml) and dried with anhydrous MgS04• The excess diethyl ether was then 
removed by evaporation under reduced pressure at O·C affording 2-(2-hydroxyethyl)-
4,5-dimethoxybenzoic acid (458) (1.08 g, 100%), as an colourless solid. Oxidation of 
this hydroxy intermediate then proceeded without purification due to relactonisation. 
Oxidation with Dess-Martin Periodinane (DMP) 
2-(2-Hydroxyethyl)-4,5-dimethoxybenzoic acid (458) (1.08 g, 4.77 mmol) was 
dissolved in dry DCM (10 ml) under a nitrogen atmosphere and was added via cannula 
to a solution of Dess-Martin periodinane (2.02 g, 4.77 mmol) in dry DCM (25 ml) also 
under a nitrogen atmosphere. The mixture was left to stir at room temperature for a 
further 20 h. After this time, the excess DCM was removed by evaporation under 
reduced pressure. The residue was purified by flash column chromatography on silica 
gel using a mixture of ethyl acetate and light petroleum (bp 40-60°C) (1: 1) as the eluent 
affording 3,4-dihydro-3-hydroxy-6,7-dimethoxy-lH-isochromen-l-one (453) (0.59 g, 
55%) as a colourless solid. 
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Oxidation with Stabilised IBX (SIBX) 
2-(2-Hydroxyethyl)-4,5-dimethoxybenzoic acid (458) (1.08 g, 4.77 mmol) was 
dissolved in dry DCM (15ml) and SIBX (0.54 g, 0.96 mmol) was added. The 
suspension was then stirred at room temperature for 20 h. After this time, the excess 
DCM was removed by evaporation under reduced pressure. The residue was the 
dissolved in ethyl acetate and filtered through celite. The filtrate was then washed with 
ethyl acetate (40 ml), extracted with water (3 x 40 ml) and dried with anhydrous 
MgS04. The excess solvent was removed by evaporation under reduced pressure 
affording a yellow solid. Purification by flash column chromatography on silica gel 
using a mixture of ethyl acetate and light petroleum (bp 40-60°C) (1:1) as the eluent 
afforded 3,4-dihydro-3-hydroxy-6,7-dimethoxy-IH-isochromen-I-one (453) (0.32 g, 
30%) as a colourless solid. 
Mp 168-170'C; Lit: Mp 168'C;23 v mID< (DCM)/cm·1 3358 (OH), 2938 (ArOCH3), 1700 
(CO), 1605 (C-O); OH (400 MHz; CDCh) 3.06-3.31 (2H, m, CH2CH(O)OH), 3.92 (3H, 
s, OCH3), 3.96 (3H, s, OCH3), 5.95 (lH, br s, CH2CH(O)OH), 6.73 (lH, s, Arlf), 7.55 
(lH, s, Arlf); oe (lOO MHz; CDCh) 33.58 (Oh), 56.! 7 (OGh), 56. 23 (Orn3), 95.80 
(rn), 1I0.!7 (ArG!), 1I1.47 (ArG!), 116.65 (ArC), 130.82 (ArC), 148.50 (ArC-
OCH3), 154.16 (ArC-OCH3), 164.98 (CO); MS (El) rnIz 224 [M", 65.6%]; (Found: M", 
224.0687. CIIHI20S requires 224.0685). 
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3.9 Towards the asymmetric synthesis of (-)-xylopinine 
(3S,1 OaR)-3-(3,4-Dim ethoxyphenyl)-2,3,1 0,1 Oa-tetrahydro-7 ,8-dimethoxyoxazolo 
[3,2-bJisoquinolin-5-one (467) 
o 
Meo~~ 
JlA)",,,o MeO OMe OMe 
(2S)-2-Amino-3-[3,4-dimethoxyphenyIJpropan-l-01 (264) (264 mg, 1.25 mmol) and 
3,4-dihydro-3-hydroxy-6, 7 -dimethoxy-lH-isochromen-l-one (453) (280 mg, 1.25 
mmo1) was refluxed in toluene under Dean-Stark conditions for 48 h. After this time, 
the resulting yellow solution was allowed to cool down and then the excess toluene was 
removed by evaporation under reduced pressure to yield a yellowlbrown oil. The 
residue was purified by flash column chromatography on silica gel using a mixture of 
ethyl acetate and light petroleum (bp 40-60°C) (1 :1) as the eluent affording (3S,10aS)-3-
(3,4-dimethoxyphenyl)-2,3, 1 0, 1 Oa-tetrahydro-7 ,8-dimethoxyoxazolo[3,2-b Jisoquinoline 
-5-one (467) (280mg, 57%) as a yellow oil. OH (400 MHz; CDCh) 2.75-2.82 (2H, m, 
ArCH(H)CHO & NCHCH(H)Ar), 3.05 (lH, dd, J 14.6, 4.1, ArCH(H)CHO), 3.36 (lH, 
dd, J 13.5, 2.8, NCHCH(H)Ar), 3.77 (3H, s, OCH3), 3.87 (3H, s, OCH3), 3.94 (3H, s, 
OCH3), 3.95 (3H, s, OCH3), 3.97-4.01 (lH, rn, NCHCH(H)O), 4.11 (lH, dd, J 9.2, 1.0, 
NCHCH(H)O), 4.37-4.44 (lH, m, NCHCH20), 5.03 (lH, dd, J 11.7, 4.0, NCHO), 6.69 
(lH, s, ArH), 6.77 (lH, s, ArH) 6.82 (lH, s, ArH), 7.60 (lH, s, ArH); Bc (100 MHz; 
CDCh) 34.49 (CH2), 37.64 (CH2), 55.74 (OCH3), 55.87 (OCH3), 56.11 (NCHCH20), 
56.12 (OCH3), 56.33 (OCH3), 70.07 (CH2), 87.18 (NCHO), 109.77 (ArCH), 110.60 
(ArCH), 111.12 (ArCH), 112.59 (ArCH), 121.48 (ArCH), 122.24 (ArC), 127.99 (ArC), 
130.31 (ArC), 147.73 (ArC-OCH3), 148.41 (ArC-OCH3), 148.87 (ArC-OCH3), 152.18 
(ArC-OCH3), 161.64 (NCO). 
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Attempted preparation: (S)-5,6,13,13a-Tetrahydro-6-(hydroxymethyl)-2,3,10,11-
tetramethoxy-8H-dihenzo[a,q]quinoliz-8-one (468) 
Me \,\\\-OH 
•• ,> 
o 
.# OMe 
OMe 
(3S, I OaR)-3-(3,4-Dimethoxyphenyl)-2,3, I 0, 1 Oa-tetrahydro-7,8-dimethoxyoxazolo[3,2-
b]isoquinolin-5-one (467) (0.28 g, 0.15 mmol) was dissolved in dry DCM (20 ml) under 
a nitrogen atmosphere. The mixture was cooled to -78°C and 3 equivalents of TiC4 
(0.25 ml, 2.25 mmol) was added dropwise by syringe. After stirring at this temperature 
for 15 min, the brown suspension was allowed to warm to room temperature where it 
was then stirred for a further 20 h. The mixture was then quenched with saturated 
ammonium chloride solution (20 ml), extracted with DCM (3 x 30 ml) and dried over 
anhydrous MgS04• The solvent was removed by evaporation under reduced pressure 
producing a yellow/orange oil. The residue was purified by flash column 
chromatography on silica gel using ethyl acetate/light petroleum (bp 40-60°C) (1: I) as 
the eluent affording the product as a yellow oil. /)H (400 MHz; CDCh): The IH NMR 
spectrum of the crude product showed no trace of starting material or the enamide, the 
p-elimination by-product. However, we are unable to say for certain that this is the 
desired product. Crude /)c (100 MHz; CDCh) 29.70 (Cfh), 34.29 (Cflz), 55.08 (OCfh), 
55.71 (OCfh), 55.76 (Cf!), 56.53 (2 x OCfh), 63.17 (CH2), 105.25 (ArCH), 111.05 
(ArCf!), 111.92 (ArCf!), 121.13 (ArCf!), 124.97 (ArC), 129.94 (ArC), 147.55 (ArC-
OCH3), 148.67 (ArC-OCH3), 153.91 (2 x ArC-OCH3), 169.16 (NCO). 
Experimental - 240-
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1.3-d<1melhoxyorylhratidinon9 9rythram1n9 
9t)'SOIramldine 
The genus Ery/hrina is common in tropical and sub-
tropical regions and the alkaloids ha"" hocn u..ed in 
indigenous medicine.' Members of the Ery/hrina family 
displaycurarc-like and hWnotic activity. and a varicty of 
pharmacological cffects are associated with the ef}thr-
inane skeleton including sedative, hy~tcnsive, ncuro· 
muscular blocking and CNS activity." Consequently 
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Appendix 
there has been much interest in the s)nthcsis of these 
alkaloids and derivatives (including pyrroloisoquinoline 
precursors) over recent )'Cars.2 
3-Demcthoxycrythratidinone. I. was isolated from 
Ery/hrina /ith""perma in 1973 by Barton and co-work-
ers.) Despite being structurally one orthe simplest of the 
Ery/hrina cl .... of alkaloid. it was not until 1984 that 
Tsuda ",ported the firsttotaJ synthesis. in mcemic fonn. 
of this natuml product.' Almost a decade latcr tbis same 
group reported an as)mmctric route to the cnantiomcric 
fonn of the natural product, the s<Kalled ·cllantio-(-). 
J.J~mrl hoxJ'~r)'(hrQtidinont'.5 
Vlc have recently concerned ourselves ~ilh the dcvcl .. 
opmcnt of novel,. efficient and stercosclcctive routes to 
complex heterocyclic targelS by employing N·aeylimin-
ium intermediates in cydisation rcactions.6 In a rOC'ent 
publication" we detailed a novel approach to an cry-
thrinane·like ring system through the application of a 
Meyers chirallactam template. We now wish to report 
the successful application of our mcthodology to con-
struct a functionaliscd crythrinane ring system in a 
highly stcrcosclcctivc manner, thus representing a ror-
mal as)mmctric s)nthcsis of both enantiomers of the 
natuml product, 3-demethoxycrythratidinone . 
Although the chiral Iactams pioneered by Me~'Crs 
have becn widcly utilised in asymmctric synthcsis. to 
the best of our knowledge. the present application. as a 
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2 
Se_I. 
precursor in an N.acyliminium mediated cyclisation 
reaction leading to crythrinane targets. represents a 
novel use of this popular chiral template. In order to 
a<rcss the more highly functionalised alkaloid skeleton 
we were required to prepare the prot<rted keto-acid 
subst,...te 3. This compound was readily acccsscd by 
enolate alkylation and subsequent ester group hydroly-
sis of the commercially available mono-protected dike-
tone 2, as shown in Scheme I. 
Our synthesis of the required Iactam subst,...te 5 then 
fonowed similar methodology to that previously dc-
scn1lcd by us,' ,,;th the required ~aminoak:ohol 4 
prepared in 97% yield by reduction of the commercially 
available amino acid, 3-(3,4-dimetbox)l'henyl).L.a1a-
nine. with LiBH. in the presence of Mc, SiC I in lHF for 
24 h at room temperature. Condensation of substrata 3 
and 4 under Dcan-Stark conditions in toluene for 48h 
gave a 63% );eld of the desired lactarn 5 as a single 
diastereol,omer (Scheme 2). The formation of a single 
product diastereoisomer of Iactam 5 from the racemie 
keto acid 3 requires the epimcrisation of the stcreogenic 
centre adjacent to the ketone during the reaction, and 
this fact has ba:n noted previously for similar substmtcs 
in the preparation of polycyclic lactarns for use us 
N·acyliminium precursors.6&.! 
With 5 in hand, we turned our attention to the proposed 
as)mmetrie eyelisation. On trcating Iactam 5 ,,;th 
3 equiv of TiO. as Le,,;' acid activator at low temper-
ature in dichloromethane for 20 h we were pleased to 
isolate the tctraeyelie product 6 in an eX<rllent 92% 
yicld. Pcrhaps not unexpectedly, the eyelisation under 
strong Le,,;' acid conditions had been accompanied by 
concomitant deprotection of the ketal prot<rting gmup. 
Reducing the number of equivalents of the Le,,;s acid 
did not result in sclocti,,, formation of the correspond-
ing cyelisation product ,,;th the ketal group intact, and 
3 • 101","" 
M:q 
/ no. 
3 
instead an inseparable prod uct mixture was obtained. 
Indocd, since the removal of the protecting group did 
not hinder the immediate progress of our work, we 
favoured the use of excess Lcwis acid to achieve clean 
and complete deprotoction at this stage. 'H NMR 
analysis of the crude product mixture re,"Caled the for-
mation of a 10: I mixture of product diastcrcoisomcrs. 
The major diastereoisomcr 6 was isolated by column 
chromatography. In our previous work on the synthesis 
of the related compound 7, prepared by analogous 
chemistry. we wcre able to determine thc rclatr.·c stc--
reochcmistry by X-ray crystanography. In this present 
case we were unable to 0 btain suitable crystals for 
X·ray, ho,,"CVcr the absence of an NOE betwcrn the 
protons at positions 4 and 13a supports tbe proposed 
structure; one would not expect a change in product 
stereochcrnistry to be fa"'ourcd on simply introducing 
the remote protecting group in this current series. The 
stereochemical outcome of thi, cyelisation reaction can 
be rationalised using the same conformational model as 
previously proposed by our group for related cyelisa-
tions.6 The presence of an asymmetric centre next to the 
iminium carbon may also act to influence the fonnation 
of the new chind centre on cyclisation. If this were to be 
a contnbuting factor, onc can appreciate that the aro-
matic ring approaches the planar acyliminium interme-
diate from the direction of lcast stcrie hindrance. 
Rcmov-.I of the pendant hydroxymcthyl substitucnt 
(auxilia!}') from the tetracyclic product 6 was achieved 
by application of a three·step procedure (Scheme 3). 
Dcss-Martin pcriodinane oxidation of the primary 
aleohol proccrdcd in 93% yidd to prmide aldehyde S. 
We then employed our favoured Rh-<:atalyscd dccarh-
onylation protocol to access enamide 9 in 55% );eld; a 
smnll amount of target compound 10 (6%) '''is also 
producrd directly in this reaction. The auxiliary removal 
.... N .... N ~ .- §:: OCM,.78'C ~ M • M:qQ;: M. 0 63% P2". 13& 7 • 6 
[0.]0. + 56.1 (c. t.14, CHCl,) 1010-·69.' (c -1.22, CHCI,) 
Scheme 2. 
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(I) LI~HO 
--"--M'~ __ ~_H) __ M~ 0 LI""'(n 0 ~~~.~ 
a o ~ 10 
[Cl]O .·36.SI (c .i.tS,CHCI,) 
11, (o.Jo •• 26.t (c.1.1S.CHC~ 
Scbme J. Reagents and conditions: (i) Dcu-Martin rcriodinlne, DCM; (i~ Rh(PPh,MCO)CI. dJlPJ'. rnesitylc:ne, A, 4d.1)-s; (iii) H,:Il(1'1. Pd--C. 
F.tOH; (iv) dhykne glycot pT'SA (cal). toluene. A. 
sequence was complcted by catalytic hydrogenation of 
the crude mixture from the previous step to furnish the 
amidoketone 10 in 79% )idd. 
The formal asymmetric synthesis of (+)..Jemethoxyery. 
thratidinone, th. natural enantiomer, simply required 
rc-protection of the ketone functional group using eth-
ylene glycol as shO\,u in Scheme 3. Compound 11 has 
hecneonverted by others to the natural product a1bcit in 
racemic form by a four ... stcp sequence." 
12 13 
(aJo.· 55.7 (ca 1.13, CHC~ (a)o •• .30.6 (c a1.t3,CHas) 
[ab-' 21.7( •• 1.33, CHC~) 
The formal as)mmetric synthcsis of the unnatural 
enantiomer followed an identical s)uthetic route, 
beginning ho\ ... ·cvcr \\ith the cnantiomcric form of the 
original amino acid substrate to nea:ss the required lac-
tarn substrate 12, which had the opposite optical rotation 
"alue to that obtained for Iaetam 5.lntcrmediate J3 gave 
an optical rotation of +39.6, comparcd to -36.9 for 
compound 10. The enanlio.targct 14, gave an optical 
rotation of+21.7,comparcd to -26.1 for compound 11. 
To summarise, we report the first synthetic application 
of our recently developed asymmetric N-acvliminium 
Appendix 
cyclisation methodology. Our approach allows a facile 
and highly stereoselectiv. formal as)mmetric s)uthcsis 
of both enantiomers of th. alkaloid 3..Jcmcthoxyery. 
thratidinonc. 
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